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1 
Zhi Li 
 
Epidermal Notch1 recruits innate lymphoid cells to orchestrate normal skin 
repair 
 
Abstract  
Skin constitutes a barrier between our body and outside environment providing the 
first line defence against microbial infection. Epithelial repair and skin wound 
healing starts with inflammation to clear up invading pathogens and debris followed 
by cell proliferation and tissue remodelling. The immune response is vital for 
protecting the body from infection and diseases, however, it remains controversial 
whether the immune cells contribute to wound closure and tissue repair, or cause 
scarring and pathology. In this thesis, I investigate the role of Notch signalling in 
epithelial tissue repair. I demonstrate Notch1 signalling activation in epidermal 
keratinocytes following acute skin injury recruits innate lymphoid cells (i.e. ILC3s) 
to the site of injury in a TNF-α/CCL20-dependent mechanism and controls 
macrophage/monocyte recruitment via ILC3-dependent CCL3. Notch1 also induces 
epidermal production of IL23 which facilitates ILC3s to produce IL22 for re-
epithelialization and skin repair.  
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Chapter 1 Introduction 
1.1 Notch Signalling 
1.1.1 Background 
The Notch gene was first discovered 100 years ago in fruit fly, Drosophila 
Melanogaster (Dexter, 1914). Mutant Notch gene has a distinct phenotype of 
‘notched’ wing tips during embryonic development (Dexter, 1914). Since that first 
discovery, it has become clear that Notch, as an evolutionary conserved gene, plays a 
key role in a range of developmental processes (Bray 2006; Penton et al., 2012; Watt 
et al., 2008). However, the implication of Notch in human development and disease 
was not revealed until early 1990s when a gain-of-function mutation in human 
Notch1 gene was reported to cause T-cell acute lymphoblastic leukaemia (Ellisen et 
al., 1991). Since that first link to human diseases, mutations of Notch family genes 
have now been related to a wide spectrum of diseases and cancers (Louvi and 
Artavanis-Tsakonas, 2012; Penton et al., 2012). The aim of this thesis is to define the 
role of Notch in skin wound healing particularly in respect to the regulation of 
immune cell recruitment and function.  
 
1.1.2 Notch signalling facilitates cell-to-cell communication 
Notch signalling is named after Notch and is essential for communication and 
interaction between different cells expressing a Notch gene encoded receptor and its 
ligand respectively at cell surface (Chiba 2006, Fortini 2009; Musse et al., 2012). In 
mammals there are four Notch (receptors), Notch1-4, with similar protein structures 
(Figure 1.1) (Chiba 2006; Musse et al., 2012). In Golgi apparatus Notch protein 
precursor undergoes post translational modification involving two events: the S1 
cleavage (Figure 1.2) mediated by furin like convertase to form a heterodimer in  
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Figure 1.1 The structures of Notch receptors and ligands (Modified from Shigeru 
Chiba, 2006). There are 36 EGF-like repeats in Notch1 and Notch2, 34 repeats in 
Notch3, 29 repeats in Notch4, 16 repeats in Jagged1 and Jagged2, and 5-9 repeats in 
Delta1 and Delta4. LNR and HD form negative regulatory region (NRR). Ligand 
binding site is located in EGF-like repeats 11 and 12. ANK, ankyrin repeat; CR, 
cysteine-rich repeat; DSL, Delta-Serrate-Lag2 domain; EGF, epidermal growth 
factor; HD, heterodimerization domain; LNR, Lin12-Notch repeat; NLS, nuclear 
localization signal; PEST, rich in proline, aspartic acid, serine and threonine residues; 
PM, plasma membrane; RAM, RBP-Jk associated molecule; TAD, transactivation 
domain.  
 
 
 
 
 
 
 
Extracellular Intracellular Intracellular 
PDZ 
C-terminus N-terminus C-terminus 
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Figure 1.2 Cleavage sites in Notch receptor and its precursor (Adapted from 
Musse et al., 2012). Mature transmembrane Notch protein is a heterodimer formed 
by furin cleavage at S1 site between N-terminal HD (yellow) and C-terminal HD 
(green) in Notch extracellular domain during post translational modification.  
Metalloproteinase ADAM10 mediated cleavage S2 site is located within C-terminal 
HD and is buried deep by Notch NRR  (negative regulatory region) domain in which 
three Notch12-Lin repeats (NLR) (purple) are conformationally compacted and wrap 
over HD to keep Notch inactivated ‘OFF state’ in the absence of ligand. The S3 
cleavage occurs in Notch intra-membrane domain and requires the substrate 
produced by S2 cleavage. The ligand binding site containing EGF (epidermal growth 
factor) like repeats 11 and 12 is indicated in red.  
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which cleaved N-terminal and C-terminal fragments remain stably associated 
through multiple non-covalent interactions between their heterodimerization 
domains (HD) HD-N and HD-C, and Fringe N-acetylglucosamine transferase 
mediated glycosylation that regulates the intensity of Notch signalling through 
altering the Notch binding affinity for ligand (Chillakuri et al., 2012; Fortini 2009; 
Musse et al., 2012). Then mature Notch receptor is transported and tethered to cell 
membrane (Chillakui et al., 2012; Fortini 2009; Musse et al., 2012). Upon binding to 
one of its ligands through epidermal growth factor (EGF) like repeats 11 and 12 in 
Notch extracellular domain, Notch undergoes sequential S2 and S3 proteolysis 
cleavages mediated by metalloproteinase ADAM10 and γ-secretase respectively 
(Figure 1.2) (Musse et al., 2012). In unbound receptors, the S2 cleavage is blocked 
by highly compacted and folded Lin12-Notch repeats (LNRs) in Notch negative 
regulatory region (NRR) (Figure 1.2) (Musse et al., 2012). The ligand binding 
stimulates a conformational change in NRR to expose the S2 site to ADAM10-
mediated cleavage which then permits S3 cleavage within Notch intra-membrane 
domain by providing a substrate for the γ-secretase enzyme catalysis (Musse et al., 
2012; Watt et al., 2008). Following S3 cleavage, Notch intracellular domain (NICD) 
is subsequently released from cell membrane and translocated into nucleus where 
NICD interacts with a DNA binding protein, recombination signal sequence binding 
protein Jκ (RBP-Jκ, also known as CSL), and a co-activator, Mastermind-like 
(MAML), through its RBP-Jκ associated molecule (RAM) and ankyrin repeat (AKN) 
domain respectively (Figure1.1) to directly activate transcription of Notch target 
genes (Ambler and Watt, 2010; Chilarkuri et al., 2012; Iso et al., 2003; Watt et al., 
2008). Notch target genes typically include basic helix-loop-helix family, such as 
Hes and Hey genes which encode transcriptional factors that in turn influence cell 
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fate and differentiation (Guruharsha et al., 2012; Kageyama et al., 2007, Watt et al., 
2008). Similar to other short-life intracellular proteins, the turnover of the NICD is 
controlled by C-terminal PEST domain, rich in proline, aspartic acid, serine and 
threonine residues, which induces NICD degradation via ubiquitin/proteasome 
mechanism to stop Notch signalling when not in need (Chillakuri et al., 2012; 
Spencer et al., 2004).  
 
Similar to Notch receptors, canonical Notch ligands are also membrane-bound 
proteins containing EGF like repeats in the extracellular domain (Figure1.1). 
Adjacent to the EGF like repeats is Notch-binding site Delta-Serrate-Lag2 (DSL) 
region. The intracellular PDZ domain has a role in promoting cell adhesion and 
inhibiting cell motility (Chillakuri et al., 2012). Notch ligands are divided into two 
families namely Jagged (Jag, also known as Serrate) and Delta (also known as Delta 
like, DLL), which are distinguished from each other by the presence or absence of a 
cysteine rich (CR) domain (Figure 1.1). At least 5 Notch ligands, Jagged1, Jagged2, 
Delta1, Delta3 and Delta4 have been detected in mammals (Musse et al., 2012).  
 
Notch and its ligands are both bound to cell membrane, thus Notch is involved in 
cell-to-cell communication and interaction. The most pronounced function of this 
interaction is to regulate cell fate decision (Blanpain et al., 2006; Moriyama et al., 
2008; Watt et al., 2008). However, new evidence suggests that Notch controls 
expression and activities of growth factors and cytokines, such as tumor necrosis 
factor-α (TNF-α), which facilitates communication between different cell types 
beyond immediate contact, for instance between epithelial cells and immune cells 
(Ambler and Watt, 2010). Furthermore, recent studies have shown that Notch 
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activation up-regulates Jagged1 expression in signal-receiving cell via nuclear factor 
NKκB or P63 pathway, which in turn relay and amplify Notch signaling from cell to 
cell (Ambler and Watt, 2010; Foldi et al., 2010; Ross and Kadesch, 2004).  
 
In conclusion, Notch, as a family of evolutionary conserved gene, has been linked to 
a range of developmental processes and human diseases (Louvi and Artavanis-
Tsakonas, 2012). Notch signaling activation in Notch-expressing cells is dependent 
on ligand-induced NRR conformational change that permits a series of proteolysis 
cleavages in Notch extracellular domain and intra-membrane domain followed by 
release of NICD to activate transcription of target genes and a signaling cascade in 
nucleus (Chillakui et al., 2012; Musse et al., 2012). Notch and its ligands are both 
bound to cell membrane, thus Notch is involved in cell-to-cell communication and 
interaction. Notch also controls expression and activity of several growth factors and 
cytokines, such as TNF-α (Ambler and Watt, 2010). 
 
1.1.3 Ligand endocytosis is required for Notch receptor activation 
Similar to other membrane-bound proteins, the surface level of Notch receptors and 
ligands are maintained appropriately through ubiquitylation-dependent endocytotic 
degradation in order to prevent over-activation of Notch signaling (Weinmaster and 
Fischer, 2011).  In mammals, ubiquitin ligases Itch/AIP4 and Neur have been found 
to promote constant endocytosis of Notch receptor and ligand respectively 
(Chastagner et al., 2008; Lai et al., 2001). By contrast, recent studies have suggested 
particular ligand endocytosis is critically required for activating ligand-induced NRR 
conformational change rather than limiting Notch signaling (Chen et al., 2009; 
Nichols et al., 2007; Wang and Struhl, 2005).  They found either genetic ablation of 
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endosomal pathway components that are known to participate in ligand 
internalization, such as dynamin, epsin and clathrin, or deletion of ligand 
intracellular domain that contains ubiquitin ligase binding sites and nuclear 
localization signal, resulted in accumulation of ligands on cell surface as expected, 
but failure in sending a signal to Notch-expressing cells (Chen et al., 2009; Nichols 
et al., 2007; Wang and Struhl, 2005). This signaling-specific endocytosis of ligand is 
thought to be unique to Notch signaling (Weinmaster and Fischer, 2011) and 
requires a specific ubiquitin ligase Mib distinct from Neur which down-regulates 
surface ligand level through constitutive ligand endocytosis (Wang and Struhl, 2005). 
The underlying mechanism is not completely understood, however, two models 
involving ligand recycling and pulling force have been proposed in order to explain 
how ligand endocytosis in signal sending cells promotes Notch activation. 
 
The recycling model is based on the finding that recycling proteins such as Rab11 
and Sec15 which are known to promote membrane-bound protein to traffic back to 
cell surface through endocytosis and exocytosis have been detected in some ligand-
expressing cells and deletion of these recycling proteins in ligand cells led to failure 
in Notch activation (Emery et al., 2005; Jafar-Nejad et al., 2005). This model (Figure 
1.3) hypothesizes that the Notch ligand initially transported to cell membrane may 
not be able to physically bind to Notch receptor in an adjacent cell due to the poor 
position of ligand against receptor, therefore dislocation of ligand into a specific 
microdomain may be required through Rab11 and Sec15 dependent ligand recycling 
to juxtapose ligand to Notch receptor before they can bind to each other (Benhra et 
al., 2010; Musse et al., 2012; Rajan et al., 2009; Weinmaster and Fischer, 2011). 
However, this proposed recycling model may only apply to polarized cells such as  
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Figure 1.3 Recycling model for ligand endocytosis to activate Notch signaling 
(Reproduced from Musse et al, 2012). The recycling model proposes ligand initially 
delivered to the cell surface is ubiquitylated (Ub) by E3 ubiquitin ligase Mindbomb 
(Mib) alone in mammals or Mib together with Neurlized (Neur) in drosophila which 
facilitates interactions with the endocytic adapter epsin, GTPase dynamin and vesicle 
coating protein clathrin to promote ligand endocytosis. Following internalization, 
ligand enters recycling endosome and traffics back a cell surface microdomain which 
supplies a better position for ligand to bind Notch receptor in adjacent cell. 
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epithelial cells since Rab11 is not required to activate Notch signaling in some other 
types of cells (Windler and Bilder, 2010). It is also believed by some researchers that 
Notch ligand might require further processing through recycling to become a more 
competent ligand with higher binding affinity for Notch, however, such an active 
form of ligand has yet to be identified (Weinmaster and Fischer, 2011).  
 
In contrast, the pulling force model (Figure 1.4) proposes ligand-Notch binding 
alone may not be sufficient to induce NRR conformational change that relieves the 
repression of S2 cleavage, and additional force may be required to pull LNR away 
from HD. This mechanical force could be generated by ligand endocytosis, and 
could invaginate cell membrane and pull ligand back into signal-sending cell during 
endosome formation. Since the fringe-enhanced binding between Notch receptor and 
ligand is strong enough, this force may unfold, stretch and pull the whole ligand-
receptor complex towards signal-sending cell and thus expose S2 site for ADAM10-
mediated cleavage.  (Liu et al., 2010; Musse et al., 2012; Nichols et al., 2007; Parks 
et al., 2000; Weinmaster et al., 2011). This model was first raised by Parks et al. 
(2000) who detected co-localization of Delta and NECD in endosomes of Delta-
expressing drosophila imaginal disc cells. It was supported by a more recent study in 
which ligand with endocytic defects was still able to physically bind to Notch, but 
failed to induce Notch signaling (Gordon et al., 2008, Nichols et al., 2007).   
 
In summary, the surface level of Notch receptor and ligand and subsequent Notch 
activity are regulated by ubiquitylation-dependent constitutive endocytosis that 
induces protein degradation (Weinmaster and Fischer, 2011). Notch activation 
requires specific ligand endocytosis which may either dislocate ligand to a better  
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Figure 1.4 Pulling force model for ligand endocytosis and the downstream 
signaling after Notch activation (Adapted from Musse et al., 2012). Pulling force 
generated by endocytosis of Notch-bound ligand pulls the LNR modules (purple) 
away from HDs (yellow and green) to directly expose S2 site in N-terminal HD 
(green) (1). Alternatively, this force unfolds HD structure and induces HD physical 
dissociation thereby removing N-terminal fragment from intact Notch dimer prior to 
S2 cleavage (2). In both cases NRR domain is targeted to expose S2 site in the 
remaining membrane bound Notch receptor for ADAM10 cleavage which directly 
generates a substrate for γ-secretase S3 cleavage. After proteolysis NICD is released 
and translocated into nucleus to bind CSL (also known as RBP-Jk) and co-regulator 
MAML to activate transcription of target genes. 
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position for binding Notch or provide pulling force for inducing NRR 
conformational change (Musse et al, 2012). 
 
1.1.4 Anti-NRR1/ NRR2 blocking antibodies target individual Notch receptor 
 Since gain-of-function mutations in Notch receptor are implicated in a number of 
diseases and cancers, most notably T-cell acute lymphoblastic leukaemia, the current 
exploration of therapeutic drugs for altering Notch signaling is focusing on how to 
block Notch signaling, ideally to block activation of individual Notch receptor 
(Groth and Fortini, 2012). Researchers were formerly interested in γ-secretase 
inhibitor (GSI) which represses γ-secretase mediated events including the S3 
cleavage of Notch, since a small number of GSIs, such as LY450139 invented by Eli 
Lilly, had entered phase III clinical trial for treating Alzheimer’s Disease by 
preventing the proteolysis of amyloid precursor protein into pathogenic amyloid 
plaques (Lanz et al., 2006; Tolia and De Strooper, 2009). However, all of these GSIs 
resulted in serious gastrointestinal toxicity and immune system defects owning to 
pan-inhibition of all Notch receptors and possibly other γ-secretase-involved 
pathways (Groth and Fortini, 2012). More recently, the development by Genotech of 
individual Notch1 and Notch2 blocking antibodies, anti-NRR1 and anti-NRR2, are 
favoured and promising due to increased specificity and reduced side effects (Wu et 
al., 2010). These individual blocking antibodies stabilize the compacted 
conformation of NRR1 or NRR2 and maintain the ‘off’ status of Notch1 or Notch2 
even when they are bound to a ligand (Wu et al., 2010).  
 
In summary, Notch is involved in a range of developmental processes and human 
diseases through cell-to-cell interaction (Bray 2006; Louvi and Artavanis-Tsakonas, 
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2010; Penton et al., 2012). Notch activation requires ligand endocytosis-dependent 
NRR conformational change which permits proteolysis cleavages and subsequently 
releases NICD (Musse et al., 2012). This activated form of Notch then translocates 
into nucleus to activate target gene transcription and a signaling cascade that usually 
functions to regulate cell fate decision (Bray 2006). Notch also controls expression 
and activity of growth factors and cytokines, such as TNF-α (Ambler and Watt, 
2010). Recently, new therapy for blocking Notch signaling has been developed by 
using anti-NRR1 or anti-NRR2 antibody to target individual Notch1 or Notch2 
receptors with high specificity and reduced side effects (Wu et al., 2010).  
 
1.2 Skin 
1. 2.1  Background 
The outer surface of our body is covered by skin which is composed of epidermal 
epithelium tissue and underlying dermal connective tissue. Skin as a physical barrier 
provides first-line defence against chemical insults and microbial penetrance from 
outside environment, and prevents excess loss of water and water-soluble salts from 
inner body (Baroni et al., 2012; Fuchs, 2007). The skin color is rendered by 
melanocytes located in epidermis via releasing pigment granules to keratinocytes to 
help protect cell nucleus from ultraviolet radiation such as sunshine (Baroni et al., 
2012). The sense of touch and other sensations are provided by epidermal Merkel 
cells which are connected with enriched nervous endings in dermis (Baroni et al., 
2012).  The tensile strength of skin is supplied by dermal myofibroblasts which are 
differentiated from dermal fibroblasts to produce components of extracellular matrix 
(ECM) such as collagen and elastic fibres (Baroni et al., 2012). The nutrients are 
supplied by blood capillaries distributed in dermis. In this section, I will focus on the 
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development and maintenance of epidermal lineages, and the properties of epidermal 
barrier. 
 
1.2.2 Epidermis is a self-renewing stratified epithelium with multiple lineages 
Epidermis is a self-renewing stratified epithelium with multiple lineages including 
interfollicular epidermis (IFE) and its specialized appendages, such as hair follicles 
(HF) and associated sebaceous gland (SG) and sweat gland (Fuchs, 2007) (Figure 
1.5a). During embryogenesis these lineages are all differentiated from a single 
epithelium (Fuchs, 2007). Invagination and down-growth of regularly spaced 
epithelium form hair follicles which are in charge of producing hairs (Alonso and 
Fuchs, 2006; Fuchs, 2007). Inside hair follicles, sebaceous and sweat glands are 
developed for producing oil-filled sebocytes and sweat (Ambler and Määttä, 2009). 
The remaining epidermis, namely interfollicular epidermis, undergoes cornification 
and stratification into several layers populated by cells with differential status of 
differentiation to form a permeability barrier at body surface for tackling the 
potential risks of excess water loss and penetrance of microbes and chemicals from 
outside environment throughout postnatal life (Ambler and Määttä, 2009; Fuchs, 
2007; Segre, 2006).  
 
Once established epidermal lineages are physiologically maintained by their own 
epidermal stem cells or progenitor cells located in distinct compartments to supply 
the needed cells through proliferation followed by terminal differentiation (Ambler 
and Määttä, 2009; Fuchs, 2007; Fuchs, 2008; Lechler and Fuchs, 2005; Plikus et al., 
2012; Watt et al., 2006). The final products of terminal differentiation, such as hairs 
and corneocytes, undergo apoptosis after a limited lifespan and shed from our body  
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Figure 1.5 Epidermis is composed of hair follicles and interfollicular epidermis 
(Adapted from Plikus et al., 2012; Shimomura and Christinano, 2010) (a) Schematic 
diagram illustrating anagen hair follicle (HF), interfollicular epidermis (IFE) and 
distinct epidermal stem cell populations. (b) Hematoxylin and eosin staining of bulb 
portion of human anagen HF. Transient amplifying cells derived from the bulge stem 
cells migrate to the matrix region (orange arrows) through outer root sheath (ORS). 
The matrix cells then differentiate into hair shaft (HS) and inner root sheath (IRS) 
layers of the HF (white arrows). The bulge stem cell also has the potential to form 
IFE. 
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to maintain homeostasis of epidermis. 
 
The predominant cell type in interfollicular epidermis is keratinocytes which are 
continuously replenished by IFE stem cells or progenitor cells in basal layer in adult 
homeostatic epidermis (Figure 1.5a) (Ambler and Määttä, 2009; Fuchs, 2007; Ito et 
al., 2005; Levi et al., 2005; Plikus et al., 2012). The currently favoured model 
proposes a proliferation-active basal cell divides into two daughter cells, one of 
which remains as progenitor cell in basal layer while the other one proceed with 
further rounds of divisions as a transient amplifying progenitor before committing 
terminal differentiation (Ambler and Määttä, 2009; Fuchs et al., 2008; Plikus et al., 
2012; Watt et al., 2006). This terminal differentiation involves withdrawal from cell 
division cycle, detachment from basement membrane, move outwards through 
spinous layer, granular layer and cornified layer while switching gene expression and 
finally production of a keratin-filled dead keratinocyte (corneocyte) in cornified 
layer (Ambler and Määttä, 2009; Fuchs et al., 2008; Watt et al., 2006). In healthy 
adults, a homeostasis is achieved to maintain normal thickness and function of IFE, 
in which only a small proportion (around 15%) of basal cells (Blanpain et al., 2006) 
are active at a time to regularly replace the older keratinocytes in interfollicular 
epidermis, which takes 4 weeks in human throughout life, while the remaining basal 
cells are resting or quiescent (Ambler and Määttä, 2009; Segre, 2006; Watt et al., 
2008). However, a larger number and more variety of epidermal stem cells localized 
in interfollicular epidermis as well as in hair follicles (e.g. bulge, isthmus and 
junctional zone) (Figure 1.5a) will be activated for re-epithelialization under certain 
circumstances, e.g. post injury (Ambler and Määttä, 2009; Blanpain et al., 2006a; 
Plikus et al., 2012).  
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Adult hair follicle composes of three concentric layers, outer rooter sheath (ORS), 
inner rooter sheath (IRS) and the final product hair shaft (HS) (Figure 1.5b) (Pan et 
al., 2004; Shimomura and Christinano, 2010). Hair follicle stem or progenitor cells 
were first found in bulge area (Cotsarelis et al., 1990), a protruding structure in the 
upper portion of ORS that is contiguous with IFE basal layer (Ambler and Määttä, 
2009). Bulge progenitor cells produce transient amplifying cells that migrate to the 
matrix of HF through ORS and differentiate into IRS and HF (Ambler and Määttä, 
2009; Shimomura and Christinano, 2010). Recently, distinct hair follicle stem cell 
populations have also been found in other areas of hair follicles, e.g. isthmus and 
junctional zone (Plikus et al., 2012). Unlike IFE terminal differentiation which is 
continuous, existing hair follicles undergo cycles of growing  (anagen), repressing 
(catagen) and resting (telogen) phases, in which the upper portion of ORS including 
bulge is permanent while the rest of ORS and entire IRS and HS are degraded and 
replaced by new hair follicles (Alonso and Fuchs, 2006). Catagen is the transition 
from anagen to telogen, which is accompanied by skin color changes from the dark 
gray to black of anagen to pale pink by telogen in pigmented mice (Alonso and 
Fuchs, 2006). Catagen is very short, lasts only 3 or 4 days in mice, while anagen and 
telogen usually last 2 or 3 weeks (Alonso and Fuchs, 2006; Oh and Smart, 1996).  A 
collection of studies have suggested that the progenies of hair follicle stem cells also 
contribute to re-epithelialization of interfollicular epidermis by migrating towards 
the centre of the wounds (Ansell et al., 2011; Langton et al., 2008; Plikus et al., 
2012). Bulge stem cells from peri-wound hair follicles contribute to wound repair 
transiently in early stage particularly during anagen (Ansell et al., 2011; Ito et al., 
2005), while a long-term role of isthmus and junctional zone stem cells in providing 
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additional interfollicular epidermal cells during wound repair has been observed 
(Langton et al., 2008; Ito and Cotsarelis, 2008; Plikus et al., 2012). 
 
1.2.3 Epidermal barrier protects from penetrance of microbes 
The cornified layer of IFE constitutes the primary barrier of skin that prevents 
penetrance of microbes and water-soluble molecules (Figure 1.6) (Segre, 2006). In 
cornified layer, keratinocytes undergo profound changes in their cell structures 
including losing nucleus and organelles (Baroni et al., 2012). Subsequently, the 
entire intracellular space is filled by structure proteins, predominantly keratins, 
which are continuously synthesized by keratinocytes and accumulated in cytoplasm 
during terminal differentiation (Baroni et al., 2012). The abundant keratin filaments 
are encased and supported by cornified envelopes formed by the other structure 
proteins, which provide a durable stress-resistant framework for corneocytes (Baroni 
et al., 2012). The individual corneocytes are held together by lipids which are 
produced by keratinocytes, stored in lamellar bodies in spinous and granular layer 
and finally extruded into intercellular space in cornified layer (Baroni et al., 2012). 
As a consequence, the primary skin barrier is now built like a wall, with protein- 
enriched corneocytes resembling the bricks and lipid-enriched intercellular media 
mimicking the cements (Baroni et al., 2012; Fuchs, 2007, Segre, 2006)   
 
In addition to preventing microbial penetrance by acting as a physical barrier, 
epidermis constitutively expresses low level of antimicrobial peptides, such as β-
defensins-1, which directly inhibit colonization of a wide spectrum of microbes by 
disrupting their phospholipid bilayer membrane in a way similar to antibiotics 
(Afshar and Gallo, 2013; Niyangsaba et al., 2007). In normal skin in steady state,  
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Figure 1.6 Schematic diagram of human skin barrier (Adapted from Segre, 2006).  
Stratum corneum also known as cornified layer which is composed of keratin 
macrofibrils and cross-linked cornified envelopes encased in lipid bilayers at the 
outmost surface of interfollicular epidermis (IFE) provides the primary barrier, like a 
wall built by bricks and mortar. The granular cells held together by tight junctions 
also play an essential role in defence against physical trauma, invading pathogens 
and fluid loss.  
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keratinocytes are the main source of antimicrobial peptides which are packaged in 
lamellar bodies in spinous and granular layer, and extruded into intercellular media 
in cornified layer (Afshar and Gallo, 2013).  Upon breakage of epidermal barrier, 
keratinocytes also produce an array of inflammatory cytokines and growth factors, 
such as TNF-α, interferon-γ (IFN-γ) and interleukin-1(IL-1), which play a role in 
activating immune system (Afshar and Gallo, 2013). In this state, the task of 
antimicrobial peptide production is primarily fulfilled by immune cells such as 
neutrophils (Afshar and Gallo, 2013).  
 
1.2.4 Notch signaling in skin 
Notch signaling, as a key regulator for cell fate decision, is typically involved in 
epithelial stratification, epidermal homeostasis and lineage decision (Ambler and 
Watt, 2010; Nicolas et al., 2003; Okuyama et al., 2008; Watt et al., 2008). The 
presence of Notch receptor and ligand including Notch1-4, Jagged1, Jagged2 and 
Delta1has been well documented in developing as well as adult epidermis 
throughout human and mouse, with the exception of Notch4 which has only been 
reported in human in rare suprabasal cells and Delta1 which is rarely detectable in 
adult mouse (Favier et al., 2000; Nickoloff et al., 2002). Nevertheless, the sub-
locations of these Notch receptors and ligands are less clear and even contradicted 
among different studies (Ambler and Watt, 2010; Blanpain et al., 2006; Estrach et al., 
2006; Estrach et al., 2007; Moriyama et al., 2008; Nickoloff et al.., 2002; Pan et al., 
2004; Thelu et al., 2002). By validating the most consistent findings from these 
studies, Fiona Watt and her colleagues (2008) have drawn a diagram illustrating the 
expression pattern of Notch1-3 and Jagged1-2 in neonatal mouse IFE and HF 
(Figure 1.7). While the expressions of Notch1-3 are somewhat overlapping with 
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abundance in neonatal suprabasal cells, complementary location of Jagged1 and 
Jagged2 are detected with Jagged1 preferentially expressed in suprabasal cells and 
Jagged2 confined to basal cells (Ambler and Watt, 2010; Blanpain et al., 2006; 
Estrach et al., 2006; Estrach et al., 2007; Moriyama et al., 2008; Nickoloff et al.., 
2002; Pan et al., 2004; Thelu et al., 2002). Deletion of Notch1, Jagged1 or Delta1 
alone causes epidermal phenotypes in mouse while loss of Notch2, Notch3, Notch4 
or Jagged2 alone has no overt impact on epidermis, suggesting Notch1 and Jagged1 
are the primary Notch receptor and ligand that may play indispensable roles in adult 
epidermis while Delta1 is essential for epidermis development (Ambler and Watt, 
2010; Estrach et al., 2007; Kerabs et al., 2000; Kerabs et al., 2003; Pan et al., 2004; 
Watt et al., 2008).  
 
However, the presence of Notch receptor and ligand does not necessarily trigger an 
active Notch signaling which normally requires ligand endocytosis-dependent NRR 
conformational change (Musse et al., 2012). Notch signaling activity in mouse 
embryonic and neonate epidermis is then confirmed by the  presence of NICD and 
expression of Notch target gene Hes1 which are both abundant in suprabasal layer 
but also detectable in basal layer corresponding to the location of Notch1 and 
Jagged1 (Estrach et al., 2006; Moriyama et al., 2008). However, Notch activity 
seems to be rapidly decreased after birth  (during the first few weeks in mouse) and 
maintained at a low level throughout adult life, since the expression of Hes1 only 
detected in rare epidermal cells in older mice at age of 7 week old (Ambler and Watt, 
2010). The decrease in mouse epidermal Notch activity after birth might be related to 
the diminished expression of Delta1 (Powell et al., 1998). 
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Figure 1.7 Sites of Notch activity in interfollicular epidermis and hair follicles in 
neonatal mice (Adapted from Watt et al., 2008). (a) Schematic diagram illustrating 
the presence and location of Notch pathway components in neonatal interfollicular 
epidermis (IFE). CL: cornified layer; GL: granular layer; SL: spinous layer. (b) 
Schematic diagram illustrating the presence and location of Notch pathway 
components in hair follicles at anagen (growing stage). Hatched shading indicates 
co-expression.  
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To investigate the function of epidermal Notch signaling, a variety of genetically 
modified mouse models have been used to mimic either loss or gain of function of 
Notch signaling by ‘knocking out’ or ‘knocking in’ a sequence that encodes a key 
component of Notch pathway, such as NICD1, Hes1 or BRP-Jκ (Table 1.1) (Ambler 
and Watt, 2010; Blanpain et al., 2006; Estrach et al., 2006;  Moriyama et al., 2008; 
Nicolas et al., 2003; Rangarajan et al., 2001; Uyttendaele et al., 2004). In these 
models, Notch signaling is altered either completely throughout body or 
conditionally within epidermis under the control of epidermis-specific promoter such 
as the promoter of keratin14 (K14) etc. Most of these studies demonstrated loss of 
Notch function in IFE resulted in decrease in basal cell fate and increase in 
suprabasal fate while gain of Notch function led to increase in basal fate and increase 
in suprabasal fate, suggesting Notch signaling promotes constitutive differentiation 
of epidermal keratinocytes from basal cell into granular cell via spinous cell. 
However, differences were noted among different studies especially among 
individual gain-of-function models and between embryo and adult models, which 
could be explained by Notch non-cell autonomous effects on adjacent layer of 
epidermis due to altered Notch activity in a single layer (Rangarajan et al. 2001) or 
skin barrier defects in adult models as a secondary effect of Notch alteration 
(Blanpain et al., 2006b). In basal layer, Notch signaling promotes transition of basal 
cell into spinous cell by repressing basal cell-specific gene expression such as 
hemidesmosome component α6β4 integrin (Figure 1.8) (Blanpain et al., 2006b; 
Estrach et al., 2006; Moriyama et al., 2008) which associates basal cell with the 
underlying basement membrane while favouring spinous cell-specific gene 
expression such as K1 and K10 through a mechanism independent of Hes1 
(Moriyama et al., 2008). In spinous layer, Notch signaling plays an essential role in 
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Table 1.1 Consequences of modulation of Notch signaling in epidermis. Arrow 
upward indicates increase; arrow downward indicates decrease. The number of 
arrows indicates the extent of the change. Horizontal line indicates no obvious 
change. UD represents undetermined.  
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homeostasis of spinous cells by maintaining spinous fate in a manner dependent on 
Hes1 while promoting transition of spinous cell into granular cell though 
upregulation of another Notch/BRP-Jk target gene Ascl2 (Moriyama et al., 2008). 
However, expression of Ascl2 gene is repressed in the presence of Hes1, thus the 
induction of granular fate in spinous cell only occurs when Hes1 is down-regulated 
probably by an auto-regulatory feedback loop (Moriyama et al., 2008).  Since either 
ectopic activating or blocking Notch signaling  causes abnormal differentiation of 
epidermis, epidermal barrier disruption may eventually occur as a side effect of 
Notch modulation (Ambler and Watt, 2010; Blanpain et al., 2006) making the 
analysis of Notch signaling function much more complicated .     
 
In addition to promoting terminal differentiation, Notch signaling also plays a role in 
regulating IFE proliferation through a mechanism which is less clear. Two separate 
studies reported that deletion of Notch1 promoted epidermal proliferation in adult 
mice through down-regulation of p21 expression which is known to induce cell 
growth arrest, suggesting Notch signaling might repress proliferation by directly 
activating transcription of p21 as a target gene (Nicolas et al., 2003; Rangarajan et al., 
2001). By contrast, a couple of studies found loss of Notch activity by deleting Hes-
1 or RBP-Jk resulted in reduced rather than increased epidermal proliferation in 
mouse embryos. Furthermore, they found such thinned hypo-proliferated epidermis 
experienced thickening and hyper-proliferation after several weeks of grafting into 
conditional RBP-Jκ or NICD1 knockout adult mice (Blanpain et al., 2006; Moriyama 
et al., 2008). Blanpain et al. (2006) and Rangarajan et al. (2001) suggested the 
distinct proliferation phenotypes observed between embryos or neonates and adults 
might be related to epidermal barrier disruption which usually causes a secondary 
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Figure 1.8 The role of Notch signaling in regulating epidermal homeostasis 
(Adapted from Blanpain et al., 2006; Moriyama et al., 2008). (a) Schematic diagram 
illustrating the role of Notch signaling in regulation of normal IFE differentiation 
and proliferation. Canonical Notch signaling (Notch/RBP-Jk) promotes basal cell 
detachment from underlying basement membrane and differentiation into spinous 
cell by repressing basal cell genes such as α6, β4 integrin and Keratin (K) 14 while 
inducing spinous cell genes such as K1 and K10 via a mechanism independent of 
Hes1. Then Notch signaling plays an essential role in maintenance of spinous fate 
and repressing transition in a manner dependent on Hes1. On the other hand, Notch 
signaling also promotes spinous cells transition into granular cells by directly 
activating Ascl2 gene expression. However, Ascl2 promoter is repressed in the 
presence of Hes1, thus the induction of granular differentiation will not occur until 
Hes1 is down-regulated in spinous layer probably by an auto-regulatory feedback 
loop. In addition, non-cell-autonomous Notch signaling from spinous cells may 
promote proliferation of basal cells probably via upregulation of p63 (Moriyama et 
al., 2008). (b) Schematic diagram illustrating Notch signaling regulates hair follicle 
maintenance by repressing the fate decision of bi-potential bulge stem cells into IFE 
(interfollicular epidermis) and promoting IRS (inner rooter sheath) differentiation 
and maturation. ORS, outer root sheath (Blanpain et al., 2006). 
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hyper-proliferation response. Moreover, Moriyama et al. (2008) suggested that a 
non-cell-autonomous Notch signaling sent by spinous cells might be constitutively 
activated in basal cells, the major population possessing proliferation potential in 
epidermis, as a result of differential levels of Notch activity between these two cell 
populations to contribute to basal cell proliferation possibly via upregulation of p63 
(Moriyama et al., 2008). Whereas, ectopic induction of NICD1 specifically in basal 
cells was sufficient to drive basal cell proliferation, suggesting epidermal 
proliferation might be independent of non-cell-autonomous Notch signaling sent by 
spinous cells (Ambler and Watt, 2010; Blanpain et al., 2006; Estrach et al., 2006). 
Although epidermal barrier defects could contribute to hyper-proliferation in 
postnatal epidermis, this increased proliferation phenotype was also detected in 
neonates with ectopic NICD1 induction suggesting a direct role of Notch signaling 
for promoting proliferation (Blanpain et al., 2006). Furthermore, it has been 
suggested that Notch signaling plays this role through a mechanism dependent of 
Jagged1, since deletion of Jagged1 eliminates the hyper-proliferation phenotype in 
K14NICDER mice with ectopic induction of NICD1 (Ambler and Watt, 2010). 
However, it is still unknown how Notch, via Jagged 1, directs keratinocytes to 
proliferate.   
 
Notch signaling also plays a direct role in regulating the terminal differentiation of 
IRS and/or HF and maintaining the existing hair follicle lineages by repressing the 
transition of bi-potential bulge progenitor cells into IFE fate (Ambler and Watt, 2010; 
Blanpain et al., 2006b; Estrach et al., 2006; Lin et al., 2000; Pan et al., 2004). 
However, Notch signaling is not capable to induce new hair follicle generation 
(Estrach et al., 2006).  
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In summary, skin is composed of epidermis and dermis, which are connected to each 
other via basement membrane. Adult epidermis is a self-renewing stratified 
epithelium with multiple lineages including IFE and its associated specialized 
appendages such as HF (Fuchs, 2007). IFE and HF are maintained by their own 
progenitor cells located in basal layer and outer root sheet through homeostasis and 
hair cycles respectively (Ambler and Määttä, 2009). The terminally differentiated 
cornified layer constitutes the primary skin barrier that prevents the penetrance of 
microbes and other insults (Baroni et al., 2012; Segre, 2006). The predominant 
epidermal cell type keratinocyte also secretes antimicrobial peptides to prevent 
microbe colonization in steady state and produce a range of inflammatory cytokines 
upon barrier disruption and microbial infection (Baroni et al., 2012). Notch signaling 
plays an essential role in maintaining homeostasis of epidermis by controlling the 
fate decision of HF bulge progenitor cells towards HF lineage, promoting terminal 
differentiation of both IFE and HF though cell-autonomous and non-cell-
autonomous effects (Blanpain et al., 2006b; Moriyama et al., 2008). Notch also plays 
a role in epidermal proliferation through a mechanism that is less clear (Ambler and 
Watt, 2010; Estrach et al., 2006).  
 
1.3 Immune system in skin 
1.3.1 Background 
Although skin keratinocytes constitute a physical barrier that provides first-line 
defence against pathogen invasion and secretes antimicrobial peptides that have a 
direct role in killing microbes (Baroni et al., 2012), these mechanisms may not be 
sufficient to prevent microbial infection especially when epidermal barrier is broken 
by injury. In that case, a variety of immune cells, also known as white blood cells or 
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leukocytes, are recruited into skin through dermal blood capillaries and activated by 
inflammatory cytokines leading to inflammatory response against different sorts of 
infections, damages or host cell pathogenesis (e.g. tumorigenesis) (Delves et al., 
2011). A number of immune cells are also present in skin as sentinels in steady state 
to provide immune surveillance (Nestle and Nickoloff, 2007). In this section, origin, 
location and classification of major types of immune cells circulating in blood 
vessels as well as residing in skin will be reviewed. Then the role of Notch signaling 
in immune system will be discussed. 
 
1.3.2 Origin, location and classification of immune cells 
In adults, immune cells are derived from self-renewing hematopoietic stem cell 
(HSC) in bone marrow (Figure 1.9) and released into blood circulation to patrol the 
whole body (Delves et al., 2011). However, macrophages and myeloid dendritic cells 
are localized and matured in peripheral tissues only and share a common blood 
circulating progenitor called monocytes in inflamed state (Merad et al., 2013). 
Thymus-derived lymphocytes (T cells) require further processing and development 
in thymus before joining circulation (Blum et al., 2013).  While bone marrow and 
thymus constitutes the primary lymphoid tissue which produce immune cells, the 
battlefronts of immunological defences are usually localized in spleen and lymph 
nodes spreading throughout the body, called secondary lymphoid tissues which are 
loaded and formed by massive immune cells (Delves et al., 2011). In addition, a 
number of immune cells are also accumulated in steady state in certain non-
lymphoid tissues such as epithelial tissues at the body surface (e.g.  skin, intestine 
and lung) (Table 1.2) where the risk of pathogen insults is higher than the other 
tissues  (Dupasquier et al., 2004; Luci et al., 2009; Macleod and Havran., 2011; 
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Figure 1.9 The vast majority of immune cells are derived from bone marrow 
hematopoietic stem cell in the presence of different soluble cytokines and 
growth factors (Adapted from Delves et al., 2011). SCF, stem cell factor; HSC, 
hematopoietic stem cell; Flt3L, FMS-like tyrosine kinase-3 ligand; TPO, 
thrombopoietin; IL, interleukin; CMP, common myeloid precursor; CLP, common 
lymphoid precursor; EPO, erythropoietin; GM-CSF, granulocyte–macrophage 
colony-stimulating factor; EB, erythroblast; MKC, megakaryocyte; MP,  monocyte 
progenitor; GP, granulocyte progenitor; M-CSF, monocyte colony-stimulating factor; 
G-CSF, granulocyte colony-stimulating factor; RBC, red blood cell; Plt, platelet; 
mDC, myeloid dendritic cell; Mϕ, macrophage; Neutro, neutrophil; Eosino, 
eosinophil; Baso, basophil; NK, natural killer;  pDC, plasmacytoid dendritic cell. 
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Table 1.2 Phenotypes and functions of immune cells residing in mouse skin in 
steady state. UD, undetermined. 
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Romani et al., 2010; Stone et al., 2009; Sumaria et al., 2011).   
 
Depending on their differentiation pathways, immune cells are broadly classified 
into two families, lymphoid cells which includes T cells, B cells and NK cells, and 
myeloid cells which are subdivided into monocytes (including macrophages and 
most dendritic cells), granulocytes (including neutrophils, eosinophils and basophils) 
and mast cells (Delves et al., 2011).  The majority of myeloid cells, NK cells and a 
small number (less than 5% of total circulating T cells) of T cells (γδ T cell) bearing 
γ and δ chains in their T cell receptor (TCRγδ) participate in rapid innate immune 
response by directly recognizing pathogens, infected cells or damaged cells 
(Dupasquier et al., 2004; Luci et al., 2009; Macleod and Havran., 2011; Romani et 
al., 2010; Stone et al., 2010; Sumaria et al., 2011). Conventional T cells (αβ T cells) 
and B cells participate in adaptive immune response by producing specific cytotoxic 
T cells and antibody respectively for adapting to a particular antigen processed and 
presented by professional antigen presenting cells (i.e. dendritic cells) or stressed 
host cells (non-professional antigen presenting cells) (Blum et al., 2013; Delves et al., 
2011). Compared to rapid innate immune response, adaptive immune response 
allows time for antigen presentation (Blum et al., 2013; Delves et al., 2011). 
However, adaptive system has long-lasting memory which allows it to be prepared 
for the next threat event by the microbe bearing the same antigen (Mueller et al., 
2013). 
 
1.3.3 Major circulating immune cells accessible to skin 
To confront the risk of microbial infection, a variety of circulating immune cells are  
recruited into the site of pathogen invasion or damage in dermis through blood 
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capillaries and activated to perform innate or adaptive immune reactions against 
different sorts of threats. The roles of immune cells are conserved throughout human 
and mammals, however, the phenotypes (i.e. the cell surface markers) can be slightly 
different (Delves et al., 2011; Mestas and Hughes, 2004). Here, I use mouse model 
to review the immune system.  
 
Neutrophils (CD11b
+
F4/80
-
Gr1
+
) and inflammatory monocyte (CD11b
+
F4/80
+
Gr1
+
) 
-derived macrophages (CD11b
+
F4/80
+
Gr1
-
), which are known as professional 
phagocytes, are the key players of innate immune system defending against bacteria, 
fungi as well as cell damage (Amulic et al., 2012; Wynn and Barron, 2010). They, 
via a range of cell surface pattern recognition receptor (PRRs) such as Toll-like 
receptor, recognize a highly conserved component either present in common 
infectious agents called pathogen associated molecular pattern (PAMP) or released 
by necrotic host cells undergoing uncontrolled death upon severe damage (danger 
associated molecular pattern, DAMP) (Amulic et al., 2012; Delves et al., 2011; 
Dupasquier et al., 2004). Upon recognition of a PAMP or DAMP, the pathogens or 
necrotic cells displaying the same PAMP or DAMP are engulfed by these 
professional phagocytes followed by intracellular digestion via destructive enzyme, 
chemicals or radicals (Delves et al., 2011; Dupasquier et al., 2004). Compared to 
neutrophils, macrophages are more powerful in phagocytosis, they can engulf 
apoptotic cells undergoing natural or programmed death, such as short-life 
neutrophils (Wynn and Barron, 2010). 
 
The minority of granulocytes, such as basophils and eosinophils, are often involved 
in innate immune defence against parasites which are too large to be engulfed by 
 
54 
professional phagocytes and thus require membrane lysis mediated by basophils and 
eosinophils before phagocytosis can take place (Stone et al., 2010).  
 
NK cells (CD3
-
NKp46
+
NK1.1
+
) play a key role in innate killing of virally infected 
host cells as well as host cells committed to undergo tumorigenesis (Cameron et al., 
2002; Delves et al., 2011; Luci et al., 2009). Although macrophages are the powerful 
phagocytes to engulf bacteria, fungi and damaged cells, they are not capable to target 
viruses, since viruses live inside host cells and use host ribosomes to replicate 
themselves, the recognition of PAMP or DAMP from these viruses is hindered by 
the intact host cell membrane (Delves et al., 2011; Luci et al., 2009). In that case, the 
recognition of abnormal host cells is performed by NK cells which detect missing or 
reduced expression of MHC-I that is normally expressed by all nucleated host cells, 
or MHC-related molecules (non-classical MHC) which is expressed by certain 
stressed cell types such as epithelial cells to convey a danger signal and thus allow 
themselves to be recognized (Delves et al., 2011; Luci et al., 2009). Following 
recognition, NK cells then induce apoptosis (assisted suicide) of these abnormal cells 
via releasing cytotoxic granules or activating death receptor in host cells, and 
produce interferon-γ (IFN-γ)that directly inhibit viral replication (Delves et al., 2011; 
Luci et al., 2009). Dead cells are finally engulfed and cleared by macrophages 
(Delves et al., 2011; Luci et al., 2009; Wynn and Barron, 2010). A small number of 
T cells called NK-like T cells (NKT cells, CD3
+
NK1.1
+
NKp46
+
) have the similar 
properties of NK cells, and plays a role in innate immune system (Cameron et al., 
2002; Delves et al., 2011). 
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Dendritic cells (most of them are CD11c
high
) are the major type of so called 
professional antigen presenting cells which also include macrophages and B cells, 
which activate adaptive immune response (Blum et al., 2012; Kushwah and Hu, 
2011; Merad et al., 2013). They can capture specific protein structures called 
antigens from outside pathogens followed by internalizing and processing these 
antigens and expressing the antigen peptides on their cell surface MHC-II, which 
allows the pathogen fragments to be recognized by CD4+ T cells (Blum et al., 2012; 
Dupasquier et al., 2004; Kushwah and Hu, 2011; Merad et al., 2013). Compared to 
macrophages, dendritic cells have limited capacity to directly kill the pathogen they 
have phagocytosed (Kushwah and Hu, 2011; Merad et al., 2013). However, 
pathogen-encountered dendritic cells are competent to activate adaptive immune 
system by migrating to the nearest lymph node and present an antigen derived from 
the pathogen to CD4
+
 T cells (Kushwah and Hu, 2011; Merad et al., 2013).  
 
Conventional T and B lymphocytes mediate antigen-specific adaptive immune 
response (Delves et al., 2011). Under inflamed state, B cells undergo clonal 
expansion and differentiation into effector plasma cell to produce an antibody that 
specifically target pathogens displaying a particular antigen. Naive CD8
+
 T cells 
induce apoptosis of infected cells expressing a foreign antigen via differentiation into 
effector cytotoxic T cell (Tc), while naive CD4
+ 
T cell differentiates into various 
subsets of  helper T cell (Th) to facilitate co-activation of B cell and enhance 
intracellular killing by macrophages and Tc (Delves et al., 2011; Zhu et al., 2011).  
This antigen-specific defence usually takes place 4-5 days later (Delves et al., 2011) 
than innate immune response because activation of conventional T and B cells is 
dependent on antigen presentation. Naive CD4
+
 or CD8
+
 T cells cannot recognize 
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antigen through T cell receptor (TCR) until antigen-derived peptide is expressed by 
professional APC, predominantly dendritic cells, via MHC-II or by viral infected 
cells via MHC-I (Zhu et al., 2011). B cells directly recognize extracellular antigen 
through B cell receptor (BCR), but antibody cannot be produced until B cell presents 
this antigen, via MHC-II, to a particular Th cell which has been encountered by the 
same antigen (Delves et al., 2011; Zhu et al., 2011). As a consequence, the 
extracellular pathogens which have not been phagocytosed by macrophage-
predominant innate immune system are targeted by B cell-mediated humoral 
immunity. The intracellular pathogens which have been phagocytosed but not been 
killed by macrophages and those pathogens living and replicating within the host 
cells which have not been targeted by NK cells are challenged by Tc cell mediated 
cytotoxicity (Delves et al., 2011; Zhu et al., 2010).  
 
1.3.4 Entry of circulating immune cells into dermis 
The motility and recruitment of circulating immune cells are regulated by a family of 
specialized message protein called chemokines, such as CCL and CXCL families, 
that attract immune cells bearing a corresponding chemokine receptor from adjacent 
tissue or blood circulation into the inflamed site (Dupasquier et al., 2004; Henri et al., 
2009). The penetrance of immune cells though blood vascular wall is mainly 
facilitated by mast cells which release mediators such as histamine to increase 
vascular permeability (Stone et al., 2010). After entering dermis, the clonal 
expansion and activity of these migratory immune cells are activated by another 
family of message proteins called cytokines such as interleukins (IL) and TNF that 
function over a shorter range. Then the activated immune cells can in turn, via NFκB 
pathway, produce their own cytokines and growth factors that influence the activity 
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of the other immune cells as well as non-immune cells nearby with an appropriate 
receptor (Delves et al., 2011; Dupasquier et al., 2004; Henri et al., 2009). As a 
consequence, the extra cells and fluids gathered at the site of infection or cell 
damage result in a so called inflammation reaction which is featured by swelling, 
redness and heating of local tissue (Delves et al., 2011).  
 
1.3.5 Skin resident immune sentinels 
In steady state, skin is constantly populated by a number of immune cells which 
provide immune surveillance by watching the signs for pathogen insults and cell 
damages, and produce cytokines that amplify inflammatory response by activating 
and attracting blood-circulating immune cells. These skin resident immune sentinels 
mainly include most common innate immune cells such as macrophages, dendritic 
cells, NK cells, mast cells  (Dupasquier et al., 2004; Luci et al., 2009) as well as 
those which are seeded in skin particularly in epidermis very early during fetal 
development with a long lifespan and thus are thought to be absent or rare in blood 
circulation, such as Langerhans cells (LCs, CD207
+
CD11c
low
) and dendritic 
epidermal T cells (DETCs, CD3
+TCRγδ+Vγ3+) (Macleod and Havran., 2011; Merad 
et al., 2013). Langerhans cells are classified as a particular subset of dendritic cells 
participating in antigen presentation. In contrast to conventional DCs which are 
characterized by high expression of CD11c integrin and replenished by blood 
circulating monocytes, LCs express low level of CD11c and are primarily produced 
in sac yolk and fetal liver and maintained by local proliferation (Merad et al., 2013). 
DETCs belong to a rare subset of T cells (γδ T cells) bearing TCR γδ chains, distinct 
from the majority (95%) of circulating T cells) of T cells which express TCR αβ 
chains (Delves et al., 2011). DETCs are only present in rodent epidermis where they 
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produce keratinocyte growth factor (KGF), insulin-like growth factor-1 (IGF-1) and 
hyaluronan in response to damaged keratinocytes, which protects epidermal barrier 
integrity by promoting keratinotye proliferation and recruits macrophages to the site 
of damage respectively (Bolleville, 2012; Macleod and Havran., 2011). Recently γδ 
T cells have also been detected in steady state dermis where they produce IL-17 that 
plays a role in neutrophils (Sumaria et al., 2011). In contrast to αβ T cells, γδ T cells 
directly recognize antigen or non-classical MHC molecules expressed by stressed 
and damaged host cells without a requirement of antigen presentation (Zhu et al., 
2010). Therefore, γδ T cells usually do not express CD4 or CD8 which acts as co-
receptor for antigen within the context of MHC-II or MHC-I (Delves et al., 2011).  
 
1.3.6 Notch signaling in skin immune system 
Notch signaling, as key regulator of cell fate decision in a range of developmental 
process, also plays a role in the development of immune system. Notch1 signaling 
controls thymic T-cell maturation (Izon et al., 2001) and Notch2 signaling maintains 
splenic marginal zone B cells (Saito et al., 2003). However, new evidence suggests 
Notch signaling may play a role for epidermal keratinocytes to contact immune cells 
(Ambler and Watt., 2010; Estrach et al., 2006). In their studies, Notch activation by 
inducing ectopic NICD1 in epidermal keratinocytes resulted in epidermal production 
of inflammatory cytokines such as TNFα and dermal accumulation of CD4+ immune 
cells via a mechanism dependent on epidermal Jagged1 expression (Ambler and 
Watt., 2010; Estrach et al., 2006). Although the role of Jagged1 in downstream 
Notch signaling is less clear, other studies have suggested Jagged1 as a target gene 
of BRP-Jκ (Foldi et al., 2011), may relays and amplifies Notch signaling from cell to 
cell, which seems to be consistent to these studies.  
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In summary, immune system provides professional defence against various insults 
such as bacteria, fungi, viruses as well as abnormal host cells (Delves et al., 2011). 
The majority of immune cells are circulating throughout body via blood vessels, 
lymph vessels and lymphoid organs, such as spleen and lymph nodes, to provide 
immune surveillance (Delves et al., 2011). Some immune cells such as LC and 
DETCs (specific to rodents) are exclusively residing in epithelial epidermis to play a 
role in local immunity (Macleod and Havran, 2011; Merad et al., 2013; Nestle and 
Nickoloff, 2007). Under the inflamed state, a variety of circulating immune cells are 
recruited into skin especially dermis by chemokines and activated by cytokines to 
perform innate and adaptive immune response via direct killing and producing 
cytokines to amplify the inflammation (Delves et al., 2011). Notch signaling plays a 
role in regulating the development of immune system as well as the recruitment of 
immune cells into dermis via TNF-α (Ambler and Watt, 2010; Estrach et al., 2006; 
Izon et al., 2001; Saito et al., 2003).  
 
1.4 Skin wound healing  
1.4.1 Background 
Wound healing in epithelial tissue is a sequential process which is initiated by 
immune cell mediated inflammation to clear wound of any damaged cells, debris and 
microbes (inflammation phase), followed by epidermal proliferation and dermal 
extracellular matrix deposition to close the wound (proliferation phase), and finished 
with remodelling of dermal tissue and resolution of excessive extracellular matrix to 
restore the normal structure and function of skin (remodelling phase) (Figure 1.10). 
These events are co-ordinated in terms of timing, duration and intensity in order to 
keep the repair progressing and maintain an equilibrium between tissue synthesis and 
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degradation (Guo and DiPitro, 2010; Martin and Leibovich, 2005; Rodero and 
Khosrotehrani, 2010).  In this section, wound healing mechanism and the role of 
immune system and Notch signaling in wound closure will be reviewed.  
 
1.4.2 Mechanism of wound healing 
In wounded area, the normal skin structures are completely lost leaving dermal blood 
capillaries with open ends (Martin et al., 2005). However, blood loss is rapidly 
ceased by a platelet-composed blood plug which is then stabilized by fibrin fibers 
converted from fibrinogen (Figure 1.10) (Rodero and Khosrotehrani, 2010). Skin 
injury also directly induces damage and stress to the local cells at the wound edge by 
exposing the skin and inner body to potential pathogens in the environment. Stressed 
keratinocytes produce antimicrobial peptides and inflammatory cytokines such as 
TNF-α (Grone, 2002). In the meanwhile, the skin resident immune sentinels which 
are already present at the time of injury are activated to clear the dead cells, cellular 
debris and any invading pathogens and produce pro-inflammatory cytokines, 
chemokines and antimicrobial peptides. The cytokines and chemokines produced by 
stressed keratinocytes as well as skin resident immune cells amplify the 
inflammatory reaction by attracting and activating more immune cells into wound 
site through dilated blood vessels with the help of skin resident mast cells. 
Neutrophils are the first cells recruited into wound site with a very short lifespan, 
while monocyte-derived macrophages become the predominant cell type from 
approximately day 2 post injury to intensively phagocytose wound debris, microbes 
and apoptotic neutrophils (Rodero and Khosrotehrani, 2010). The adaptive immune 
cells such as conventional T cells and B cells are thought not to be significantly 
involved in inflammation phase in acute wound healing (Stout, 2010), probably 
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Figure 1.10 Schematics of normal skin wound healing (Modified from Martin and 
Leibovich, 2005). (a) Normal skin consists of epidermal barrier and underlying 
dermis enriched with capillary blood vessels. (b) Physical injury causes disruption of 
epidermal barrier and damage of dermis. Platelets are immediately activated and 
aggregated to prevent blood loss. Massive immune cells from adjacent dermis and 
from circulating blood vessels are recruited into wound site to promote a protective 
inflammatory response to clear damaged cells and invading microbes. (c) Fibrin clot 
is formed to cover the wound edge and (d) serve as a matrix that allows 
keratinocytes proliferation and migration along its undersurface to close the wound.  
Dermis undergoes massive angiogenesis and deposition of extracellular matrix 
(dermal scar) that gradually replaces the fibrin clot. (e) When the epidermis has 
healed over the exposed wound, dermis undergoes remodelling involving resolution 
of vascular sprouting and dermal scar to restore tissue strength.   
(a) (b) 
(c) (d) (e) 
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because the defence against common environmental pathogens do not require 
antigen-specific response. 
 
The later stage of inflammation phase is overlapped with proliferation phase where 
fibrin clot acts as a scaffold for keratinocytes at the wound edge to proliferate and 
migrate along the undersurface of fibrin clot to bridge the gap between wound edges 
(Martin and Leibovich, 2005).  In wound dermis, a large number of fibroblasts from 
adjacent dermis and derived from circulating fibrocytes are accumulated to form so 
called granulation tissues with macrophages to promote dermal extracellular matrix 
deposition and wound contraction as well as inflammation. In these specialized 
granulation tissues,  massive blood vessels are generated to supply cytokines, growth 
factors as well as nutrients to tissue repair, some fibroblasts are converted to 
myofibroblasts which synthesize extracellular matrix components  such as collagens,  
contract wound edges and drawing up wound bed thereby promoting wound closure 
(Rodero and Khosrotehrani, 2010).  
 
Subsequently, wound is closed when keratinocytes migrated from wound edges 
confront and adhere to one another. Whereas, wound dermis, which is largely 
composed of granulation tissues and collagen scar, requires remodeling to replace 
collagen-producing granulation tissue and restore the normal structure and tensile. 
This remodeling could last for years involving apoptosis of myofibroblasts, vascular 
endothelial cells and macrophages, degradation of excessive extracellular matrix via 
metalloproteinases which are expressed by epidermal cells, fibroblasts and remaining 
macrophages (Guo and DiPietro, 2010). However, it is not always possible to restore 
adult skin to its pre-injury state and scar formation usually occurs as a common 
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result of adult wound healing, although incisional fetal wound may heal perfectly 
without scar (Guo and DiPietro, 2010).  
 
1.4.3 The role of immune cells in wound closure 
The three phases of wound healing are coordinated and occur in an order. 
Inflammation  phase is typically mediated by immune cells that protect host body 
from infection and clear wound of damaged cells and debris, proliferation phase 
contributes to wound closure, while remodeling phase replace dermal scar with 
normal skin structure. However, inflammation must be self-sustained once pathogen 
infection and wound clearance is under control to allow proliferation phase to 
proceed. Therefore, the entry and exit of inflammatory immune cells in appropriate 
timing are equally important for wound closure (Guo and DiPitro, 2010; Martin and 
Leibovich, 2005; Rodero and Khosrotehrani, 2010). Macrophages have long been 
considered the key regulator for wound healing, since they not only act as a 
predominant type of inflammatory cells (M1 macrophage) in inflammation phase, 
but also are involved in proliferation phase (M2 macrophage) as well as remodeling 
phase, following being activated by different pathways (Rodero and Khosrotehrani, 
2010).  
As a main type of professional phagocyte, macrophages are recruited into wound site 
following neutrophils and become the predominant immune cells present in the 
wound approximately from day 2 post injuries (Rodero and Khosrotehrani, 2010). In 
the initial inflammation phase, the majority of macrophages are classically activated 
by interferon-γ (IFN-γ) (M1 macrophages)  to perform extensive phagocytosis to 
clear wound of any debris including the short-life neutrophils and secrete pro-
inflammatory cytokines such as TNF-α, IL-1β, IL-6 (Rodero and Khosrotehrani, 
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2010). During later inflammation phase and proliferation phase, the functional 
phenotypes of macrophages are converted (M2) to promote granulation tissue 
formation angiogenesis, collagen synthesis, ECM deposition and wound contraction 
through producing transforming growth factor β (TGFβ) (Rodero and Khosrotehrani, 
2010). These macrophages displaying M2 phenotypes are thought to be alternatively 
activated by IL-4 or IL-13 (Martin and Leibovich, 2005; Rodero and Khosrotehrani, 
2010). As the main source of TGF-β that activates dermal myofibroblast 
differentiation, which in turn switches on collagen production to generate 
extracellular matrix, macrophages have also been considered as a key contributor to 
fibrosis and scarring formation especially when inflammation is persistent or 
repeated (Wynn and Barron, 2010). However, the issue of fibrotic and scarring 
wound healing is beyond the focus of this thesis. In remodeling phase, macrophages 
undergo apoptosis and remaining macrophages play a minor role in promoting 
degradation of excessive extracellular matrix via directly producing 
metalloproteinase (Wynn and Barron, 2010; Leibovich and Ross, 1975). The critical 
importance of macrophages over the other common immune cells to normal  wound 
healing is supported by a collection of studies, where depletion of macrophages 
during inflammation phase or proliferation phase of wound healing by using anti-
macrophage serum or macrophage- knockout animals hinders wound closure (Goren 
et al., 2009; Leibovich and Ross, 1975; Lucas et al., 2009; Mirza et al., 2009; Rodero 
and Khosrotehroni, 2010), while depletion of neutrophils, mast cells or conventional 
T cells (Grawnska-Kozak et al., 2006) by using antiserum or genetic knock-out 
animals leads to normal or speedier healing (Simpson and Ross al., 1972; Dovi et al., 
2003; Egozi et al., 2003; Martin and Leibovich, 2005). These studies suggest that 
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macrophages may play a non-redundant role in inflammation and proliferation 
phases in normal wound healing. 
 
However, the non-redundant role of macrophages and even the requirement for 
immune cells in adult wound closure are disfavored by an older study. In the year of 
2003, Martin et al. reported that PU.1 null mice which lacked macrophages along 
with neutrophils and were pre-treated with antibiotics to prevent infection, had 
decreased levels of granulation tissues, less efficient phagocytosis and reduced TGF-
β production in their skin wounds. However, these PU.1 null mice had similar 
reconstitution rate of both wound epidermis and dermis and no overt wound closure 
defects compared to wild type mice (Martin et al., 2003). Furthermore, the normal 
presence of myofibroblasts which is associated with wound contraction was detected 
in PU.1 null wound and dermal fibroblasts were found to act as candidate phagocytes 
to clear cell and matrix debris to compensate for the absence of macrophages (Martin 
et al., 2003). Therefore, it was suggested that immune cells are not absolutely needed 
for tissue repair (Martin et al., 2003). Whereas, the author admitted that the 
administration of antibiotics and deficiency in neutrophils might have led to reduced 
requirement for macrophage-associated phagocytosis and following intracellular 
killing, thus the candidate phagocyte dermal fibroblasts was proved to be capable to 
play macrophages role in that case (Martin and Leibovich, 2005).  
 
In addition, skin-resident DETCs have shown a role in promoting skin wound 
healing by activating keratinocytes proliferation via KGF and IGF-1 and by 
recruiting macrophages into wound site via hyaluronan (Jameson et al., 2002; 
Macleod and Havran, 2011). In their studies, TCR-δ deficient mice had a 2- or 3- 
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day delay in wound closure and reduced epidermal thickness compared to wild type 
mice (Jameson et al., 2002; Macleod and Havran, 2011).  
 
New evidence suggested IL-22 as a key signaling for epithelial tissue repair 
promotes fibroblast-mediated skin repair (Dudakov et al., 2012; McGee et al., 2013). 
Their study demonstrated IL-22 receptor which was thought to be exclusively 
expressed by epithelial cells is also expressed by dermal fibroblasts in vivo and IL-22 
knockout mice had wound closure defects resulting from the failure in myofibroblast 
differentiation (McGee et al., 2013). However, the source of IL-22 needs to be 
determined yet, although IL-22 has been reported to be produced by novel innate 
lymphoid cells in intestine to promote epithelial proliferation (Spits and Cupedo, 
2012; Spits and Santo, 2011).   
 
1.4.4 The role of Innate lymphoid cells in epithelial repair  
A novel group of innate lymphoid cells (ILCs) (ILC3s, characterized by CD3
-
CD127
+RORγ+) distinct from NK cells which belong to Group 1 innate lymphoid 
cells, has drawn our attention due to its role in promoting epithelial tissue repair in 
intestine via producing IL-22 that induce epithelial tissue proliferation (Spits and 
Cupedo, 2012; Spits et al., 2013; Spits and Santo, 2011). Activation of IL-22 
production in these ILCs requires IL-23 released from dendritic cells (Spits and 
Cupedo, 2012). The term innate lymphoid cells (ILCs) have been recently given to a 
heterogeneous immune cell family that have morphological characteristics of 
lymphoid cells and share cytokine production profile with various T helper cells (Th) 
subsets, but lack a specific antigen receptor which is usually required for adaptive 
immune cells (Spits and Cupedo, 2012). Therefore, ILCs are likely to be derived 
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from common lymphoid precursor but do not express CD3 which is considered as a 
T cell marker (Spits and Cupedo, 2012). They participate in innate immune response 
and function in lymphoid organogenesis, tissue remodeling, antimicrobial immunity, 
and inflammation, particularly at barrier surfaces (Spits and Cupedo, 2012). ILCs 
can be grouped into three major categories (Table 1.3): (1) Group 1 ILCs (ILC1s) 
including NK cells, which mainly produce IFN-γ; (2) Group 2 ILCs (ILC2) , which  
are RORγ t-independent and function in helminth immunity; (3) Group 3 ILCs 
(ILC3s, also known as RORγ+ ILC), which are dependent on IL-7 and retinoid-
related orphan receptor gamma (RORγ, a key nuclear transcriptional factor) during 
development and maturation , express IL-7 receptor (CD127) and RORγt,  and 
produce IL-17, IL-22 or both in a mechanism dependent on IL-23 (Spits and Cupedo, 
2012; Spits and Santo, 2011). ILC3s may contain several distinct subsets such as 
lymphoid tissue inducer cells (LTi), IL17-expressing cells (ILC17), IL22 expressing 
cells (ILC22), depending on the main cytokines they produce (Spits and Cupedo, 
2012). However, the current classification and nomenclature within this category are 
not clear or uniform, and require further knowledge of lineage development and 
relationship (Spits and Cupedo, 2012; Spits et al., 2013).  Although the presence of 
ILC3s has not been reported in skin, the finding that IL-22 has a significant role in 
skin repair suggests the repair mechanism might be conserved among tissues 
containing epithelium. 
 
1.4.5 Notch signaling in wound healing 
It has been suggested that Notch signaling might be involved in wound healing by a 
study using topically-applied pan-Notch activator and inhibitor (Chigurupai et al., 
2007). However, the action site and mechanism remain less clear. Recently our lab 
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has demonstrated forced activation of epidermal Notch signaling promotes dermal 
accumulation of immune cells via epidermal production of TNF and epidermal 
proliferation, resembling the remarks of early and middle stages of wound healing 
(Ambler and Watt 2010; Estrach et al., 2006). These results suggest a potential link 
between epidermal Notch signaling and skin wound healing. 
 
In summary, skin wound healing is a coordinated and sequential process including 
inflammation phase which clears wound of any damaged or dead cells, debris and 
microbes, proliferation phase which involves epidermal proliferation, dermal 
extracellular matrix deposition and remodeling phase which restore the normal 
architecture of skin (Martin and Leibovich, 2005). Macrophages have long been the 
key immune cells that participate in normal wound healing by serving as major 
professional phagocytes that stimulating inflammation and by acting as the main 
source of TGF-β that promotes wound contraction and dermal extracellular matrix 
deposition (Rodero and Khosrotehrani, 2010). However, the redundant role of 
immune cells in skin repair is in dispute. Recent studies suggest IL-22 which could 
be produced by a novel population ILC3s plays a key role in promoting intestine 
epithelial repair and dermal repair by mediating the interaction between immune 
cells and non-immune cells (Luci et al., 2009; McGee et al., 2013; Sonnenberg et al., 
2012). Notch signaling might be involved in skin wound healing (Ambler and Watt, 
2010; Chigurupai et al., 2007; Estrach et al., 2006). 
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Table 1.3 Family of innate lymphoid cells (ILCs) in mouse. (Information based on 
Luci et al., 2011; Sonnenberg et al., 2011; Spits and Cupedo, 2012; Spits et al., 2013;  
Spits and Santo, 2011) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
71 
1.5 Hypothesis 
Slow or non-healing wounds have affected many people especially for diabetics and 
elderly people (Guo and DiPietro, 2010). Wound healing requires immune cells 
especially innate immune cells, such as macrophages and DETCs, to stimulate an 
acute inflammatory response to remove pathogen threats and damaged cells, and to 
communicate with epidermal keratinocytes, dermal fibroblast and vascular 
endothelial cells to start epidermal proliferation, dermal extracellular matrix 
deposition and wound contraction via releasing cytokines and growth factors. The 
timing of inflammation is tightly controlled to allow healing proceed with 
proliferation phase. Persistent inflammation infiltrate could impact this coordinated 
process and lead to massive scar formation (Guo and DiPietro, 2010; Martin and 
Leibovich, 2005).  
 
I hypothesize that some currently poorly defined immune cells, such as ILC3s, a 
novel group of innate lymphoid cells recently found to promote epithelial repair in 
intestine via IL-22 (Luci et al., 2009; McGee et al., 2012; Sonnenberg et al., 2012), 
other than macrophages (Stout, 2010) or DETCs (Jameson et al., 2002; Macleod and 
Havran., 2011) may play a uncovered role in skin repair. Recently a skin study 
suggests dermal fibroblasts require IL-22 signal to start differentiation and skin 
repair (MacGee et al., 2013). However, the role of IL-22 in epidermal compartment 
and the source of IL-22 in skin wound healing have not been determined. It is 
possible that this possible key signal in skin repair could be provided by ILC3s as 
demonstrated by recent studies in intestinal repair (Luci et al., 2009; Sonnenberg et 
al., 2012). It is possible that ILC3s also be recruited in wound inflammatory phase 
and produce IL-22 in skin, which orchestrates skin repair by mediating the 
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interaction between immune cells, epidermal keratinocytes and dermal fibroblasts. I 
will examine the presence of ILC3s in post injury skin, determine the role of ILC3s 
(RORγt+ILCs) in wound healing by comparing the wound closure rate between  
RORγ-/- mice and wild type mice, and study the mechanism of how ILC3s mediates 
skin repair.  
 
I also hypothesize epidermal Notch signaling might be involved in skin wound 
healing by promoting a prompt inflammation reaction and mediating the interaction 
between keratinocytes and immune cells. Previous studies suggests a role of Notch 
signaling in promoting skin wound healing by using pan-Notch inhibitor (Chigurupai 
et al., 2007). However, the underlying mechanism is less clear, and the individual 
roles of Notch1 and Notch2 are unknown due to lack of appropriate agents. Recent 
studies showed forced activation of epidermal Notch signaling promotes dermal 
accumulation of immune cells via epidermal production of TNF-α and stimulates 
epidermal proliferation  via a mechanism that is less clear (Ambler and Watt 2010; 
Estrach et al., 2006). These two striking phenotypes highly resemble the remarks of 
inflammation and proliferation stages of wound healing. It is possible that Notch 
signaling might play a role in recruitment of ILC3s that produce IL-22, which might 
in turn activate epidermal epithelial cells to proliferate as it does in intestinal 
epithelial cells (Luci et al., 2009; McGee et al., 2012; Sonnenberg et al., 2012). 
Therefore, I will examine the correlation between ILC3s and Notch activity using 
Notch activation and blocking models. With the recent progress in development of 
Notch individual antibodies, I will be able to study the individual roles of Notch1 
and Notch2 signaling in ILC3 recruitment (Wu et al., 2010). I will also determine the 
mechanism of how Notch signaling, via TNF-α, regulates ILC3 recruitment. 
 
73 
Chapter 2 Methods 
2.1 Research animals 
K14NICDER, RORγGFP/GFP (RORγ-/-), Rag2-/-, CD11cCreRosa26iDTR and CXCL13-/- 
mice have been described previously (Ambler and Watt, 2010; Ansel et al., 2000; 
Buch et al., 2005; Estrach et al., 2006; Johnston et al., 2013; Jung et al., 2002; Luther 
et al., 2000; Sun et al., 2000). All experimental procedures were performed with 
ethical permission by Durham Universities under appropriate UK government Home 
Office licenses. Experiments followed the national and institutional guidelines for 
the care and use of animals based on the Animal [Scientific Procedures] Act 1986. In 
every experiment mice were age and sex matched with wild type littermate controls 
used when possible and within each experiment 3 or more mice per 
genotype/experimental group were included. Experiments were repeated 2 to 4 times 
to confirm results. The majority of mice reported were females between 6 and 9 
weeks of age. Occasionally, male mice or mice between 9 and 18 weeks were 
included in an experiment, however RNA and protein analysis was performed on age 
and sex-matched tissues and analysis was performed amongst experimental 
replicates where appropriate. Mice were housed in pathogen-free facilities and had 
access to food and water. In K14NICDER mice, estrogen-inducible ectopic Notch 
activity (i.e. fragment of Notch1 intracellular domain (NICD1)  was induced and 
activated specifically in epidermal basal cells under the control of Keratin 14 (K14) 
promoter by topical application of 2mg of 4-hydroxytamoxifen (4OHT, H6278 from 
Sigma) dissolved in acetone (Figure 2.1). In RORγGFP/GFP (RORγ-/-) mice, a 200-bp 
fragment containing the exon encoding the DNA-binding domain of RORγ gene was 
replaced with the 1.2-kb neomycin resistance gene and flanking a coding sequence 
of enhanced green fluorescence protein (eGFP) (Sun et al., 2000). RORγ-/- were born  
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Figure 2.1 Ectopically activated Notch signaling in 4OHT treated K14NICDER 
mice (Adapted from Estrach et al., 2006; Watt et al., 2008). Black arrow represents 
normal Notch signaling. Red arrow represents ectopically activated Notch signaling. 
In K14NICDER mice, ectopic Notch1 intracellular domain is specifically induced in 
basal cells of epidermis under the control of keratin 14 promoter (K14Pr) and enters 
nucleus to activate Notch signaling when a chemical drug 4-hydroxytamoxifen 
(4OHT) is topically applied. To make this transgenic model, a vector containing the 
sequence encoding amino acid 1751-2290 of NICD1 and a modified 4OHT 
responsive human oestrogen receptor (ER) was generated. For stabilizing its 
transcript, a rabbit β-globin untranslated region (UTR) encompassing a human β- 
globin gene intronic sequence to a BamHI site (βg int), K14 UTR and 
polyadenylation signal from human K14 mRNA (K14pA) was added into this vector. 
Then this stable NICDER construct was sub-cloned into the BamHI restriction site 
of the K14 promoter cassette and injected into the pronucleus of F1 embryos. 
ADAM10 
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healthy, had no discernible physical defect, and were fertile. However, these mice 
completely lack lymph nodes and Peyer’s patches (Sun et al., 2000). Mice 
heterozygous for this targeted mutation RORγ+/- (RORγ+/eGFP) were used as controls 
by breeding RORγ-/- mice to wildtype C57Bl/6 mice. In Rag2-/- mice, mature T and B 
cells are depleted (Hao and Rajewsky, 2001). CD11c
Cre
Rosa26
iDTR 
mice were 
produced by cross-breeding B6.Rosa26
iDTR
 mice to B6.CD11c
cre 
mice.
 
In 
CD11c
Cre
Rosa26
iDTR 
mice, Cre recombinase is expressed under the control of CD11c 
promoter permitting the expression of induced simian Diphtheria Toxin Receptor 
(iDTR) in CD11c
+
 cells (Buch et al., 2005; Jung et al., 2002). When being treated 
with 100 nanograms of Diphtheria Toxin (DT) (D0564, Sigma) per mouse via 
intraperitoneal (i.p.) injection for 4 consecutive days before wounding, mouse 
CD11c
+
 cells are killed by DT via uptake through Cre-induced iDTR. CXCL13
-/- 
mice do not display any gross physical or behavioral abnormalities but have defects 
in lymphoid tissue (e.g. lymph node) development (Luther et al., 2000). 
 
2.2 Wound healing 
Mice were anesthetized using 2% inhaled isoflurane and then injected 
subcutaneously with the analgesic, Vetergesic (0.05mg/kg, Alstoe Animal Health). 
The back skin was shaved and sterilized with Videne surgical scrub (from Ecolab) 
then rinsed with sterile water. Two full-thicknesses, 4mm diameter back skin 
wounds were made using a punch biopsy (from Stiefel) (Figure 2.2). Some wounds 
were then topically treated daily with recombinant TNFα (8 µg/kg, product code: 
PNRMTNFAI, Thermo Scientific Pierce), TNFα antagonist (10 mg/kg, Adalimumab, 
Humira, Abbott Laboratories) or PBS until humanely sacrificed 2 days or 5 days 
post-wounding. Some mice were i.p. injected with anti-NRR1 (5mg/kg, from  
 
76 
 
Figure 2.2 Surgical wounding model. (a) Full thickness-skin wounds were created 
by using a 4mm punch biopsy on mouse back skin with hairs shaved. (b) Mice with 
two wounds on back skin were kept up to 8 days post injury for examining the 
wound closure rate, cytokine production profile and immune cell recruitment. 
 
 
 
 
 
 
 
 
 
 
 
 
                                    (A)                 (B) 
 
77 
(a) Collection 
 
(b) Embedding 
 
(c) Cryostat 
 
Figure 2.3 Collection and frozen sectioning of skin wounds. (a) Back skin from 
wounded mice was collected. (b) 1.5cm x 0.5cm piece of skin sample including half 
a wound and surrounding area was immersed into optimal cutting temperature 
compound (OCT) in a 24cm x 24cm mold before being frozen in liquid nitrogen or 
in cold isopentane.  (c) Frozen sample was cut into 8 micron sections using a cryostat.  
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Genotech), anti-NRR2 (5mg/kg, from Genotech), or both anti-NRR1 and anti- NRR2 
(2.5mg/kg for each), or control (anti-ragweed, 5mg/kg, from Genotech) for 7 days 
prior to wounding and then every 2 to 3 days post-wounding for the duration of the 
experiment (Wu et al., 2010). CD11c
Cre
Rosa26
iDTR 
mice were treated with 
100ng/mouse DT via i.p. for 4 consecutive days prior to wounding. Some RORγ-/- 
mice received splenocyte transplantation 1 day prior to wounding. In these RORγ-/- 
mice 1x10
6
 cells harvested from Rag2
-/- 
spleen were injected via tail vein. Wounds 
were photographed daily using a Canon digital camera.  
 
2.3. HE staining and antibody labeling 
Back skin tissue was collected and processed as previously described (Figure 2.3) 
(Braun et al., 2003; Estrach et al., 2006). For Haematoxylin and Eosin (HE) staining, 
8µm-thick paraffin sections were dewaxed by immersing into xylene, ethanol and 
distilled water sequentially and stained with Harris’ haematoxylin for 10 minutes. 
Then sections were washed and stained with Eosin for 30 seconds. Finally, the slides 
were mounted with DPX media (06552, Sigma). For antibody labeling, 8µm-thick 
frozen or paraffin sections were fixed in 4% or 0.4% paraformaldehyde (PFA) for 15 
minutes, blocked in 10% goat or donkey serum, 0.25% fish skin gelatin and 0.2% 
bovine serum albumin for 30 minutes, and then stained with the following antibodies 
diluted in blocking solution (dilutions in brackets) for 1 hour or overnight: activated 
Notch1 (1:200, Abcam, ab8925), Activated Notch2 (1:200, Abcam, ab8926), CD3 
(1:100, BD Biosciences, clone 17A2), CD4 (1:100, BD Biosciences, clone RM4-5), 
CD8a (1:100, BD Biosciences, 53-6.7), CD11b (1:100, BD Biosciences, clone 
M1/70), CD11c (1:100, Biolegend, clone N418), CD19 (1:100, BD Biosciences, 
clone 1D3), CD117 (also known as C-kit, 1:100, BD Biosciences, clone 2B8), 
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CD127 (also known as IL7R, 1:100, eBiosciences, clone SB/199), CD207 (also 
known as Langerin, 1:100, eBioscience); F4/80 (1:100, eBiosiences, clone BM8), 
Gr-1 (Ly-6G, 1:100, eBiosiences, clone BR6-8C5), NKp46 (also known as CD335, 
NCR1, 1:100, eBiosciences, clone 29A1.4), Ki67 (1:400, NeoMarkers), CXCL13 
(also known as BLC, BCA-1, 1:300, eBiosciences, polyclone). Tissue sections were 
stained with appropriate fluorescent secondary antibodies (1:1000, Invitrogen), 
counterstained with DAPI and mounted with Mowiol (2.4g Mowiol, 6g glycerol, 
12.5ml Tris pH8.5, topping up to 50ml with water) before imaging tissues using a 
Leica Tandem SP5 confocal microscope. To detect RORγ, 8µm frozen sections were 
fixed in 4% PFA for 10 minutes then incubated with antibody as described above. 
Sections were incubated with PE-conjugated RORγ antibody (eBiosciences, clone 
AFKJS-9, Cat. 12-6988-82) diluted to 1:100 in permeabilization buffer 
(eBiosciences, Kit 00-5521) for 1 hour. Brightness of images was adjusted using 
Adobe Photoshop CS3 software.  
 
2.4  Isolation of cells for flow cytometry 
A 4-5 cm
2 
piece mouse back skin was removed then dermal surface was gently 
scraped to remove subcutaneous fat and muscle. Tissue was floated in freshly-
prepared 2mg/ml dispase (17105-041, Invitrogen) 0.01% DNase I (Roche) in 
Roswell Park Memorial Institute (RPMI) 1640 medium (R8758, Sigma) with dermal 
side down overnight at 4
o
C. The following day, epidermis was separated from 
dermis using forceps, then dermis was chopped into tiny pieces and dermis and/or 
epidermis were incubated with 1mg/ml collagenase type I (17100-017, Invitrogen) 
and collagenase type II (LS004176, Worthington) in RPMI 1640 media in an orbital 
mixer for 2 hours at 37
o
C. After incubation the suspension of digested tissue was put 
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through a 70µm strainer to isolate single cells. Thymocytes were collected by gentle 
disruption of the thymus in RPMI media. Cutaneous lymph nodes from axillary and 
inguinal regions and splenocytes were collected by using a syringe to gently smash 
the tissue through cell strainer. Then splenocytes were subjected by incubation with 
red blood cell lysis buffer (0.15M NH4Cl, 1mM NaHCO3, 0.1mM EDTA) for 1 
minute. Cell suspensions from all types of tissue were pelleted and re-suspended in 
0.5% BSA in PBS prior to antibody staining for flow cytometry. 
 
2.5 Antibody staining for flow cytometry 
Antibody staining was performed in 96-well V-bottom plates with the following 
antibodies: CD3 Alexa-647 (BD Bioscience, clone 17A2) or Allophycocyanin-
Cyanine 7 (APC-Cy7) (Biolegend, clone 17A2), CD4 Alex-488 or Phycoerythrin 
(PE) or Allophycocyanin (APC) (BD Bioscience, clone RM4-5), CD5 (BD 
Biosciences, clone 53-7.3), CD8a PE (BD Biosciences, clone 53-6.7) or APC,  
CD11b Alexa-647 (BD Bioscience, clone M1/70), CD19 Alexa-647 or PE-Cy7 (BD 
Biosciences, clone 1D3), CD21 Alexa 647 (BD Bioscience, clone 7G6), CD23 Alexa 
488 (BD Bioscience, clone B3B4), CD45 Peridinin Chlorophyll (PerCP) (BD 
Biosciences, clone 30-F11) or pacific blue (Biolegend, clone 30-F11), CD45R PerCP 
(also known as B220, BD Bioscience, clone RA3-6B2), TCR-β PE-Cy7 (Biolegend, 
clone H57-597), Vγ3 APC (Biolegend, clone 536), Gr-1 FITC (Biolegend, clone 
BR6-8C5), CD11c PE (Biolegend, clone N418), F4/80 PE-Cy7 (Biolegend, BM8),  
CD127 PE or APC (Biolegend, clone SB/199), NK1.1 PE-Cy5 (Biolegend, clone 
PK136), NKp46 Alexa-647 (eBiosciences, clone 29A1.4), CD117 PE-Cy7 (BD 
Bioscience, clone 2B8) incubated with cells for 1 hour on ice. Following surface 
labeling, cells were prepared for intracellular staining and fixed overnight in Fixation 
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buffer (kit 00-5521, eBiosciences). After incubation, PE-conjugated RORγt antibody 
was added to the cells for 1 hour with permeabilization buffer (00-5521, 
eBiosciences) before analyzing cells. Cells were analysed using a FACSCaliber 
Flow Cytometer (BD Bioscience) or CYAN (Beckman-Coulter).  
 
2.6 Protein extraction/ Western blotting 
Pieces of back skin (0.5-1 cm
2
) were snap-frozen in liquid nitrogen and stored in -
80
o
C freezer. Frozen tissue was homogenized in Radio-immunoprecipitation Assay 
(RIPA) buffer [150 mM NaCl, 50 mM Tris-HCl (pH 7.5), 1% Nonidet P-40, 0.25% 
sodium deoxycholate with cOmplete, Mini, EDTA-free proteinase inhibitor cocktail 
tablet (1 tablet in 10ml RIPA buffer, product No. 04693159001, Roche)]. Lysates 
were run on a 10% gradient polyacrylamide gel (Invitrogen), transferred to 
polyvinylidene difluoride (PVDF) membrane, blocked with 3% cold water fish skin 
gelatin (Sigma)/0.2% Tween-20/PBS or 5% powdered skimed milk/0.2% Tween-
20/PBS and hybridised with antibodies to activated Notch1 (ab8925, 1:400, Abcam), 
activated Notch2 (1:400, Abcam, ab8926) or beta-actin (A5441, 1:3000, Sigma). 
Blots were rinsed in 0.2% Tween-20/PBS, incubated with horseradish peroxidase 
(HRP)-conjugated anti-rabbit or anti-mouse secondary antibody (Sigma) and 
visualized with enhanced chemiluminescence (ECL) Western Blotting Substrate 
(Pierce). Following film detection of blots, band intensity was quantified using 
ImageJ and the mean band intensity value was calculated against the loading control.  
 
2.7 RNA extraction  
RNA extraction methods have been described previously (Ambler and Watt, 2010). 
In summary, freshly-isolated tissues were immediately snap-frozen in liquid nitrogen 
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or immersed in RNAlater (Invitrogen) for 24 hours prior to freezing. Tissues were 
homogenized using polytron tissue homogenizer then RNA was isolated using a 
Qiagen, RNeasy Mini Kit following manufacturer’s instructions including the 
optional, on-column DNase I digestion step. An additional proteinase K digestion 
step was performed in the protocol. Briefly, after homogenising lysates in Qiagen 
RLT buffer (from RNeasy Mini kit) + 1% ß-mercaptoethanol (BME) , 40 microliters 
of proteinase K (20mg.ml, P6556, Sigma) and RNase-free water were added to a 
final volume of 1.8 ml and incubated  at 55
o
C for 10 minutes. RNA concentrations 
were quantified using a Nanodrop microspectrophotometer and cDNA prepared 
using a High Capacity cDNA Reverse Transcription Kit (Cat. 4368814, Life 
Technology). 
  
2.8 Quantitative polymerase chain reaction (QPCR) 
To quantify the mRNA levels of IL-22, IL-23a (p19), CCL20 and TNFα, QPCR was 
performed using a Rotor-Gene Q instrument (Qiagen), with a two-step rapid-cycling 
procedure as described by the manufacturer (Roter-Gene Probe Handbook, Qiagen). 
Triplicate reactions (20 microlitre) of each experimental sample were analysed using 
fluorescein amidite (FAM) probes for the gene of interest (TNFα, Mm00443258.m1; 
CCL20, Mm01268754.m1; IL23a (P19), Mm01160011.g1, Life Technologies) at a 
final concentration of 900 nM for each primer and 250nM for the probe and TaqMan 
Fast Universal PR master mix (ABI) at 1x. Reactions were subjected to an initial 3-
minute denaturation step at 95
o
C, followed by 45 cycles of 95
o
C for 3 seconds and 
60
o
C for 10 seconds. Data was analysed using the Comparative Quantitation 
algorithm in the Rotor-Gene software, with calibrator samples for each run being 
compared in a common experiment. MIP1α and IL-22 mRNA levels were examined 
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using unlabelled primers (MIP1α: Forward 5’-GTTCTTCTCTGTACCATGAC-3’; 
Reverse 5’-CTCTTAGTCAGGAAAATGAC-3’, final concentration 400 nM; IL-22: 
PPM05481A-200, Qiagen) in a reaction using SYBR-green master mix (Sigma). 
Reactions were subjected to an initial 3-minute denaturation step at 95
o
C, followed 
by 45 cycles of 95
o
C for 10 seconds, 60
o
C for 10 seconds and 72
o
C for 10 seconds. 
Reference genes Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and β-2 
microglobulin (B2M) were used to quantify genes of interest. 
 
2.9 Primary dermal cells 
Primary mouse fibroblasts were isolated using a method based on Jahoda and Oliver 
(1984). In brief, after sacrificing the mouse, the back skin hair was clipped and then 
the skin tissue was washed in Dulbecco’s modified Eagle’s medium (DMEM) 
(Invitrogen) with double strength antibiotics (2x Pen/Strep - Penicillin 100 Unit/ml 
Streptomycin 100 µg/ml, Fisher). The fat and non-dermal tissue was gently scrapped 
from the tissue before cutting into pieces of approximately 10mm
2
. Each piece of 
tissue was cut repeatedly using curved blade scissors until it became slurry and the 
tissue was spread onto the bottom of a 6-well plate. The tissue was then covered with 
DMEM + 10% fetal calf serum (FCS, PAA Laboratories) and 1x Pen/Strep and 
placed in a 37ºC incubator at 5% CO2. After 12 days cells were passaged. 
 
Then passaged (P1) mouse fibroblasts when 90% confluent were treated with either 
TNFα (20 ng/ml, product code: PNRMTNFAI, Thermo Scientific Pierce), TNFα 
antagonist (50 µg/ml, Adalimumab, Humira, Abbott Laboratories) or both diluted in 
DMEM + 10% FCS and 1x strength Penicillin/Streptomycin. Some passaged (P1) 
cells were left untreated. Cells were incubated for an additional 24 hours then lysed 
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by using Qiagen RLT buffer (Qiagen RNeasy Mini Kit) + 1% BME and RNA 
collected using an RNeasy Mini Kit (Qiagen) following the manufacturer’s protocol.  
 
 
2.10 Systems Biology Analysis of Gene Expression Data Sets   
To determine the key signaling pathways involved in Notch-mediated wound 
healing, unbiased analysis of gene arrays from RORγ+ innate lymphoid cells (NIH 
GEO: GSE29777, in Reynders et al., 2011 and unpublished results) and from 
uninjured, K14NICDER transgenic mouse back skin epidermis and dermis (NIH 
GEO: GSE23782, in Ambler and Watt, 2010) was used. The MAS5-processed 
datasets of differentially expressed genes were imported into Ingenuity Pathway 
Analysis software (Ingenuity® Systems, www.ingenuity.com) for analysis. All 
secreted, skin-derived factors that could interact with a cytokine or chemokine 
receptor on ILCs were determined. The highly upregulated genes in the epidermis 
and the dermis were filtered by the "extracellular matrix" gene ontology term. 
Ingenuity Pathway Analysis was used to build direct connections from the 
upregulated genes to their possible target receptors. The genes displayed in Figure 
6.1 were further selected to show the most probable/relevant/interesting interactions 
between secreted factors and their target receptors. 
 
 
2.11 Statistical Analysis 
For western blotting and mRNA quantification samples were normalized where the 
average of uninjured skin control unless otherwise stated was designated as 1 or 
100%. Independent samples from at least 3 individual animals or wounds were used 
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to calculate group averages. Standard error of the mean (SEM) was calculated and 
significance determined using a Student’s t-test to compare the means of two 
unpaired samples. Results are shown as mean ± SEM. In figure legends, * denotes p 
value < 0.05; ** denotes p value < 0.005; *** denotes p value < 0.0005 unless 
otherwise stated.  
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Chapter 3 Involvement of immune cell in normal skin wound healing 
3.1 Introduction 
Skin wound healing is a coordinated and sequential process which is initiated by 
inflammation phase where a large number of immune cells either migrate from 
adjacent skin or are recruited by chemokines from blood circulation into the wound 
site and are activated by cytokines to clear damaged cells, debris and pathogens 
(Martin and Leibovich, 2005). This inflammatory reaction is thought to be largely 
mediated by innate immune system, especially professional phagocytes such as 
neutrophils and macrophages (Rodero and Khosrotehrani 2010; Stout, 2010). By 
contrast, antigen-specific adaptive system including conventional αβ T cells and B 
cells, is considered not to be significantly involved in wound healing (Stout, 2010). 
Neutrophils are the earliest immune cell type that are recruited into wound site 
within hours, while blood-derived macrophages arrives at wound site approximately 
day 2 post-wounding to perform intensive phagocytosis of wound debris and 
microbes and apoptotic short-life neutrophils (Stout, 2010). However, the evidence 
for the infiltration of skin wound by the other cells of innate immune system, such as 
NK cells, dendritic cells, etc., is less clear (Liu et al., 2012).  
 
In addition to promote inflammation after injury, some immune cells have shown 
roles in tissue regeneration by communicating with other cell types. Wound 
associated M2 macrophages, via TGFβ, contact dermal fibroblasts to activate their 
differentiation into myofibroblasts that are in charge of producing matrix collagens 
and wound contraction (Rodero and Khosrotehrani, 2010). DETCs contact 
keratinocytes to promote their proliferation after damage via IGF-1 and KGF, and 
promote macrophage recruitment via hyaluronan (Jameson et al., 2002; Macleod and 
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Havran, 2011). Given the new evidence that subsets of emerging RORγt+ innate 
lymphoid cells (ILC3s) play key roles in epithelial tissue homeostasis and repair in 
thymus and intestine after damage or infection via producing IL-22 (Dudakov et al., 
2012) and IL-22 contributes to epidermal proliferation during skin wound healing 
(McGee et al., 2012), I hypothesize ILC3s might be present in skin and involved in 
skin wound healing through IL-22 production.  
 
To examine the presence and involvement of individual immune cell subsets in skin 
wound healing, flow cytometry and immunofluorescence chemistry were performed 
using a variety of antibodies to analyze the quantification and location of well-
defined immune cell types, such as neutrophils (CD11b
+
CD11c
-
Gr-1
+
F4/80
-
), mature 
macrophages (CD11b
+
CD11c
-
Gr-1
-
F4/80
+
), conventional dendritic cells (cDC, 
CD11b
+/-
CD11c
high
), Langerhans cells (LC, CD11b
+
CD11c
low
), inflamed monocytes 
(CD11b
+
CD11c
- 
Gr-1
+
F4/80
+
, which give rise to macrophages, cDC and possibly 
LC), NK cells (NK1.1
+
NKp46
+
CD3
-
), NK-like T cells (NKT cells, NK1.1
+
NKp46
+
 
CD3
+
), dendritic epidermal T cells (DETCs, CD3
+
 TCRβ- Vγ3+), αβ T cells (CD3+ 
TCR-β+ Vγ3-), dermal γδ T cells (CD3+ TCR-β- Vγ3-) and B cells (CD19+) as well as 
ILC3s (RORγ+CD127+CD3-) at different time-points following wounding in 
wildtype mouse back skin. To determine the phenotypical markers and subsets of  
RORγt+ ILCs in skin, punch-wounded wildtype as well as GFP-expressing RORγ+/-
mice were analyzed. 
 
3.2 Results 
3.2.1 Timing of the healing process of skin wound  
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To examine skin wound healing process, wounded mouse model was used. Two 4-
mm diameter full-thickness wounds were made by using punch biopsy on wildtype 
mouse back skin. Wounded skin including central wound as well as surrounding area 
was collected on day 2, 5 and 8 post-wounding representing the early, middle and 
late stages of wound healing. To examine the histology of normal healing of skin 
wound, skin sections were analyzed by using hematoxylin and eosin (HE) stainings. 
On day 2, the wound was covered by a clot (Figure 3.1A) composed of platelets and 
fibrin (Martin and Leibovich, 2005). The cellular density in dermis at the wound 
edges is increased resulting from infiltration of immune cells (Figure 3.1E) and other 
cell types (Martin and Leibovich, 2005). Epidermis at the wound edges was slightly 
thickened (Figure 3.1A) suggesting epidermal proliferation had just started, which is 
consistent with the fact that the wound healing is a coordinated process, sequential 
inflammation and proliferation phases in wound healing are somewhat overlapped 
(Martin and Leibovich, 2005). On day 5, hyper-thickening of epidermis was detected 
underneath the clot and migrated towards the wound (Data not shown). Dermal 
cellular density was continuously increased resulting from persistent inflammation 
infiltration (Figure 3.1F), granular tissue generation and dermal matrix deposition 
(Martin and Leibovich, 2005). These results suggested the healing programme was 
in intensive proliferation phase on day 5 post-wounding. On day 8, the wound was 
almost closed and drawn up to the normal level parallel to the surrounding area 
(Figure 3.1B). This was accompanied by dramatically reduced immune cell 
infiltration (Figure 3.1G). These results suggested the healing programme had started 
remodeling phase. 
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Figure 3.1 Skin wound healing is initiated by immune response. (A-B) Histology 
of wounded mouse back skin is shown by HE staining on paraffin sections at early 
stage (day 2 post-wounding) (A) and late stage (day 8 post-wounding) (B) of wound 
healing. (C-G) Cells isolated from wounded skin were analyzed by flow cytometry 
for CD45, a pan marker for immune cells. Total skin cells are first gated on forward 
scatter and side scatter to remove dead cells and debris (C). (D-G) show flow 
cytometry histograms of CD45 staining (red line) of total skin cells gated on FSC vs 
SSC from unwounded back skin (D), wounded back skin on day 2 (E), 5 (F) and 8 
(G) post-wounding. Negative control without adding CD45 antibody is indicated in 
blue line. Gate frequencies are indicated in percentages. Shown one biological 
sample; 3 individual biological replicates were tested (not shown). Scale bars equal 
300 micron. 
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To define the timing of inflammatory cell infiltration, wounded skin was analyzed 
for CD45, a pan cell surface marker for immune cells, by flow cytometry. A same 
size of skin with the same location in unwound mice was used as control. Total skin 
cells were gated by forward scatter (FSC) and side scatter (SSC) (Figure 3.1C). In 
unwounded skin, immune cells accounted for around 8-12% of total skin cells 
(Figure 3.1D), which represents the skin resident immune cells in steady state. This 
percentage was dramatically increased by nearly 2 fold by day 5 post-wounding 
(Figure 3.1F) with the sharpest rise within the first 2 days post-wounding (Figure 
3.1E), confirming the inflammation phase is initiated early upon injury. On day 8 
post-wounding, this percentage dropped back to unwounded level (Figure 3.1G) 
confirming the healing programme was in late proliferation phase and early 
remodeling phase. 
 
Taken together, these results suggest the time-points day 2, day 5 and day 8 post-
wounding represent intensive inflammation and proliferation phase, and the start of 
remodeling phase respectively wound healing process in mouse skin. 
 
3.2.2 Myeloid cells 
To examine myeloid cells including granulocytes (mostly neutrophils), macrophages, 
monocytes, cDC and LCs, wounded skin were analyzed for CD11b (a marker for the 
majority of myeloid cells except CD11b
-
cDC ), CD11c (expressed by cDC with high 
level and by LC with low level) (Romani et al., 2009), F4/80 (a marker for 
macrophages, monocytes, Langerhans cells as well as CD11b
+ 
cDC), and Gr-1 (a 
maker for neutrophils and inflamed (activated) monocytes which give rise to mature 
macrophages and cDC and possibly  LC) (Auffray et al., 2009).  
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To distinguish cDC (CD11c
high
 CD11b
+/-
) and LCs (CD11c
low
 CD11b
+
) from the 
other myeloid cells (CD11c
-
 CD11b
+
), I first analyzed their expression of CD11b 
and CD11c. A rare number of CD11c
high
 cDCs were detected in unwounded skin, 
accounting for 0.1-0.2% of total skin cells (Figure 3.2A). This percentage was 
increased by 1.7 ± 0.2 fold on day 2 post-wounding (Figure 3.2C) arising from 
derivation from inflamed monocytes (Figure 3.2D) and dropped back to unwounded 
level on day 5 and day 8 (Figure 3.2E and G), suggesting cDCs are present in skin 
wound healing especially at early stage of inflammation. To confirm the location of 
DCs, skin sections were analyzed using CD11c antibody which could detect both 
CD11c
high
 cDCs and CD11c
low
 LCs. However, I was only able to detect CD11c
+
 cells 
in dermis but not in epidermis where resident LCs are constantly present, suggesting 
these detectable CD11c
+
 cells were uniformly CD11c
high 
cDCs. CD11c
high 
DC were 
detected in rare dermis in unwounded skin with an rounded morphology (Figure 
3.3A and B), suggesting they were immature DC with high ability to phagocytose, 
poor motility and low potential for antigen presentation (Delves et al., 2011). 
However, an increased number of these CD11c
high
 dendritic cells were detected in 
dermis adjacent to the wound on day 2 post-wounding (Figure 3.3C). The 
morphology of the cells which were immediately adjacent to the wound became 
dendritic, suggesting they were mature DC with poor ability to phagocytose but with 
high motility that had enabled them to migrate to wound site from distal area and 
wound enable them to migrate to the draining lymph nodes nearby to present antigen 
to T cells (Delves et al., 2011). In contrast, the cells which were not immediately 
adjacent to the wound remained rounded suggesting these immature DC might be 
recently derived from inflamed monocytes recruited to the wounded dermis (Figure 
3.2D). On day 5 post-wounding, less CD11c
high
 DC were detected in dermis  
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Figure 3.2 Quantification of myeloid cells and dendritic/Langerhans cells in 
skin wounds. Cells isolated from unwounded (A-B) as well as wounded mouse back 
skin on day 2 (C-D), 5 (E-F) and 8 (G-H) post-wounding were labelled with CD11b, 
CD11c, Gr1 and F4/80 antibodies and were first analyzed by flow cytometry for 
CD11c, CD11b to distinguish dendritic cells (DC) (CD11c
high
 CD11b
+/-
) and 
Langerhans cells (LC) (CD11c
low
 CD11b
+
) from the rest cells (A, C, E, G). Then 
CD11b
+
 CD11c
-
 myeloid cells were gated and analysed for F4/80 and Gr-1 to 
distinguish between neutrophils (Gr1
+
 F4/80
-
), mature macrophages (Gr1
-
 F4/80
+
) 
and inflamed monocytes (Gr1
+
 F4/80
+
). Gate frequencies are indicated in 
percentages. Shown one biological sample; 3 individual biological replicates were 
tested (not shown).  
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Figure 3.3 Dendritic cells are recruited into dermis in wound edges. Back skin 
tissues from unwounded (A and B) as well as wounded mice on day 2 (C) or 5 (D) 
post-wounding were collected. A shows unstained negative control. In B-D, sections 
were stained with an antibody to CD11c antigen (green) and DAPI counterstained 
(blue). Arrows indicates CD11c
high
 dendritic cells. Asterisk marks wound site. Scale 
bars equal 100 microns. 
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compared to day 2 post-wounding and all of them were located immediately adjacent 
to the wound with dendritic morphology (Figure 3.3D), suggesting no CD11c
high
 
were being differentiated from inflamed monocytes. These results confirm that  
CD11c
high
 DC are involved in skin wound healing, especially in early stage (first 2 
days post-wounding) of  healing programme.  
 
In contrast to cDCs, CD11c
low
 CD11b
+
 LCs were relatively abundant in unwounded 
skin, accounting for 0.9-1.0% of total skin cells determined by flow cytometry 
(Figure 3.2A). This percentage was rapidly increased by 1.3 ± 0.1 fold on day 2 post-
wounding (Figure 3.2C), possibly resulting from increased self-proliferation (Merad 
et al., 2013) and derivation from inflamed monocytes (Figure 3.2D). Subsequently, 
this percentage remained above unwounded levels at both day 5 (Figure 3.2E) and 
day 8 time-points (Figure 3.2G) probably due to their long lifespan, capability to 
self-proliferation and also derivation from inflamed monocytes (Merad et al., 2013; 
Romani et al., 2009). These results suggest that LCs constitute the predominant skin 
resident DCs and were accumulated upon wounding throughout the healing 
programme. To confirm the location of LCs, skin sections were analyzed by using 
CD207 (Langerin) antibody which could detect Langerhans cells as well as a 
recently discovered, rare subset of dermal cDC cells (Henri et al., 2009). In 
unwounded skin, CD207
+
 LCs were detected in epidermis with a frequency of 4-7 
cells per mm length of skin (Figure 3.4A). An increased number of CD207
+
 LCs was 
detected in epidermis at wound edges with a frequency of 15-20 cells per mm length 
of skin on day 2 post-wounding (Figure 3.4B) and maintained afterwards on day 5 
and 8 (Figure 3.4C and data not shown). These results confirm epidermal LCs 
constitute the predominant DC in skin and are present in skin wound  
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Figure 3.4 Langerhans cells reside in epidermis and are replenished early 
following wound healing. Back skin tissues from unwounded (A) as well as 
wounded mice on day 2 (B) or 5 (C) post-wounding were collected. Sections were 
stained with an antibody to CD207 antigen (green) and DAPI counterstained (blue). 
Long arrows indicate epidermal Langerhans cells. Arrow heads indicate either 
migratory Langerhans cells trafficking to lymph nodes through dermis or a rare 
subset of dermal dendritic cells (Langerin-expressing dermal dendritic cells). 
Asterisk marks wound site. Scale bars equal 100 microns. 
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healing, probably at all stages of healing programme.  
 
Then I analyzed CD11b
+
 CD11c
-
 myeloid cells, among which neutrophils (Gr-1
+
 
F4/80
-
), mature macrophages (Gr-1
-
 F4/80
+
) and inflamed monocytes (Gr1
+
 F4/80
+
, 
including immature macrophages and possibly monocyte-derived Langerhans cells 
and dendritic cells in transition status) were distinguished by the expression of Gr-1 
and F4/80. Neutrophils (CD11b
+
 CD11c
-
 Gr-1
+
 F4/80
-
) were hardly detectable (less 
than 0.001% of total skin cells) in unwounded skin (Figure 3.2A and B) and were 
detected with a small percentage to total skin cells on day 2 (0.23 ± 0.03%) and 5 
(0.28 ± 0.04%) post-wounding. This percentage was dramatically reduced to less 
than 0.05% by day 8 post-wounding. These results suggest neutrophils may be 
involved in early stage of skin wound healing probably within early hours. To 
confirm the location of neutrophils, skin sections were analyzed using Gr-1 antibody 
which could detect both neutrophils and inflamed monocytes which are known as 
precursors for mature macrophages, cDCs and possibly LCs in inflamed settings 
(Auffray et al., 2009). Unwounded skin was largely devoid of neutrophils (Figure 
3.5A), however, a few Gr-1
+
 cells were detected in hypodermis, which were 
probably circulating neutrophils in skin blood networks. On day 2 post-wounding, a 
large number of Gr-1
+
 cells were detected in both dermis and hypodermis adjacent to 
the wound (Figure 3.5B). According to flow cytometry results, the majority of Gr-1
+
 
cells at this time-point were in deed CD11b
+
 CD11c
- 
Gr1
+
 F4/80
+ 
inflamed 
monocytes (Figure 3.2D) which are supposed to be located in blood vessels in 
hypodermis as well as in newly generated dermal granular tissues (Martin and 
Leibovich, 2005), while the majority of neutrophils are supposed to be outside blood 
vessels in dermis. To test this, skin sections were analyzed for  
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Figure 3.5 Neutrophils are recruited into dermis in wound edges. Back skin 
tissues from unwounded (A) as well as wounded mice on day 2 (B), 5 (C) or 8 (D) 
post-wounding were collected. Sections were stained with an antibody to Gr1 
antigen (green) and DAPI counterstained (blue). Some sections were co-stained with 
antibodies to Gr-1 (green) and CD31 (red). Long arrows indicate neutrophils in 
dermis. Arrow heads indicate either neutrophils or inflamed monocytes in 
hypodermis blood capillaries Asterisk marks wound site scale bars equal 100 
microns. 
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CD31 (a marker for blood vascular endothelial cells) together with Gr-1. Most of Gr-
1
+ 
cells in reticular (lower part) dermis and hypodermis were surrounded by CD31
+
 
vascular endothelial cells (Figure 3.5B) confirming the dramatic increase in the 
number of Gr-1
+ 
cells on day 2 post-wounding were related to massive granular 
tissue generation in which new blood vessels were formed and massive inflamed 
monocytes as precursors of macrophages as well as DCs were recruited into wound 
site to transiently express Gr-1 (Howe et al, 2012; Hume et al., 2008). On day 5, Gr-
1
+
 cells were mostly detected hypodermis and in rare papillary dermis (upper portion 
of dermis), and were absent in reticular dermis (Figure 3.5C). Combined with the 
flow cytometry results that neutrophils remained in the wound site at a low 
percentage at this time-point and the percentage of inflamed monocytes were 
decreased compared to day 2 post-wounding (Figure 3.2F), I confirmed that those 
rare Gr-1
+
 cells detected in rare papillary dermis were neutrophils, while those 
detected in hypodermis were primarily inflamed monocytes. In addition, the absence 
of Gr-1
+
 cells in reticular dermis indicated that granular tissue might be repressed on 
day 5 post-wounding leading to the decrease of inflamed monocyte infiltration. 
These results confirmed that a small number of neutrophils were maintained in 
papillary dermis adjacent to the wound on day 5 post-wounding when the healing 
programme was in the transition from proliferation phase to remodelling phase. On 
day 8 post-wounding, neutrophils were hardly detectable in dermis, and the number 
of inflamed monocytes in hypodermis were also dramatically reduced (Figure 3.5 D), 
which is consistent with flow cytometry results (Figure 3.2H). All of these results 
suggest that neutrophils are present in skin wound healing, especially within early 
hours of the healing programme, and day 5 post-wounding is probably the transition 
point from proliferation phase to remodelling phase in mouse skin wound healing. 
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Mature macrophages (CD11b
+
 CD11c
- 
Gr-1
-
 F4/80
+
) accounted for 5-6% of total 
skin cells in unwounded skin, which made them become the major resident immune 
cells in skin (Dupasquier et al, 2004). The percentage of mature macrophages to total 
skin cells in wounded skin was not evidently changed within the first 2 days post-
wounding (Figure 3.2D). However, this percentage was rapidly increased afterwards 
and reached its peak with a 1.5 ± 0.2 fold increase on 5 post-wounding (Figure 3.2F) 
resulting from derivation from massive inflamed monocytes that were recruited into 
wound site from approximately day 2 post-wounding (Figure 3.2D). On day 8 post-
wounding, there was an sharp decrease in the recruitment of inflamed monocytes 
leading to an reduction in the percentage of mature macrophages to the unwounded 
level (Figure 3.2H). To confirm the location of macrophages, skin sections were 
analyzed using F4/80 antibody which could also detect LCs, some cDC (Merad et al., 
2013) and inflamed monocytes the vast majority of which are recruited into skin as 
the precursors of mature macrophages in inflamed setting (Hume, 2008). At all time-
points, the epidermal F4/80
+
 cells (Figure 3.6) were detected with a similar 
frequency to CD207
+
 epidermal LCs (Figure 3.4), suggesting F4/80
+
 cells in 
epidermis are uniformly LCs. Since cDC were very rare accounting for up to 0.3% of 
total skin cells at all time-points (Figure 3.2A, C, E and G), the dermal F4/80
+
 cells 
were considered to be primarily composed of mature macrophages and inflamed 
monocytes. In unwounded skin where the inflamed monocytes were not present 
(Figure 3.2B), skin resident macrophages were detected throughout dermis (Figure 
3.6A). Following wounding, massive infiltration of F4/80+ macrophages/monocytes 
were detected in dermis and hypodermis adjacent to the wound on both day 2 and 
day 5 (Figure 3.4B and C) with different proportions (Figure 3.2F and H). On day 2 
post-wounding, 48.7 ± 5.3% of macrophage/monocytes heterogeneous population  
 
105 
F4/80 DAPI staining  
 
 
 
 
* 
(A) Unwounded skin 
(B) Day 2 post-wounding 
(C) Day 5 post-wounding 
(D) Day 8 post-wounding 
* 
* 
 
106 
Figure 3.6 Monocytes/Macrophages are recruited into dermis in wound edges. 
Back skin tissues from unwounded (A) as well as wounded mice on day 2 (B), 5 (C) 
or 8 (D) post-wounding were collected. Sections were stained with an antibody to 
F4/80 antigen (green) and DAPI counterstained (blue). Note F4/80
+
 in epidermis are 
Langerhans cells. Asterisk marks wound site scale bars equal 100 microns. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
107 
were mature macrophages (Figure 3.2F), while this proportion was increased to 63.7 
± 4.2% on day 5 post-wounding (Figure 3.2H) due to the conversion from inflamed 
monocytes to mature macrophages and reduction in the number of inflamed 
monocytes accompanied by granular tissue degeneration (Figure 3.5C). By day 8 
post-wounding, the number of dermal macrophages were dramatically reduced to 
unwounded level, and the number of inflamed monocytes as detected in hypodermis 
were also dramatically reduced to a low level (Figure 3.4D). These results suggest 
that dermal macrophages are the predominant skin resident immune cells, and 
macrophages/ monocytes constitute the predominant immune cells involved in skin 
wound healing. Specifically, skin resident macrophages are present in early stage 
(first 2 days post-wounding), while monocyte-derived macrophages are involved in 
later stage (after 2 days post-wounding) of healing programme.  
 
3.2.3 T cells 
To examine if T cells are present in skin wound healing, wounded skin from 
wildtype mice were analyzed for CD45, CD3 (a pan-marker for all the T cells),  
TCRβ (a marker for αβ T cells), Vγ3 (a marker for the majority of DETCs) (Jameson 
et al., 2004) by flow cytometry. I first gated on CD3
 low to high
 CD45
+
 T cells, among 
which αβ T cells (CD45+ CD3+ TCRβ+ Vγ3-), DETCs (CD45+ CD3+ TCRβ- Vγ3+) 
and dermal γδ T cells (CD45+ CD3+ TCRβ- Vγ3-) were distinguishable by their 
expression of TCRβ and Vγ3. In unwounded skin control, αβ T cells accounted for 
1.2-1.4% of total skin cells suggesting αβ T cells are one of the major resident 
immune cell type in skin (Figure 3.7A and B). This percentage was continuously 
reduced following wounding at all time-points probably suggesting αβ T cells are not 
significantly involved in skin wound healing. DETCs accounted for 1.6-1.8% of total 
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Figure 3.7 Quantification of T cell subsets in skin wounds.  Cells isolated from 
unwounded (A-B) as well as wounded mouse back skin on day 2 (C-D), 5 (E-F) or 8 
(G-H) post-wounding were labelled with CD3, CD45, TCRβ and Vγ3 antibodies and 
were first analyzed by flow cytometry for CD3, CD45 for total T cells (CD45
+
 CD3
+
) 
(A, C, E, G). Then CD45
+ 
 CD3
+
 T cells were gated and analyzed for TCRβ and Vγ3 
to distinguish αβ T cells (ab T cells) (TCRβ+Vγ3-), dendritic epidermal T cells 
(DETCs) (TCRβ-Vγ3+) and dermal γδ T cells (gd T cells) (TCRβ-Vγ3- ) from each 
other. Note αβ T cells are continuously decreased following wounding. DETCs are 
replenished and dermal γδ T cells are replenished after 5 days post-wounding. Gate 
frequencies are indicated in percentages. Shown one biological sample; 3 individual 
biological replicates were tested (not shown). 
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skin cells in unwounded skin (Figure 3.7A and B). Previous studies suggest DETCs 
are resident T cells specifically in rodent epidermis and the epidermal T cells are 
uniformly DETCs (MacLeod and Havrand, 2011; Sumuria et al., 2012). The 
percentage of DETCs to total skin cells was dramatically reduced by 2.0 ± 0.3 fold 
on day 2 post-wounding (Figure 3.7C and D), partly due to the massive infiltration 
of other immune cells and other cell types in wound site. However, they were rapidly 
replenished and increased afterwards on day 5 and day 8 post-wounding (Figure 
3.7E-H), probably through self-proliferation (Sumaria et al., 2011). However, the 
mechanism for maintenance of DETCs in injury state is yet to be determined. These 
results suggest that DETCs are involved in skin wound healing, especially in later 
stage (after 2 days post-wounding) of healing programme. 
 
In addition, a small number of γδ T cells other than DETCs were detected in 
unwounded skin, accounting for 0.5-0.6% of total skin cells (Figure 3.7A and B). 
These γδ T have been recently determined as a mixture population of resident Vγ3- 
γδ T cells in dermis (Sumaria et al., 2011). Similar to DETCs, these Vγ3- γδ T cells 
are self-proliferative in steady state (Mumaria et al., 2011) and were not expanded 
until day 5 post-wounding (Figure 3.7C and D). However, the percentage of Vγ3- γδ 
T cells was reduced on day 8 compared to day 5 post-wounding (Figure 3.7E and F). 
These results suggest that dermal γδ T cells are involved in skin wound healing, 
especially in later stage (after 2 days post-wounding) of the healing programme. 
 
To visualize of T cells, skin section were analyzed by using CD3, which could detect 
all T cell subsets. DETCs cells were detected in interfollicular epidermal  basal layer 
and hair follicle outer root sheath with dendritic morphology (Figure 3.8A), while a 
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few CD3
+
 T cells were also detected in dermis, which were composed of αβ T cells 
and dermal γδ T cells (Figure 3.7B). On day 2 post-wounding, the number of DETCs 
was dramatically reduced in epidermal compartment (Figure 3.8B), which is 
consistent with the decreased percentage of CD45
+ 
CD3
+ TCRβ- Vγ3+ DETCs 
detected by flow cytometry (Figure 3.7C and D). However, a similar number of 
CD3
+
 T cells were detected at this time-point in dermal compartment adjacent to the 
wound compared to the unwounded skin (Figure 3.8B), which is apparently 
contradicted with the substantially decreased percentages of total CD3
+
 T cells and 
all T cell subsets detected by flow cytometry (Figure 3.7C and D). Although the 
migration of T cells from distal dermis into wound site could lead to T cell 
accumulation at wound edges without changing the overall T cell number in dermis, 
it could not explain the decrease in the number of dermal T cell  subsets (Figure 3.7B 
and Figure 3.8B). One of the possible reasons for the loss of all T cell subsets and 
persistent dermal presence of T cells might be increased trafficking of resident T 
cells including both αβ and γδ T cells into skin draining lymph nodes in response to 
injury or infection (Vireling et al., 2012), some T cells detected in dermis at this 
time-point might be migratory DETCs that travelled through dermis. However, it yet 
needs to be determined since DETCs, as a specialized γδ T cells, are considered to be 
immobile in steady state and reside in epidermis for life-time once they get there 
during development of early fetus (Gray et al., 2011; MacLeod and Havran, 2011). 
On day 5 post-wounding, an increased number of T cells were detected adjacent to 
the wound especially in epidermis and reticular dermis (Figure 3.8C), suggesting 
DETCs and dermal γδ T cells (Figure 3.7E and F) were replenished and expanded at 
this time-point, probably through recruitment of blood-derived γδ T cells as well as 
self-proliferation (Gray et al., 2011; MacLeod and Havran, 2011). However, the 
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Figure 3.8 T cells reside in epidermis and rare dermis, and are replenished late 
following wounding.  Back skin tissues from unwounded (A) as well as wounded 
mice on day 2 (B) or 8 (C) post-wounding were collected. Sections were stained with 
an antibody to CD3 antigen (green) and DAPI counterstained (blue). Note DETCs 
reside in epidermis and replenished after 5 days post-wounding. CD3+ T cells in 
dermis include αβ T cells dermal γδ T cells and possibly DETC precursors which are 
trafficking from blood circulation to epidermis through dermis. Asterisk marks 
wound site. Scale bars equal 100 microns. 
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mechanism of maintenance of self-proliferative DETCs and dermal γδ T cells in 
inflamed settings are currently unknown (Gray et al., 2011; MacLeod and Havran, 
2011) and needs to be determined. In addition, I found the morphologies of those 
DETCs which were most proximal to wound site became rounded in response to 
keratinocyte injury, which is consistent with previous results (Havran and Jameson, 
2010). All of these results suggest γδ T cells including both DETCs and dermal γδ T 
cells are involved in skin wound healing, especially in later stage (after 2 days post-
wounding) of healing programme, while αβ T cells may not be significantly involved 
in this healing process. 
 
3.2.4 B cells 
To examine if B lymphocytes are involved in skin wound healing, wildtype wounded 
mice were analyzed for CD45, CD19 (a marker for B cells) by flow cytometry. 
CD19
+
 B cells were very rare in both unwounded and wounded skin at all time 
points with no increase during the time course, accounting for up to 0.1% of total 
skin cells (Figure 3.9). To verify this result, skin sections were analyzed for CD19 by 
using anti-CD19 antibody. B cells were detectable in neither unwounded nor 
wounded skin (data not shown). These results suggest B cells may not be 
significantly involved in skin wound healing.  
 
3.2.5 NK cells 
To examine if NK cells are involved in skin wound healing, wounded skin was 
analyzed for NK1.1 (a marker for NK and rare T cells known as NKT cells), CD3 (a 
marker for T cells) and NKp46 (also known as natural cytotoxicity triggering 
receptor, NCR), which is co-expressed with NK1.1 by mouse NK and NKT cells, 
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Figure 3.9 B cells are not involved in skin wound healing.  Cells isolated from 
unwounded (A) as well as wounded mouse back skin on day 2 (B), 5 (C) or 8 (D) 
post-wounding (PSW) were labelled with CD45 and CD19 and were analyzed by 
flow cytometry for B cells (CD45
+
 CD19
+
). Gate frequencies are indicated in 
percentages. Shown one biological sample; 3 individual biological replicates were 
tested (not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
117 
and expressed by ILC22 in intestine) (Luci et al., 2009). NK cells (NK1.1
+
 CD3
+
) 
are distinguishable from NKT cells (NK1.1
+
 CD3
-
) and other immune cells by their 
expression of NK1.1 and lacking CD3. NKT cells were detected at a very small 
percentage (0.02-0.03%) to total skin cells in both unwounded and wounded skin at 
all time points and there was no increase during the time course up to day 8 post-
wounding (Figure 3.10), suggesting NKT cells, like the other αβ T cells, may not be 
significantly involved in skin wound healing.  
 
Compared to NKT cells, NK1.1
+
 CD3
- 
NK cells were nearly 10-fold more abundant 
in skin, accounting for 0.1-0.2% of total skin cells in steady state (Figure 3.10A). 
This percentage was considerably increased by 2.9 ± 0.3 fold on day 2 post-
wounding (Figure 3.10B) followed by a gradual decrease afterwards on day 5 
(Figure 3.10C) and day 8 (Figure 3.10D) post-wounding. I found that all of these cell 
were positive for NKp46 (data not shown), which confirmed their NK cell identity. 
These results suggest that NK cell are recruited to the wounded skin on day 2 post-
wounding and are present in skin wound healing, especially in early stage of healing 
programme. 
 
To confirm the location of NK cells in skin,  skin sections were analyzed by using 
NKp46 antibody which could detect NK cells which constitute the majority of 
NKp46
+
 cells, NKT cells, and possibly ILC22 if they exist (Luci et al., 2009). In 
contrast to spleen (Figure 3.11A), NKp46
+
 cells were hardly detectable in dermis in 
unwounded skin (Figure 3.11B). Since NK cells were increased in skin on day 2 
post-wounding (Figure 3.10B), I expected a larger number of NKp46
+
 cell detected 
in dermis adjacent to the wound. Surprisingly, rare NKp46
+
 cells were detected on  
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Figure 3.10 NK cells are recruited early into wound site determined by flow 
cytometry.  Cells isolated from unwounded (A) as well as wounded mouse back 
skin on day 2 (B), 5 (C) or 8 (D) post-wounding were labelled with CD3 and NK1.1 
and were analyzed by flow cytometry for NK cells (NK1.1
+
 CD3
-
) and NKT cells 
(NK1.1
+
 CD3
+
). Gate frequencies are indicated in percentages. Shown one biological 
sample; 3 individual biological replicates were tested (not shown). 
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Figure 3.11 NKp46
+
 cells are hardly detectable in skin wound sections.  Mouse 
spleen (A) and back skin tissues from unwounded (B) as well as wounded mice on 
day 2 (C) post-wounding were collected. Sections were stained with an antibody to 
NKp46 antigen (green) and DAPI counterstained (blue). Arrow indicates NKp46
+
 
NK or NKT cell. Asterisk marks wound site. Scale bars equal 100 microns. 
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day 2 post-wounding with a frequency similar to unwounded level (Figure 3.11C). I 
failed to detect NK cells on day 5 post-wounding (Data not shown). These two 
apparently contradicted results determined by using different methods might indicate 
that the majority of blood-derived NK cells recruited upon wounding are likely to 
express a low level of NKp46, which is below the threshold of the fluorescence 
microscopy and only detectable by flow cytometry.  
 
3.2.6 Innate lymphoid cells 
RORγt+ ILCs (also known as ILC3s) are an emerging group of rare innate lymphoid 
cells that play a central role in promoting innate immunity and epithelial tissue repair 
in lung and intestine (Dudakov et al., 2012) in adult human and mouse through 
producing IL-17 and/or IL-22 which were considered as Th17 cytokines (Spits et al., 
2013). Similar to Th17 cells, they are dependent on transcriptional factor RORγt for 
their development and function (Spits and Cupedo, 2012; Spit et al., 2013; Spits and 
Santo, 2011). However, they lack T cell markers such as CD3, which makes them 
distinguishable from RORγt+ T cells. In addition, the development of ILC3s is also 
dependent on a cytokine IL-7 through IL-7 receptor α (CD127). By inducing 
different infections to adult mouse models, at least 3 subsets of RORγt+ ILCs have 
been identified and named according to their phenotypical markers (e.g. CD117, 
CD4, NKp46) and cytokine production (i.e. IL-22 or IL17 or both) (Luci et al., 2009; 
Sonnenberg et al., 2012; Spits and Cupedo, 2012; Spit et al., 2013; Spits and Santo, 
2011). These RORγt+ ILCs in adults include lymphoid inducer cells (LTi cells, 
RORγt+ CD3- CD127+ CD4+ CD117+ NKp46-) which mainly produce IL-22 but also 
IL-17, ILC22 (also named as NCR
+ILC3s, RORγt+ CD3- CD127+ CD4+/- CD117+ 
NKp46
+
) which mainly produce IL-22, and ILC17 (also named as NCR
- 
ILC3s, 
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RORγt+  CD3- CD127+ CD4- CD117- NKp46-) which produce both IL-17 and IL-22 
as well as IFN-γ) .   
 
To examine if ILC3s are present in skin and involved in skin wound healing and to 
define their phenotypes, wounded as well as unwounded RORγ+/- mice with RORγ-
GFP transgene were analyzed by flow cytometry for CD45, CD3, TCRβ, TCRδ, Vγ3, 
CD127, CD4, CD117 and NKp46. I first analyzed CD45
+
 RORγ-GFP+ cells which 
could include ILC3s as well as rare RORγt+ T cells such as Th17, Th22 and some 
dermal γδ T cells (Gray et al., 2011). In both unwounded skin and wounded skin, the 
vast majority of RORγ-GFP+ cells are positive for CD45 (Figure 3.12A-C), 
suggesting RORγ is almost exclusively expressed by immune cells. In unwounded 
skin, RORγ-GFP+ cells were very rare, accounting for 0.06 ± 0.02% of total skin 
cells (Figure 3.12A and B). This percentage was dramatically increased to 0.28 ± 
0.06% on day 2 post-wounding (Figure 3.12C), suggesting RORγ+ cells may be 
involved in early stage of skin wound healing. To distinguish ILC3s (CD3
-
) from 
RORγt+ T cells (CD3+), CD45+ RORγ-GFP+ cells were analyzed for CD3 expression. 
The vast majority (approximately 95%) of CD45
+ RORγ-GFP+ cells were negative 
for CD3 (Figure 3.12D and E), suggesting the majority of RORγ+ cells recruited into 
skin wound site at this time-point are not T cells. To confirm this, CD45
+
 RORγ-
GFP
+ cells were analyzed for markers for different T cell subsets, such as TCRβ and 
TCRγ and Vγ3. Similarly, the vast majority (approximately 99%) of CD45+ RORγ-
GFP
+
 cells were negative for TCRβ and TCRγ or Vγ3 (data not shown). To our best 
knowledge, only ILC3s or certain subsets of T cells are found to express RORγt 
(Spits et al., 2013), therefore these
 RORγ+ non-T cells found in skin wounds are very 
likely to be ILC3s. In order to define the phenotypes and subsets of these RORγ+  
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Figure 3.12 The phenotypes of the vast majority of RORγ-expressing cells 
recruited in skin wounds are CD3
- 
CD4
dim to + 
CD127
dim to + 
CD117
-
 NKp46
- 
ILC3s. Cells isolated from uninjured wild type GFP-negative back skin (A), 
uninjured RORγ+/-(GFP) (B) and injured RORγ+/-(GFP)  mouse back skin at day 2 (C-M) 
post-wounding were labelled with CD45, CD3, CD127, CD4, NKp46 and CD117 
and were first analyzed for CD45
+
 RORγ/GFP+ cells (A-C). Then CD45+ 
RORγ/GFP+ cells as well as CD45+ RORγ/GFP- cells in wounded RORγ+/- skin on 
day 2 post-wounding were gated and compared for expression of CD3, CD127, CD4, 
NKp46 and CD117 (D-M). Gate frequencies are indicated in percentages. Shown 
one biological sample; 3 individual biological replicates were tested (not shown). 
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non-T cells, CD45
+  RORγ-GFP+ cells were analyzed for expression of CD127 (IL-7 
receptor, IL-7R), CD4, CD117 (C-kit receptor) and NKp46. Approximately 60-70% 
of CD45
+ RORγ-GFP+ cells were positive for CD127 (Figure 3.12 E-F), while the 
rest of CD45
+  RORγ-GFP+ cells expressed a very low level of CD127. Similarly, 60-
70% of CD45
+ RORγ-GFP+ cells were positive for CD4 (Figure 3.12 G-H), while the 
rest of CD45
+ RORγ-GFP+ cells expressed a very low level of CD4. In contrast, the 
vast majority (over 95%) of CD45
+ RORγ-GFP+ cells were negative for CD117 and 
NKp46 (Figure 3.12J-M). Similar phenotypes were detected on day 5 post-wounding 
(data not shown). Taken together, these results suggest the phenotypes of the vast 
majority of RORγt+ cells involved in skin wound healing are CD45+ CD3-  CD127 dim 
to +
 CD4 
dim to +
 CD117
-
 NKp46
-. Therefore, these RORγ+ cells belong to ILC3s which 
by definition are innate lymphocytes (CD3
-
) and dependent on transcriptional factor 
RORγ (RORγ+) and IL-7 (CD127+) for their development (Spits and Cupedo, 2012; 
Spit et al., 2013; Spits and Santo, 2011). However, they may be a heterogeneous 
population or a distinct subset from currently known RORγt+ ILCs, such as LTi cells 
(CD4
+50%
 CD117
+
 NKp46
-
), ILC22 (CD4
+10%
 CD117
+
 NKp46
+
) or ILC17 (CD4
-
 
CD117
-
 NKp46
-
) because of their CD4
dim to +
 CD117
-
 NKp46
- 
phenotypes. 
 
 
To verify if GFP in these mice was expressed by genuine RORγt+ cells, skin sections 
from wounded RORγ+/-(GFP) mice were analyzed by using anti-RORγt and anti-GFP 
antibody. I confirmed that all GFP
+
 cells were detected by anti-RORγt antibody 
(Figure 3.13A) and thus were genuine RORγt+ cells. Then to verify the location, 
identity and phenotypes of these RORγt+ ILCs, skin sections from wounded 
wildtype mice were analyzed by using anti-RORγt antibody together with anti-CD3, 
CD4, CD127, CD117 or NKp46 antibody. I confirmed that the vast majority of  
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Figure 3.13 Phenotypes of RORγ-expressing cells are confirmed by 
immunofluorescence chemistry on skin wound sections. Back skin tissues from 
wounded RORγ/ GFP mice on day 2 post-wounding (A) and wildtype mice on day 5 
post-wounding (B-E)were collected. Sections were double or triple stained with 
antibodies to RORγ antigen (red in A, and green in B-E) together with CD3 (purple 
in B), CD4 (red in B), CD127 (red in C), CD117 (red in D) or NKp46 (red in E) and 
DAPI counterstained (blue). RORγ/GFP cells are shown in green in A. Arrows 
indicate double positive RORγ+ cells. Arrows indicate single positive 
RORγ+ cells Scale bar 100 µm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
130 
RORγt+ cells were localized in dermis adjacent to the wounds and were CD3- CD4dim 
to + 
CD127
dim to + 
CD117
-
 NKp46
-
 ILC3s (Figure 3.13B-E).  
 
To examine the presence and the involvement of ILC3s at different stages of skin 
wound healing, dermis as well as axillary and inguinal skin draining lymph nodes 
from wounded wild type mice were collected on day 1, 3, 5 and 8 post-wounding 
and analyzed by flow cytometry using anti-CD45 and RORγ antibodies. At all time 
points, a small number of ILC3s were detected in both dermis and draining lymph 
nodes, accounting for less than 2% of total cells in respective tissue (Figure 3.14A). 
The percentage of ILC3s was rapidly increased in dermis on day 1 post-wounding 
and continuously increased to its peak on day 5 post-wounding. This was 
accompanied by a reduction in the number of ILC3s in skin draining lymph nodes to 
its lowest level on day 5 post-wounding, suggesting the trafficking of blood-derived 
ILC3s back to blood circulation via lymph might be blocked or delayed to allow 
more ILC3s to maintain in wounded skin. By day 8 post-wounding, the percentage 
of ILC3s in dermis was dramatically decreased to unwounded level. 
Correspondingly, this was accompanied by a considerable increase in the percentage 
of ILC3s in skin draining lymph nodes, suggesting ILC3s left the wound and 
migrated to draining lymph nodes on 8 post-wounding. To verify these results and 
confirm the location of ILC3s, skin sections from wounded wild type mice were 
analyzed by using RORγ antibody. While ILC3s were detected in the dermis at all 
time-points (Figure 3.14B-E), the maximal number of ILC3s were detected on day 5 
post-wounding at wound edges (Figure 3.14D). On day 2 post-wounding, most 
ILC3s were found in the reticular dermis (Figure 3.14 C), however, by day 5 and day 
8 post-wounding, ILC3s were detected in both the reticular and papillary dermis 
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Figure 3.14 ILC3s are recruited into dermis following wounding and are most 
abundant on day 5 post-wounding. (a) The percentage of RORγ+ CD45+ cells in 
dermis and draining lymph nodes from uninjured or wounded mice at day 1, 3, 5 and 
8 post-wounding were determined by flow cytometry. Graph bars represent 
experimental mean of biological replicates and error bars represent standard error of 
the mean (SEM). (b)-(e) Immunofluorescence chemistry of RORγ staining (green) 
on skin sections from uninjured (b) or wounded mice at day 2 (c), 5 (d) and 8 (e) 
post-wounding. Counterstained with DAPI (blue). Asterisk marks wound site. Arrow 
marks positive cells. Scale bar 100 micron.  
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(Figure 3.14 D and E) confirming active recruitment of cells from the reticular blood 
vascular network into the dermis. These results suggest ILC3s are involved in both 
early and later stages of skin wound healing. 
 
3.3 Summary 
In this chapter, I examined the presence and dynamics of common immune cell types 
as well as an emerging group of innate lymphoid cells (i.e. ILC3s) at inflammation 
(day 2 post-wounding, or day 1 and 3 post-wounding), proliferation (day 5 post-
wounding) and remodeling phases (day 8 post-wounding) of skin wound healing by 
flow cytometry and immunofluorescence chemistry using wounded mouse model. In 
steady state, skin was populated by resident immune cells accounting for 8-12% total 
skin cells, among which macrophages residing in dermis were the predominant cell 
type. I also detected a considerable number of dermal αβ T cells and epidermal 
dendritic T cells and Langerhans cells residing in unwounded skin. On day 2 post-
wounding, the wound site was infiltrated by massive inflammatory cells which were 
either migrated from the adjacent skin or recruited from blood circulation through 
reticular blood capillaries. On day 5 post-wounding when the healing was in 
intensive proliferation phase, inflammatory infiltration at wound site was persistent 
but with a reduced speed of immune cell recruitment. By day 8 post-wounding when 
the wound was almost closed, inflammation was repressed and remodeling phase 
started. As for the specific cell types (Figure 3.15), most immune cells such as 
neutrophils, inflamed monocytes most of which gave to mature macrophages and a 
few of which acted as precursors for dendritic cells and possibly Langerhans cells, 
dendritic cells, Langerhans cells and NK cells reached their maximal number in early 
stage of wound healing followed by a reduction or maintenance (i.e. Langerhans  
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Figure 3.15 Summary of inflammation response in skin wound healing. Skin 
wound healing initiates with inflammation phase followed by proliferation phase and 
remodeling phase with the indicated timing. The overall inflammation response is 
immediately promoted upon wounding, dramatically increased on day 2 post-
wounding and persistent on day 5 post-wounding, and repressed on day 8. The 
cellular changes are shown in arrows. Upwards arrows indicate increase; downward 
arrows indicate decrease. 
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cells) in proliferation phase. Due to recruitment inflamed monocytes, the numbers of 
mature macrophages was dramatically increased in proliferation phase. In contrast, 
the numbers of γδ T cells including DETCs and dermal γδ T cells were first 
decreased in early stage of wound healing followed by recovery in proliferation 
phase probably through self-proliferation as well as recruitment of blood-derived γδ 
T cells. However, the key cells in adaptive system, αβ T cells and B cells, appeared 
not to be significantly involved in skin wound healing, which is consistent with 
previous findings (Stout, 2010). 
 
Most strikingly, in dermis from both unwounded and wounded mice, I detected 
ILC3s, a rare emerging population of innate lymphocytes which have been recently 
been identified to play a role in local immunity and epithelial tissue repair in thymus 
and intestine through producing IL-22 (Dudakov et al., 2012; Spits and Cupedo, 
2012; Spits et al., 2013; Spits and Santo, 2011). However, these ILC3s have unique 
phenotypes RORγt+ CD3- CD4dim to + CD127dim to + CD117- NKp46-, which are distinct 
from currently known ILC3 subsets such as LTi cells (RORγt+ CD3- CD127+ CD4+50% 
CD117
+ 
NKp46
-), ILC22 (RORγt+ CD3- CD127+ CD4+10% CD117+ NKp46+) or 
ILC17 (RORγt+ CD3- CD127+ CD4- CD117- NKp46-).   
 
I found these ILC3s were rapidly recruited into wound site dermis through blood 
vessels and reached their maximal number in proliferation phase. Interestingly, the 
other immune cells, such as macrophages, γδ T cells, which also had a pronounced 
expansion in their numbers in proliferation phase in wound healing (around day 5 
post-wounding), are found to play important roles in skin repair (Bolleville et al., 
2012; Macleod and Havran., 2011; Rodero and Khosrotehrani 2010; Stout 2010; 
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Sumaria et al., 2011). Macrophages contribute to myofibroblast-mediated wound 
contraction and dermal matrix deposition by producing TGF-β (Rodero and 
Khosrotehrani 2010; Stout 2010). Epidermal γδ T cells (DETCs) contributes to 
keratinocyte proliferation and migration of macrophage by producing IGF-1, KGF 
and hyaluronan respectively (Bolleville et al., 2012; Macleod and Havran, 2011). 
Dermal γδ T cells are believed to play a similar role with DETCs in wound healing, 
although no evidence has been obtained (Sumaria et al., 2011).  Therefore, it would 
be very interesting to expect a role for
 
ILC3s in skin wound healing, and this will be 
tested in the next chapter.  
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Chapter 4 The function of Group 3 ILCs (ILC3s) in skin wound healing 
4.1 Introduction 
Innate lymphoid cells (ILCs) are rare populations of lymphocytes that have key roles 
in secondary lymphoid tissue formation, homeostasis and cytokine production in 
response to pathogen infection or damage (Spits and Cupedo, 2012; Spits et al., 
2013). One group of ILCs (Group 3 ILCs, ILC3s), also known as RORγt+ ILCs, are 
characterized by the expression of RORγt transcription factor and have key roles in 
adult thymus regeneration and intestinal epithelial barrier homeostasis and repair 
through IL22 production (Dudakov et al., 2012; Spits and Santo, 2011) which is 
dependent on IL23 produced by localized dendritic cell (Lee et al., 2012).   
 
In last chapter, I presented evidence that RORγ+ CD3- CD4dim to + CD127dim to + 
CD117
- 
NKp46
- 
ILC3s are recruited early into skin wound site with a peak in 
proliferation phase of the healing programme. In contrast, RORγ+ T cells were hardly 
detectable in wounded skin especially at earlier time points, suggesting RORγ+ cells 
recruited into wound site are primarily ILC3s. To determine whether these ILC3s 
play similar roles in tissue repair in skin as they do in the other epithelial tissues 
through producing IL-22, wounded RORγ-/- mice lacking ILC3s as well as other 
RORγ+ cells were analyzed and compared to control littermate in respect with wound 
healing rate, inflammation influx and epidermal proliferation rate. Since skin 
resident γδ T cells play a role in wound healing as suggested by previous studies 
(Bolleville et al., 2012; Macleod and Havran, 2011; Sumaria et al., 2011), Rag2
-/-
 
mice with deficiency in γδ T cells as well as αβ T cells and B cells were used as 
defective healing controls. I found that RORγ-/- mice had poorly healed wounds 
compared to control littermates and Rag2
-/-
 mice, which was directly caused by loss 
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of ILC3s. I conclude that ILC3s contribute to normal wound healing by controlling 
the timing of epidermal proliferation, regulating monocyte/macrophage entry into 
wounded dermis and supplying an important early source of IL-23-dependent IL22.  
 
4.2 Results 
4.2.1 RORγ-/- mice have poorly healed wounds partly due to delayed epidermal 
proliferation 
The wound healing rate in RORγ-/- (Rag2+/-RORγ-/-, deficient in ILC3s and other 
RORγ+ cells i.e. RORγ+ T cells), Rag2-/- (Rag2-/-RORγ+/-, deficient in T cells and B 
cells) and littermate controls were analyzed. Mice were photographed daily and by 
day 3 post-wounding, wound size was delectably larger in RORγ-/- mice compared to 
control and Rag2
-/-
 littermates (data not shown). By day 8 post-wounding, wounds 
were fully closed in control and Rag2
-/-
 mice, while a large, crusty eschar remained 
in the poorly healed wounds in RORγ-/- mice (Figure 4.1A). Consistent with previous 
studies, there was some delay in wound closure in Rag2
-/-
 mice probably due to loss 
of γδ T cells (Jameson et al., 2002), however RORγ-/- mice exhibited a severe defect 
demonstrating a key, previously unrecognized role for RORγ+ cells in wound 
healing. As wounds in RORγ-/- mice remained large, I analyzed epidermal 
proliferation by Ki67 proliferation-marker expression; proliferation was quantified 
within a 0.5-millimetre distance from the wound site. On day 5 post-wounding, 
RORγ-/- mice had a marked reduction in Ki67+ cells compared to controls (p=0.0006, 
t-test) (Figure 4.1B and C), by day 8 post-wounding, an increase in proliferative cells 
was detected in RORγ-/- mice (p=0.0143, t-test) (Figure 4.1C), suggesting the wound 
healing defect in RORγ-/- mice is partly caused by delayed epidermal proliferation. 
 
 
140 
A B 
 
 
 
  
C        
 
 
 
 
 
 
 
 
*** 
 
141 
Figure 4.1 Skin wound healing in RORγ KO mice are delayed partly due to 
reduced epidermal proliferation. 4mm full-thickness wounds were created in 7-
week-old RORγ+/- Rag2+/- (control), RORγ-/- (RORγ KO) and Rag2-/- (Rag2 KO) 
mice.(A) On day 8 post-wounding, wounds in RORγ-/- mice remained large and 
crusty compared to Rag2
-/-
 and wild type controls.(B) Sections of wounded RORγ-/- 
(RORγ KO) and control tissues collected on day 5 post-wounding were stained with 
antibodies to Ki67 (white). Scale bars equal 100 microns. Experiment repeated ≥ 3 
times. (C) Graph shows percentage of Ki67
+
 basal epidermal cells within 500 
microns of the wound site in control verses RORγ-/- mice on day 5 and day 8 post-
wounding. Tissues from 4 wounds (biological replicates) from both genotypes and 
time points were quantified. Statistics of normally distributed data compared by 
Student’s t-test between control and RORγ KO samples on day 5 (p=0.0006***) and 
day 8 (p=0.0143*) post-wounding. Graph bars represent experimental mean of 
biological replicates and error bars represent standard error of the mean (SEM).  
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4.2.2 CCL-3 dependent monocyte/macrophage recruitment is delayed in 
wounded RORγ-/- back skin 
To examine if loss of RORγt+ cells impacts the activities of the other immune cells, 
such as macrophages, that have key roles in skin repair, wounded RORγ-/- back skin 
sections were analyzed using anti-F4/80 antibody which could detect Langerhans 
cells in epidermis, macrophages including resident macrophages and blood-recruited 
monocytes (immature macrophages), and subsets of dermal dendritic cells which 
counted for less than 3% of total F4/80
+
 cells in skin (Figure 3.2). There was no 
detectable change in F4/80
+
 cells in epidermal compartment, however, a three-fold 
reduction in dermal F4/80
+
 cells was detected on day 2 post-wounding, compared to 
control (p=0.0315, t-test) and Rag2
-/- 
littermates (Figure 4.2A and data not shown). 
Since at this time-point, a large number of inflamed monocytes as precursors of 
macrophages are normally recruited into wound dermis through dermal blood 
networks in hypodermis and granular tissues (Figure 3.2), the reduction in the 
number of dermal F4/80
+
 cells (Figure 4.2A and B) reflects that 
monocyte/macrophage recruitment was impaired in RORγ-/- mice. These results 
suggest RORγt+ cells but not T cells promote macrophage entry into dermis. This is 
consistent with a previous study which has shown DETCs do not contribute to 
macrophage recruitment (Macleod and Havran., 2011). By day 5 post-wounding, 
F4/80
+
 cells were plentiful within the dermis in all genotypes (Figure 4.2A right 
panel) suggesting that loss of ILC3s causes a delay, but not a block in macrophage 
infiltration. To examine the mechanism underlying the impaired macrophage 
recruitment, mRNA from wounded RORγ-/- back skin was analyzed for a chemokine 
CCL3 (also known as MIP1α, macrophage inflammatory protein-1α) which attracts  
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Figure 4.2 Macrophage recruitment is delayed in wounded RORγ-/- back skin.  
Back skin tissues from wounded 7-week-old RORγ+/- Rag2+/- (control), RORγ-/- 
Rag2
+/-
 (RORγ KO) and RORγ+/- Rag2-/- (Rag2 KO) were collected on day 2 or 5 
post-wounding. (A) Sections were stained with an antibody to F4/80 antigen (green) 
and DAPI counterstained (blue). Note RORγ KO wounds lack of dermal F4/80 
positive cells on day 2 post-wounding, but not on day 5 post-wounding. Red, dashed 
line marks epidermal-dermal boundary; asterisk marks wound site scale bars equal 
100 microns. (B) Graph shows percentage of F4/80
+
 dermal cells in control verses 
RORγ KO mice on day 2 post-wounding. Normally distributed data were compared 
by Student’s t-test; p=0.0315 (*). Graph bars represent experimental mean of 
biological replicates and error bars represent standard error of the mean (3SEM). (C) 
Relative mRNA levels of MIP1α (CCL3) quantified by quantitative PCR in 
unwounded back skin (UW) or wounded back skin on day 2 and 5 post-wounding 
from RORγ-/-, Rag2-/-, RORγ-/- Rag2-/- and littermate control mice using biological 
replicates (n = 3). mRNA levels were normalised to control mice on day 2 or day 5 
post-wounding (designated 1). MIP1α mRNA transcripts were undetectable (ND) in 
uninjured control skin. Note mean levels of MIP1α were 1.6-fold lower in 2-day 
wounded RORγ KO skin. Experiments were repeated ≥ 2 times. 
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the monocyte/macrophages to inflammatory sites. Compared to littermate controls, 
RORγ-/- mice had lower levels of CCL3 mRNA on day 2 post-wounding (Figure 
4.2C) when the maximal number of monocytes are activated in normal wound 
healing (Figure 3.2), but had dramatically higher level on day 5 post-wounding 
(Figure 4.2C) when monocyte recruitment are unusually reduced in normal wound 
healing (Figure 3.2). In contrast, CCL3 mRNA level was considerably higher in 
wounded Rag2
-/- 
 back skin than that in littermate controls on both day 2 and day 5 
post-wounding (Figure 4.2C), suggesting T cells, probably skin resident γδ T cells 
might have a regulatory role in monocytes/macrophages recruitment. These results 
confirm that monocyte/macrophage recruitment is delayed in RORγ-/- mice in a 
mechanism dependent on CCL3. 
 
4.2.3 Loss of ILC3s directly causes wound healing defect in RORγ-/- mice  
Although I have determined the vast majority of infiltrating RORγ+ cells in wildtype 
skin wound are negative for CD3, TCRβ and TCRγ, and thus are not T cells, a rare 
subset of RORγ+ γδ T cells are present at low levels in dermis (accounting for less 
than 1% of total RORγ+ cells, Figure 3.12) (Gray et al, 2011) and might infiltrate 
skin wounds together with other γδ T cells at later stage of wound healing as 
suggested by the increase in dermal γδ T cell influx on day 5 post-wounding (Figure 
3.7). In addition, since RORγ is also transiently expressed by double positive CD4+ 
CD8
+
 T cells in thymus (Sun et al., 2000), T cell development and function could be 
disrupted or altered in RORγ-/- mice, although the role of RORγ for T cell 
development is yet to be determined. Therefore, to determine if abnormal function of 
the remaining RORγ- γδ T exist and impacted wound healing in RORγ-/- mice. I 
examined wound healing in Rag2
-/-
ROR
-/-
 mice, which lack ILC3s and all T and B  
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(A)  Wound phenotypes on day 5 post-wounding 
    
(B) RORγ  DAPI               day 5 post-wounding 
 
 
Figure 4.3 Loss of ILC3s directly causes wound healing defects. (A) Pictures of 
skin wounds taken on day 5 post-wounding show wound healing was delayed in 
RORγ-/- skin, however wound size in RORγ-/- Rag2-/- was similar to wounded 
littermate controls. Rag2
-/-
 (deficient in T cells and B cells) spleen cells (SPCs) were 
transplanted into RORγ-/- mice prior to wounding (n = 3 mice). The wound size from 
RORγ-/- mice with transplanted Rag2-/- spleen cells (including ILC3s, but excluding 
T cells) were similar to controls). (B) Tissue sections antibody stained for RORγ 
reveal ILC3s were recruited to wound sites in RORγ-/- skin with transplanted Rag2-/- 
spleen cells. White arrows mark positive cells; asterisk marks wound site.  
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cells. Wound healing was not delayed significantly compared to control
 
littermates 
(Figure 4.3), suggesting that T cells contribute to RORγ-/- wound pathology in some 
degree but that neither ILC3s nor RORγt+ T cells are absolutely required for wound 
healing. To determine if the phenotype observed in the RORγ-/- mice was a result of 
loss of 
 
ILC3s rather than T cells, spleen cells from Rag2
-/-
 mice (lacking αβ and γδ T 
cells but containing ILC3s) were transferred into RORγ-/- mice 24 hours prior to 
wounding. Cell transplantation ameliorated wound pathology observed in control 
RORγ-/- mice and donor ILC3s could be detected adjacent to wound sites (Figure 
4.3B). Therefore I conclude that the loss of ILC3s in RORγ-/- mice directly causes 
wound pathology.  
 
4.2.4
 
ILC3s supply early IL-22 in skin wound healing 
By definition, ILCs are innate lymphocytes that produce the cytokines which were 
originally thought to be produced by their corresponding counterparts T lymphocytes 
(Spits and Cupedo, 2002; Spits et al., 2013). Specifically, ILC3s are considered as 
counterparts of Th17 or Th22 cells, and produce IL17 and/or IL22 in response to IL-
23 (Spits and Cupedo, 2002; Spits et al., 2013). In addition, some infiltrating γδ T 
cells may produce IL17 and/or IL22 (Gray et al., 2011). IL22 mediates its functions 
in tissues by binding to its heterodimeric receptor consisting of IL-10 receptor β (IL-
10Rβ) and IL-22 receptor α (IL-22Rα) (Xie et al., 2000). IL-22 signaling is typically 
involved in hemostasis and immunity in epithelial tissues, since IL-22Rα is almost 
exclusively expressed by epithelial cells such as epidermal keratinocytes (McGee et 
al., 2013; Wolk et al., 2006). Furthermore, IL-22 has shown a key role in tissue 
repair and regeneration in thymus and intestine (Dudakov et al 2012), and promotes 
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keratinocyte proliferation and migration while repressing their differentiation in vivo 
(Boniface et al., 2005; Wolk et al., 2006; McGee et al., 2013). In addition McGee et 
al (2013) has shown that IL22 also promotes dermal repair by functioning on dermal 
fibroblasts. Given the results in the last chapter that ILC3s are recruited early to 
wound sites and promote epidermal proliferation during wound healing, I 
hypothesize ILC3s play this role via IL-22. To test this, IL-22 mRNA levels were 
examined by QPCR. In unwounded skin, IL-22 mRNA level was at the lower limit 
of detection by QPCR. On day 2 post-wounding, IL-22 mRNA levels in RORγ-/- 
wounds were not significantly different from unwounded controls (Figure 4.4A). 
Rag2
-/-
 mice also had reduced levels of IL22 consistent with a role for infiltrating γδ 
T cells in wound healing (Gray et al., 2011). Only control littermates displayed an 
evident increase in IL22 mRNA levels. Normally distributed data were compared 
between RORγ-/- and control littermates at day 2 post-wounding by Student’s t-test 
(p=0.017) (Figure 4.4A), suggesting a significant reduction of IL-22 mRNA levels in 
RORγ-/-. This reduction in IL-22 was not caused by lack of IL-23 as IL-23 mRNA 
expression was similar between RORγ-/- and control wounds (Figure 4.4A). These 
results suggest the delay in epidermal proliferation in RORγ-/- wounds is likely due 
in part to reduction in early IL22 expression. 
 
Surprisingly, on day 5 post-wounding, increased levels of IL-22 mRNA were 
detected in both RORγ-/- and Rag2-/-wounds as well as control wounds compared to 
unwounded control, with highest levels detected in RORγ-/- wounds (Figure 4.4B). 
Since IL-22 is known to be primarily produced by T cells (e.g. Th22) and ILC3s 
(Delves et al., 2011), this result suggested that some currently uncovered IL-22 
producing cells might switch on IL-22 synthesis and compensate for the absence of 
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Figure 4.4
 
ILC3s are an important early source of IL22. (A) mRNA was isolated 
from unwounded controls or wounded RORγ+/- Rag2+/- (WT), RORγ-/- (RORγ KO), 
Rag2
-/-
 (Rag2 KO), RORγ-/-/Rag2-/-, or common γ chain-/- Rag2-/-  skin collected 2 
days post wounding (dpw). Relative mRNA levels of IL22 and IL23 was quantified 
by QPCR. mRNA levels were normalised to unwounded control for IL22 
(designated 1) or to wounded control mice for IL23 (designated 1). IL22 and IL23 
mRNA transcripts were undetectable (ND) in uninjured control skin. Note only 
control mice 2 dpw (p=0.0170) had statistically significant upregulation of IL22 
compared to unwounded controls, whilst IL23 levels were not significantly different 
amongst genotypes. (B) By day 5 post-wounding, IL22 levels were elevated 
compared to unwounded controls in both wild type (WT) and leukocyte-deficient 
mice (RORγ-/-, Rag2-/-, RORγ-/-Rag2-/- and common γ chain-/- Rag2-/-). Error bars 
show standard error of the mean (SEM). For IL22, analysis = 5 or 6 biological 
replicates; for IL23, 3 replicates.  
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ILC3s or RORγ+ T cells at later stage of wound healing. To test this, Rag2-/-RORγ-/- 
wounds which lack ILC3s as well as both T cells and B cells, and γc-/-Rag2-/- wounds 
which lack all lymphoid cells including NK cells were examined. Like the other 
immune-compromised mice examined, IL-22 mRNA levels were also elevated in 
day 5 wounds in Rag2
-/-RORγ-/- and γc-/- Rag2-/- mice, confirming non-lymphocyte 
source of IL22 exist in skin wounds and provide IL22 at later stage required for 
tissue repair. The RORγ-/- wounds lacking early presence of IL-22 healed poorly 
despite an increased expression of IL22 at later stage, suggesting that the early IL-22 
production is essential for wound healing and is dependent on ILC3s.  
 
4.2.5 IL-23 from dendritic/Langerhans cells is required for IL-22 production in 
skin wounds 
It is well established that IL-23, a protein formed of two subunits, P19 and p40, 
stimulates ILCs to produce IL-22 or IL-17 (Sonnenberg et al., 2011). Dendritic cells 
are considered as a source of abundant IL-23, however the IL-23 subunit p19 can be 
expressed by other cell types, such as colonic sub-epithelial myofibroblasts after 
being stimulated by TNFα (McGee et al, 2013). To confirm that skin dendritic cells 
are the source of IL-23 during wound healing, CD11c
Cre
Rosa26
iDTR
 (Jung et al., 
2002) were injected intraperitoneally with diphtheria toxin (DT) to deplete all 
dendritic cells including epidermal Langerhans cells or with PBS as a control for 4 
consecutive days before wounding. Tissues were analyzed 2 or 5 days post-
wounding and I confirmed that skin dendritic cells and Langerhans cells were 
deleted in DT-treated CD11c
Cre
Rosa26
iDTR
 mice by skin section staining with CD11c 
and CD207 (Figure 4.5 B and C). From day 2 post-wounding, the wound sizes in DT 
treated animals were detectably larger than PBS-treated animals (Figure 4.5A). Both  
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Figure 4.5 IL22 production is dependent on IL23 supplied mainly by dendritic / 
Langerhans cells. CD11
cre
Rosa26
iDTR
 (CD11c-DTR) mice were injected with PBS 
or diphtheria toxin (DT) for 4 days prior to wounding. Back skin tissues were 
collected on day 2or day 5 post-wounding. (A) Pictures were taken on day 5 post-
wounding. (B-C) Tissue sections antibody stained for CD207 on day 5 post-
wounding and CD11c on day 2 post-wounding confirm Langerhans cells and 
dendritic cells were depleted in CD11c-DTR  White arrows mark positive cells; 
asterisk marks wound site. Scale bars equal 100 microns. (D and E) mRNA was 
isolated from wounded mice and IL22 or IL23 levels quantified by QPCR. mRNA 
levels were normalised to PBS-injected day 2 or day 5 wounded CD11c-DTR mice 
(designated 100%). DT-treatment reduced IL22 and IL23 levels in wounds on both 
day 2 (D) and day 5 (E) post-wounding. Error bars show standard error of the mean 
(SEM). Statistic differences were compared by using Student’s t-test in IL-23 
mRNA on day 2 (p=0.0025**) and day 5(p=0.0028**), and in IL-22 mRNA on day 
2 (p=0.0006**) and day 5 (p=0.0054*). 
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IL-23 and IL-22 mRNA levels in DT-treated animals were reduced by nearly 50% 
compared to PBS-treated animals (p=0.0025 and 0.0006 for IL-23 and IL-22 
respectively, t-test) (Figure 4.5D). On day 5 post-wounding, IL23 mRNA level was 
further substantially reduced (14% of PBS-control treated animals) (p=0.0028, t-test), 
correspondingly, IL-22 was also considerably reduced (8% of PBS-control treated 
animals) in DT-treated CD11c
Cre
Rosa26
iDTR 
wounds (p=0.0054, t-test) (Figure 4.5E). 
Taken together, these results confirm that dendritic cells in skin are the main source 
of IL-23 which is required for IL-22 production during wound healing.  
 
4.2.6 IL23 is required for IL22-dependent epidermal proliferation but not for 
monocyte/macrophage recruitment 
Since  differential productions of IL-22 were detected in DT-treated and PBS-treated 
CD11c
Cre
Rosa26
iDTR 
due to loss of dendritic/Langerhans cell-produced IL23, 
epidermal proliferation rates and monocyte/macrophage recruitment were then 
compared between these mice in order to confirm if IL22/IL23 play a role in 
macrophage/monocyte recruitment as well as epidermal proliferation. Wounded skin 
sections were first analyzed for proliferation marker Ki67 on day 5 post wounding 
using an antibody specific to Ki67. As expected, a large number of Ki67
+
 cells were 
detected in wound edge epidermis in PBS-treated CD11c
Cre
Rosa26
iDTR 
animals 
(Figure 4.6A), confirming the epidermal predominant cell type, keratinocytes, were 
undergoing extensive proliferation, although a small proportion of Ki67+ cells could 
be self-proliferating Langerhans cells. By contrast, the epidermal layers in DT-
treated CD11c
Cre
Rosa26
iDTR
 mice were much thinner than PBS-treated animals.  
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Figure 4.6 IL23/IL22 is required for epidermal proliferation but not for 
macrophage/monocyte recruitment.  CD11
cre
Rosa26
iDTR
 (CD11c-DTR) mice were 
injected with PBS or diphtheria toxin (DT) for 4 days prior to wounding. Back skin 
tissues were collected on day 2or day 5 post-wounding. Tissue sections antibody 
stained for Ki67 (A) on day 5 post-wounding and F4/80 (B) on day 2 post-wounding 
reveal dramatic reduction in epidermal proliferation but apparently normal 
macrophage recruitment in CD11c-DTR. Asterisk marks wound site. Scale bars 
equal 100 microns 
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Correspondingly, Ki67
+
 cells were almost undetectable. Skin sections were then 
analyzed for monocytes/macrophages by using an antibody to their marker F4/80 on 
day 2 post-wounding marker when a large number of monocytes/macrophages are 
normally recruited into wound site. F4/80
+
 monocyte/macrophage were plentiful in 
both wound edge dermis and hypodermis in both DT and PBS treated 
CD11c
Cre
Rosa26
iDTR
 mice (Figure 4.6B). It should be noted, the vast majority of 
epidermal F4/80
+
 cells were lost in DT-treated CD11c
Cre
Rosa26
iDTR 
mouse 
epidermis, confirming the deletion of F4/80
+
 Langerhans cells. These results suggest 
epidermal proliferation but not monocyte/macrophage recruitment is dependent on 
IL23/IL22 signaling. Consistent with previous results (Boniface et al., 2005; Wolk et 
al., 2006), I have shown a co-relationship between IL22 and epidermal proliferation. 
In addition, I found IL22 may not be required for monocyte/macrophage recruitment, 
although this is to be confirmed yet by future experiments where IL-22 needs to be 
directly targeted. 
  
4.3 Summary 
In this chapter, I presented evidence that loss of  ILC3s in RORγ-/- mice directly 
impacted the wound healing rate with delayed dependent epidermal proliferation and 
monocyte/macrophage recruitment due to lack of early IL-22 and CCL3 
respectively. I also demonstrated loss of dendritic/Langerhans cells in DT-treated 
CD11c
Cre
Rosa26
iDTR
 mice causes dramatic reduction of IL-23 production and its 
dependent IL-22 production thereby indirectly impacting wound healing. These 
results suggest that ILC3s play a key role in normal skin wound healing by 
promoting early entry of monocyte/ macrophage into wound site via CCL3, and 
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supplying early source of IL-22 for epidermal proliferation. Skin localized dendritic 
cells including both Langerhans cells and dermal dendritic cells also may play a role 
in wound healing by producing IL-23 that activates ILC3s and other IL22-producing 
non-lymphocytes to produce IL22, a key signaling in epithelial tissue repair.   
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Chapter 5 Epidermal Notch1 signaling promotes skin wound healing through 
recruiting ILC3s  
5.1 Introduction 
The Notch pathway is a key, cell-autonomous signaling pathway that directs cell fate 
and has pleiotropic functions in the skin (Ambler and Watt, 2010; Watt et al., 2008). 
Notch signaling initiates when a Notch ligand binds to one of four receptors present 
on mammalian cells, which causes receptor cleavage and enables the intracellular 
domain to undergo nuclear translocation and affect changes in gene transcription 
(Artavanis-Tsakonas et al., 1999). There are 4 mammalian Notch receptors, 
expression of all 4 receptors in the epidermis has been reported (Nickoloff et al., 
2002). Genetic studies suggest Notch1 is the primary receptor needed to regulate cell 
differentiation required to maintain hair and skin epithelium (Ambler and Watt, 
2010; Estrach et al., 2007; Kerabs et al., 2000; Kerabs et al., 2003; Pan et al., 2004; 
Watt et al., 2008). However, some studies suggest Notch2 also plays a non-
redundant role in embryonic development and tissue maintenance (Pan et al., 2004; 
Saito et al., 2003). A previous study using topically-applied pan-Notch activators 
and inhibitors suggested that Notch might be involved in wound healing, however, 
the mechanistic details and site of action were unknown (Chigurupati et al., 2007). 
Our lab’s previous previous work showed that forced, ectopic epidermal Notch1 
activity in by applying 4OHT to K14NICDER mice resulted in extensive, epidermal 
proliferation and severe inflammation, two phenotypic hallmarks of skin wound 
healing (Ambler and Watt, 2007; Ambler and Watt, 2010; Estrach et al., 2006). 
Therefore, I hypothesized adult epidermal Notch signaling might play roles in skin 
wound healing by contributing to inflammatory cell recruitment and epidermal 
proliferation.  
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In this chapter, Notch1 and Notch2 activity was examined during skin wound 
healing. I found both Notch1 and Notch2 were rapidly activated in skin 
predominantly within epidermal compartment after injury with different timings, 
suggesting epidermal Notch1 and Notch2 might play different roles in skin wound 
healing. To investigate their individual roles, mice were pre-treated with individual 
Notch receptor blocking antibody, anti-NRR1 or anti-NRR2 before wounding. I 
found that the wound healing rate in anti-NRR1 treated were significantly impacted 
at early stage (2 days post-wounding) compared to control mice. However, there is 
no significant difference in later stage on day 5 post-wounding. I hypothesized the 
delay in wound healing might be caused by lack of early IL-22 following blocking 
Notch1. Since in the last chapter, I presented evidence that ILC3s supplies early IL-
22, a key signaling in epidermal proliferation in wound healing, it is possible that 
Notch1 exerts its role in wound healing via ILC3s. To test this, inflammatory cellular 
influxes were analyzed in anti-NRR1 treated wounded mice and in 4OHT-treated 
uninjured K14NICDER mice where Notch1 activity can be tightly controlled in the 
epidermis. The K14NICDER transgene contains a truncated, Notch1 intracellular 
domain (NICD1) that can be temporally and spatially activated by 4-hydroxy-
tamoxifen (4OHT) in the basal, keratin 14-expressing epidermis. I confirmed that 
ILC3 recruitment were recruited into dermis in a manner dependent on epidermal 
Notch1 signaling, which contributes to wound closure by producing early IL-22 as 
well as recruiting monocyte/macrophage early to the wound site. These results 
suggest epidermal Notch1 signaling promotes skin wound healing through an ILC3-
mediated process. 
 
5.2 Results 
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5.2.1 Skin injury activates epidermal Notch1 and Notch2  
To determine the Notch1 and Notch2 activities in wound healing, wounded mouse 
back skin were collected on day 1, 3/4 and 7 days post-wounding, and analyzed by 
western blotting and immunofluorescence chemistry using specific antibodies to 
activated forms of Notch1 or Notch2. Western blotting results (Figure 5.1A) showed 
that wounding caused an immediate increase in Notch1 activity on day 1 post-
wounding (7x) (p=0.0183, t-test) with peak activity detected on day 4 post-wounding 
(16x) (p=0.0011, t-test) (data collected by Soulmaz Boroumand). Notch2 activity 
was also immediately increased after injury with a less significant rate than Notch1. 
Notch2 activity reached its peak (2.5x) (p<0.05, t-test) on day 1 post-wounding and 
was gradually decreased afterwards, and dropped back to unwounded level by day 8 
post-wounding (Data was collected by Soulmaz Boroumand). The location of 
Notch1 and Notch2 expression in epidermis was confirmed by immunofluorescence 
chemistry on skin sections (Figure 5.1B, data collected by Soulmaz Boroumand). In 
unwounded skin, Notch activity was detected only in rare epidermal supra-basal cells 
(data not shown; Ambler and Watt, 2010). However, increased Notch1 and Notch2 
activity was detected in all epidermal layers (Figure 5.1 B, data collected by 
Soulmaz Boroumand). These results suggest skin injury results in immediate 
activation of Notch1 and Notch2 activity in epidermal keratinocytes. However, there 
is a difference in the timings and the fold-changes between Notch1 and Notch2 
activity, suggesting Notch1 and Notch2 might have different roles in wound healing.    
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Figure 5.1 Epidermal Notch1 and Notch2 are activated upon skin injury (Data 
was collected by Soulmaz Boroumand). Back skin tissues from punch-wounded 
wild type mice were collected 1, 4 and 7 days post-wounding. (A) Quantified levels 
of cleaved, activated Notch1 and Notch2 proteins by antibody probes in a western 
immunoblotting assay. As loading controls, Notch1 and Notch2 levels were 
standardized to β-actin levels as a loading control and normalized to the average 
back skin protein levels (designated as 1) of Notch1 or Notch2 in uninjured 
littermate mice (n=3). Unwounded back skin was taken from a punch-wounded 
mouse at a distal site (minimum 2 cm) from wound site. Protein lysates from 3 
different mice were analyzed for each time point post-wounding (dpw). Statistics of 
normally distributed data are compared by Student’s t-test between wounded and 
unwounded samples at the stated days post-wounding. Notch1, 1 dpw p=0.0183 (*), 
4 dpw p=0.0011 (**), 7 dpw p=0.0001(***); Notch2, 1dpw p<0.05(*). (B) 
Antibodies specific for activated Notch1 and Notch2 and reacted with cells adjacent 
to wound on day 4 post-wounding. Note activated Notch1 and Notch2 is detectable 
in all epidermal layers. Asterisk marks wound site. Scale bar equals to 50 microns. 
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5.2.2 Treating with anti-NRR1 and anti-NRR2 blocking antibodies specifically 
reduce Notch1 or Notch2 activity in wounded skin 
To investigate the role of Notch pathway in wound healing, Notch signaling was 
blocked prior to wounding. With the most recent pharmaceutic development of 
Notch-blocking antibodies, anti-NRR1 and anti-NRR2, ligand-activation of 
individual Notch receptor (i.e. Notch1 or Notch2) could be blocked (Wu et al., 
2010). To test if anti-NRR1 and anti-NRR2 treatments were effective to block Notch 
signaling in our wounded mouse model, wildtype mice were injected 
intraperitoneally (i.p.) with 5mg/kg of anti-NRR1, 5mg/kg of anti-NRR2, 5mg/kg of 
control (anti-ragweed) or 2.5mg/kg of both anti-NRR1 and anti-NRR2 every 3 or 4 
days for 7 days prior to wounding (Figure 5.2A). Since combined treatment with 
anti-NRR1 and anti-NRR2 are reported to cause severe adverse effects on mouse 
intestine and body weight loss by at least 10% due to blockage of both Notch1 and 
Notch2 signaling (Wu et al., 2010), the body weight of mice was scaled at the 
indicated days (Figure 5.2A) and compared to their body weight prior to the initial 
treatment. As expected, the body weight of combined anti-NRR1 and anti-NRR2 
treated mice were dramatically reduced 3 days after the initial treatment and by day 7 
their body weight was decreased by over 10% compared to their original body 
weight prior to treatment. By contrast, the mice which were treated with the other 
antibodies maintained their body weight (change <5%) before wounding. It is not 
surprising that all mice lost body weight at some degrees after wounding, since 
injury causes both physical and physiological stress to mice (Guo and DiPietro, 
2010). These results confirmed that combined treatment with anti-NRR1 and anti-
NRR2 blocking antibodies caused intestinal effects as expected in our wounded 
mouse model. 
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Figure 5.2 Systemic effects of anti-NRR1 and anti-NRR2 treatment. Punch-
wounded wild type mice were injected peritoneally with 5mg/kg of anti-NRR1, 
5mg/kg of anti-NRR2, 2.5mg/kg of both anti-NRR1 and anti-NRR2 antibodies or 
5mg/kg anti-ragweed control for 7 days prior to wounding. (A) Body weight changes 
within 9 days following anti-NRR1/NRR2 treatment and wounding at day 7 
(indicated by red asterisk). Arrow heads marks the timing of anti-NRR1/NRR2 
treatment. Note the body weight in combined anti-NRR1and anti-NRR2 treated mice 
was dramatically reduced. (B) Thymus was collected on day 2 post-wounding. Cells 
isolated from thymus were labelled with CD4 and CD8 antibodies and analysed by 
flow cytometry, only 2.1% of cells are CD4
+
CD8
+
 in NRR1 treated mice. (C) Spleen 
was collected on day 2 post-wounding, cells isolated from spleen were labelled with 
CD45R (B220), CD5, CD21 and CD23, and analyzed by flow cytometry, only 0.34% 
of CD45R
+ 
B cells are CD21
+
 CD23
-
 cells. Note Notch1 activity is required for T 
cell maturation in thymus, while Notch2 activity is required for B cell maintenance 
in spleen marginal zone (Izon et al., 2001; Saito et al., 2003). (B-C) represent one 
biological sample, 3 individual biological replicates were tested (not shown).  
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To test if anti-NRR1 and anti-NRR2 are effective to specifically block Notch1 or 
Notch2 activity, wildtype mice were i.p. treated with 5mg/kg of anti-NRR1, 5mg/kg 
of anti-NRR2 or 5mg/kg of anti-ragweed control for 7 days prior to wounding, then 
thymus and spleen were collected on day 2 post-wounding. Previous studies have 
shown Notch1 activity is required for T cell maturation in thymus, while Notch2 
activity is required for B cell maintenance in spleen marginal zone (Izon et al., 2001; 
Saito et al., 2003). Therefore, cells isolated from thymus were stained with 
antibodies to CD4 and CD8 to examine double positive thymocytes (CD4
+
 CD8
+
) 
and cells isolated from spleen were stained with antibodies to CD45R (B220), CD5, 
CD21 and CD23 to examine the splenic marginal zone B cells  (CD45R
+ 
CD21
+ 
CD23
-
) (Wu et al., 2010). As seen in Figure 5.2B, there was a sharp reduction in the 
percentage of double positive thymocytes (CD4
+
CD8
+
) in anti-NRR1 treated mice 
from over 80% to below 3%, while this percentage was not significantly changed in 
anti-NRR2 treated mice (data not shown). As seen in Figure 5.2C, splenic marginal 
zone B cells were detected in anti-ragweed-treated mice, representing over 10% of 
total CD45R
+
 B cell in spleen. However, this percentage was dramatically reduced to 
less than 1% in anti-NRR2 treated mice. There was no significant change in the 
number of splenic marginal zone B cells in anti-NRR1 treated mice (data not 
shown). These results confirmed that treatment with anti-NRR1 or anti-NRR2 
specifically and completely blocked Notch1 or Notch2 signaling in large lymphoid 
organs, such as spleen and thymus as expected, in our wounded mouse model. 
 
To test if peritoneal injection with anti-NRR1 and anti-NRR2 antibodies was 
effective to target Notch1 or Notch2 activity in skin both of which have shown an 
significant increase upon wounding (Figure 5.1A), punch-wounded wildtype mice 
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were i.p. treated with 5mg/kg of anti-NRR1, 5mg/kg of anti-NRR2 or 5mg/kg anti-
ragweed control for 7 days prior to wounding, then wounded skin tissues were 
collected and processed on day 2 post-wounding. Wounded skin sections were 
stained with an antibody to activated form (cleaved form) of Notch1 or Notch2 
intracellular domain.  As seen in Figure 5.3A-D, the detectable levels of cleaved 
Notch1 and Notch2 upon wounding were lowered by anti-NRR1 or anti-NRR2 
treatment, however, cleaved Notch1 or Notch2 were still detectable in epidermis 
(indicated by arrows in Figure 5.3B and D), suggesting epidermal Notch1 and 
Notch2 activities, unlike the ones in thymus or spleen, was incompletely inhibited by 
corresponding blocking antibodies. The differential effectiveness observed between 
skin and central organs (i.e. Thymus and spleen) may be due to the relatively limited 
entry of chemicals to skin through blood circulation. To confirm if epidermal Notch1 
or Notch2 was inhibited, western immunoblotting of protein lysates extracted from 
wounded back skin from anti-NRR1, anti-NRR2, combined anti-NRR1 and anti-
NRR2, and anti-ragweed control treated mice were probed with an antibody to 
cleaved Notch1 or Notch2 as well as loading control β-actin (Figure 5.3E-F). As 
expected, the lowest levels of cleaved Notch1 protein were detected in anti-NRR1 as 
well as combined anti-NRR1 and anti-NRR2 treated mice, while the lowest levels of 
cleaved Notch2 protein were detected in anti-NRR2 as well as combined anti-NRR1 
and anti-NRR2 treated mice. Note, compared to Notch1, less abundant levels of 
cleaved Notch2 protein were detected in anti-ragweed treated mice, which is 
consistent with our finding (Figure 5.1) that the increase in Notch2 activity upon 
wounding is not as evident as Notch1 activity. In summary, I confirmed that i.p. 
treatment with anti-NRR1 and anti-NRR2 blocking antibodies specifically reduced 
Notch1 or Notch2 activity in wounded mouse back skin (i.e. epidermis). 
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Figure 5.3 Epidermal Notch1 and Notch2 activities are reduced by anti-NRR1 
or anti-NRR2 treatment. Punch-wounded wildtype mice were injected peritoneally 
with 5mg/kg of anti-NRR1, anti-NRR2, anti-ragweed control for 7 days prior to 
wounding. Skin tissues were collected and processed on day 2 post-wounding. (A-D) 
Skin sections from anti-ragweed IgG control (A, C), anti-NRR1 (B), anti-NRR2 (D) 
treated mice were stained with activated cleaved Notch1 (A-B) and Notch2 (C-D) 
respectively. Scale bars equal 50 microns. (E-F) Western immunoblotting of protein 
lysates were probed with antibodies to cleaved Notch1, Notch2 or β-actin. Shown 
one biological sample; 3 individual biological replicates were tested (not shown) and 
experiments performed twice per sample. Note, NRR1 treatment lowered detectable 
levels of cleaved Notch1 by in sections (B, arrows) and immunoblotting (E), 
however, Notch1 receptor cleavage was not completely inhibited by NRR1 blocking 
antibodies in wounded skin.  
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5.2.3 Inhibiting Notch1 activity causes wound healing delay partly due to lack of 
early IL-22 
Earlier results in this Chapter have suggested epidermal Notch1 and Notch2 
activities are involved and activated in skin wound healing, and treating with anti-
NRR1 or anti-NRR2 blocking antibody specifically reduces epidermal Notch1 or 
Notch2 activity in wounded mice. In this section, the individual roles of Notch1 and 
Notch2 activities in wound healing are determined by examining the wound healing 
rates in anti-NRR1 or anti-NRR2 treated mice with inhibited Notch1 or Notch2 
activity. Wildtype mince were i.p. treated with 5mg/kg of anti-NRR1, 5mg/kg anti-
NRR2 or 5mg/kg IgG control for 7 days prior to wounding, then mice were 
examined on day 2 or day 5 post-wounding. Wound closure rates were measured as a 
percentage of wound size at the time of examination to their initial size. On day 2, 
wounds treated with anti-NRR1 were significantly more open (77%; p=0.021, t-test) 
compared to control mice injected with anti-ragweed (66%) (Figure 5.4A and C). 
However, wounds treated with anti-NRR2 had similar sizes to anti-ragweed treated 
wounds (Figure 5.4 A and C). By 5 days post-wounding, wound size in anti-NRR1-
treated mice did not differ from controls, however, their wounds displayed a distinct 
phenotype: wounds were redder, with domed margins (signs of abnormal wound 
granulation), compared anti-ragweed treated control wounds (Figure 5.4 B and C). 
Anti-NRR2 treated mice were not well and thus were not determined at this time 
point. Since wounds remained larger in anti-NRR1 treated mice on day 2 post-
wounding, the key signaling in epidermal proliferation, IL-22 was quantified by 
QPCR at mRNA levels isolated from skin wounds. The IL22 mRNA levels in anti-
ragweed treated wounds were used as control and designated as 1. As can be seen in 
Figure 5.4D, IL22 mRNA levels were significantly reduced by 50% in anti-NRR1- 
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Figure 5.4 Inhibiting Notch1 activity delays wound closure.  Punch-wounded 
wild type mice injected peritoneally with 5mg/kg anti-NRR1, anti-NRR2 or anti-
ragweed control antibody for 7 days prior to injury. (A-B) Photos of skin wounds 
were taken on day 2 (A) and day 5 (B) post-wounding. Anti-NRR2 treated mice 
were not well and thus were not examined on day 5 post-wounding. (C) Wound 
openness was measured as a percent of initial wound size on day 2 and day 5 post-
wounding. Note NRR1-treated wounds were significantly more open on day 2 post-
wounding (* p=0.0210) but not on day 5. However, on day 5 wounds were redder 
with raised, domed margins compared to controls. (D) mRNA was isolated from 
wounded mice on day 2 post-wounding and IL22  levels  were quantified by QPCR. 
mRNA levels were normalised to IgG control-injected day 2 wounded mice 
(designated as 1). IL22 mRNA level was significantly reduced in anti-NRR1-
injected mice compared to the controls (* p=0.010). Graph bars represent 
experimental mean of biological replicates and error bars represent standard error of 
the mean (SEM). Statistics of normally distributed data compared by Student’s t-test. 
All experiments were repeated ≥ 2 times.   
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injected mice (p=0.010, t-test), while IL22 mRNA levels in anti-NRR2 treated 
wounds did not differ from control. These results suggest that inhibiting Notch1 
activity causes wound healing delay partly due to lack of early IL-22, and epidermal 
Notch1 activity may be required for IL22-dependent skin repair.   
 
5.2.4 IL22-producing ILC3s are recruited to dermis in a Notch1-dependent 
manner 
Since ILC3s are the main source of IL-22 in early wound on day 2 post-wounding 
(Figure 4.4), I hypothesize the reduction in IL-22 mRNA levels in anti-NRR1 treated 
early wounds (Figure 5.4D) are caused by lack of ILC3s. To test this, wildtype mice 
were i.p injected with anti-NRR1 and anti-ragweed control for 7 days prior to 
wounding, then wounded back skin tissues were collected on day 2 post-wounding. 
Cells isolated from anti-NRR1 or anti-ragweed treated wounded skin were labelled 
with antibodies to CD45 and RORγ and analyzed by flow cytometry, revealing that 
the recruitment of CD45
+
 RORγt+ cells (the majority of which are ILC3s, Figure 
3.12) as well as the total immune cell (CD45
+
) were decreased by 2.3 ± 0.2 fold 
(Mean ± SEM) in anti-NRR1 treated mice compared to anti-ragweed treated controls 
(Figure 5.5 A). Wounded skin sections from anti-NRR1 and anti-ragweed treated 
control mice were analyzed by using an antibody to RORγ, confirming ILC3 
recruitment were inhibited by anti-NRR1 treatment (Figure 5.5 B). These results 
suggest a role of Notch1 activity, probably from epidermis, in recruiting ILC3s 
which produce early IL22 and in turn promote skin repair. However, blocking Notch 
signaling could also impact ILC3 development, since Notch signaling activity within 
ILC3 is required for adult ILC3 development (Possot et al., 2011). Although 
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 Figure 5.5 Inhibiting Notch1 blocks ILC3 recruitment following wounding. 
Punch-wounded wild type mice injected peritoneally with 5mg/kg anti-NRR1, anti-
NRR2 or anti-ragweed IgG control antibody for 7 days prior to injury. Wounded 
back skin was collected on day 2 post-wounding. (A) Cells isolated from anti-IgG 
control and anti-NRR1 treated wounded skin were labelled with CD45 and RORγ 
and were analyzed by flow cytometry, confirming the ILC3s as well as total immune 
cell recruitment were dramatically reduced in anti-NRR1 treated mice on day 2 post-
wounding. One biological sample is shown, at least 3 biological samples were 
analyzed (not shown). (B)Wounded skin stained with an antibody RORγ revealed 
that the infiltration of RORγ+ cells (mostly ILC3s) was blocked in anti-NRR1 treated 
mice on day 2 post-wounding. Scale bars equal 100 microns. Asterisk marks wound 
site. Experiments were repeated ≥ 3 times. 
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blocking Notch1 alone is unlikely to influence ILC3 development (Possot et al., 
2011), to confirm if ILC3 recruitment into skin is dependent on epidermal Notch1 
signaling, uninjured back skin from K14NICDER mice carrying a ectopic functional 
fragment of Notch1 intracellular domain as well as littermate controls were topically 
treated with 4OHT for 3 days to activate ectopic Notch1 signaling specifically in 
epidermis. 4OHT treated uninjured skin sections were analyzed for ILC3 recruitment 
in skin by using an antibody to RORγt. RORγt+ cells were dramatically accumulated 
in 4OHT-treated K14NICDER dermis compared to 4OHT-treated littermate controls 
(Figure 5.6 A and B), confirming the active recruitment of ILC3s by epidermal 
Notch1 signaling. To confirm the phenotypes of these RORγt+ cells in uninjured 
skin, back skin sections from 3-day-4OHT- treated K14NICDER were co-stained 
with antibodies to RORγt together with one or two of the following antibodies to 
CD3, CD4 or CD127 (Figure 5.6 C and D). I confirmed that the RORγt+ cells 
recruited in uninjured skin by Notch1 signaling were CD3
- 
CD4
dim to + 
CD127
+ 
RORγ+ ILC3s, which is consistent with the phenotypes of ILC3s recruited in skin 
wounds. These epidermal Notch1-recruited ILC3s may also produce IL-22 in 
uninjured skin in 4OHT-treated K14NICDER mice, which could lead to epidermal 
hyper-proliferation as detected previously (Ambler and Watt, 2010; Estrach et al., 
2006). In summary, I confirmed that ILC3s are recruited to dermis in an epidermal 
Notch1-dependent manner, which is an important early source of IL-22, a key 
signaling to skin repair.  
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(B) RORrt / DAPI   4OHT treated K14NICDER   
(A) RORrt / DAPI   4OHT treated WT 
(C1) RORrt / DAPI   4OHT treated K14NICDER   
(C2) CD4 / DAPI   4OHT treated K14NICDER   
(C3) CD3 / DAPI   4OHT treated K14NICDER   
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(D1) RORrt / DAPI   4OHT treated K14NICDER   
 
(D2) CD127 / DAPI  4OHT treated K14NICDER   
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Figure 5.6 Ectopic activation of Notch1 signaling promotes ILC3 recruitment 
into uninjured skin dermis.  K14NICDER mice and wildtype littermates were 
topically treated with 4OHT for 3 days. (A-B)Skin sections from 4OHT treated 
wildtype and K14NICDER were stained with an antibody to RORγt (green, indicated 
by arrows) and counterstained with DAPI (blue). (C1-C3) show higher magnification 
view of the indicated area in (B) from 4OHT treated K14NICDER and was co-
stained with RORγt (green), CD4 (red) and CD3 (purple). Arrows indicate CD3-
CD4
+ RORγt+ cells; star marks CD3- CD4low RORγt+ cells. Counterstained with 
DAPI (blue). (D1-2) Skin section from 3-day-4OHT-treated K14NICDER mice were 
co-stained with RORγt (green) and CD127 (red) and counterstained with DAPI 
(blue). Arrows mark CD127
+
 RORγt+ cells. Scale bar equals to 100 microns. 
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5.2.5 Recruitment of monocytes/macrophages, but not of neutrophils or 
dendritic/Langerhans cells, is dependent on epidermal Notch1 signaling 
I have presented evidence in last Chapter that ILC3s promote early monocyte/ 
macrophage recruitment into wound site dermis via CCL3 (Figure 4.2), which partly 
contribute to ILC3-mediated skin repair. M2 macrophages have been considered as 
the master regulator in wound healing through switching on cytokine production of 
TGF-β that is in favor of tissue repair by inducing angiogenesis for granulation tissue 
formation and activating myofibroblast differentiation for dermal extracellular 
matrix deposition and wound contraction (Rodero and Khosrotehrani 2010). 
Therefore I hypothesize monocyte/macrophage recruitment might be impaired in 
anti-NRR1 treated wounds due to loss of ILC3s. To test this, wildtype mice were i.p. 
treated with anti-NRR1 and anti-ragweed control for 7 days prior to wounding, and 
wounded back skin tissues were collected on day 2 post-wounding. Cells isolated 
from wounded back skin from anti-NRR1 and anti-ragweed control treated mice 
were labelled with antibodies to CD11b, CD11c, F4/80 and Gr-1 and were analyzed 
by flow cytometry. To distinguish monocytes/ macrophages (CD11c
- 
CD11b
+
) from 
dermal dendritic cells (CD11c
high
 CD11b
+/-
) and Langerhans cells (CD11c
low
 
CD11b
+
), I first analyzed their expression of CD11b and CD11c, revealing the cell 
number of Langerhans cells and dermal dendritic cells were not significantly 
changed in anti-NRR1 treated mice compared to control (Figure 5.7) (p=0.29, t-test), 
while the percentage of CD11c
-
CD11b
+ 
myeloid cells including monocytes/ 
macrophages were dramatically reduced by nearly 50% in anti-NRR1 treated mice 
on day 2 post-wounding compared to wounded control (p=0.0068, t-test). Since 
dermal dendritic cells are normally recruited and reach their maximal number at this 
time-point (Figure 3.2), these results suggested that Notch1 signaling or its recruited  
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Figure 5.7 Inhibiting Notch1 activity reduces monocyte/ macrophage 
recruitment. Punch-wounded wild type mice injected peritoneally with 5mg/kg anti-
NRR1 or anti-ragweed control antibody for 7 days prior to injury. Wounded back 
skin was collected on day 2 post-wounding. Cells isolated from wounded skin were 
labelled with CD11b, CD11c, F4/80 and Gr-1 were analyzed by flow cytometry, 
revealing nomoncyte/macrophage recruitment was dramatically reduced in anti-
NRR1 treated mice on day 2 post-wounding. One biological sample is shown, at 
least 3 biological samples were analyzed (not shown). Experiments were repeated ≥ 
3 times.  
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ILC3s do not have a significant role in recruiting or replenishing 
dendritic/Langerhans cells during normal wound healing. Then I analyzed 
CD11b
+
CD11c
-
 myeloid cells, among which neutrophils (Gr-1
+
F4/80
-
), mature 
macrophages (Gr-1
-
F4/80
+
) and inflamed monocytes (Gr1
+
F4/80
+
) were 
distinguished from each other by Gr-1 and F4/80 expression. In anti-NRR1 treated 
wounds, the percentage of inflamed monocytes (p=0.0002, t-test) and mature 
macrophages (p=0.0011, t-test) to the total skin cells were both significantly reduced 
compared to anti-ragweed treated wounds, while the percentage of neutrophils to the 
total skin cells were not even increased, suggesting Notch1 activity is required for 
recruitment of monocytes/macrophages but not for neutrophils, probably through 
ILC3-mediated process (i.e. ILC3-dependent CCL3).  
 
However, recent studies have suggested Notch1 activity inside macrophages is 
required for macrophage recruitment, since Notch1
+/-
 mice had fewer macrophages 
at wound site (Outtz, et al., 2010; Outtz et al., 2011). To confirm if monocyte/ 
macrophage recruitment is dependent on epidermal Notch1 signaling through a 
ILC3-mediated process, uninjured back skin from K14NICDER mice as well as 
littermate controls were topically treated with 4OHT for 3 days to activate ectopic 
Notch1 signaling specifically in epidermis and skin sections were stained with an 
antibody to monocyte/macrophage marker F4/80 (Figure 5.8 A), revealing that 
monocytes/ monocytes were dramatically recruited to dermis in Notch1 activated 
back skin, co-related to recruitment of ILC3s. In addition, the number of epidermal 
F4/80
+
 cells was not significantly increased confirming epidermal Notch1 signaling 
has no effect on Langerhans cell self-proliferation or expansion. Since some dermal 
dendritic cells also express F4/80, to confirm the vast majority of accumulated  
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Figure 5.8 Ectopic activation of epidermal Notch1 activity results in 
monocyte/macrophage recruitment in uninjured skin dermis, but has no 
evident effects on neutrophils or dendritic/Langerhans cells.  K14NICDER mice 
and wildtype littermates were topically treated with 4OHT for 3 days. (A)Skin 
sections from 4OHT treated wildtype and K14NICDER were stained with an 
antibody to F4/80 (green) and counterstained with DAPI (blue). (B) Skin sections 
from 4OHT treated K14NICDER were stained with antibodies to F4/80 (green), 
CD11c (red) and counterstained with DAPI (blue). (C)  Skin sections from 4OHT 
treated wildtype and K14NICDER were stained with an antibody to Gr-1 (green) and 
counterstained with DAPI (blue). Arrows mark positive cells. Scale bar equals to 100 
microns. 
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F4/80
+
 cells were in deed monocytes/ macrophages, 3 day-4OHT-treated 
K14NICDER back skin sections were co-stained with F4/80 and CD11c. As 
expected, CD11c
hgih
 dermal dendritic cells, unlike monocytes/ macrophages, were 
not accumulated in Notch1 activated uninjured skin (Figure 5.8B). Similarly, Gr-1
+
 
neutrophils were not accumulated in uninjured skin with ectopic epidermal Notch1 
signaling (Figure 5.8C). Taken together, these results suggest that the recruitment of 
monocytes/macrophages but not of neutrophils or dendritic/Langerhans cells into 
skin is dependent on epidermal Notch1 signaling, probably through ILC3-mediated 
process. 
 
5.2.6 Notch1 signaling has no significant effect on NK cell recruitment 
Since a small number of NK cells are normally recruited into skin wounds early on 
day 2 post-wounding (Figure 3.10), to determine if Notch1 signaling has a role in 
NK cell recruitment upon wounding, wildtype mice were i.p. treated with anti-NRR1 
and anti-ragweed control for 7 days prior to wounding, then wounded back skin 
tissues were collected on day 2 post-wounding. Cells isolated from wounded back 
skin from anti-NRR1 and anti-ragweed control treated mice were labelled with 
antibodies to CD3, NK1.1 and were analyzed by flow cytometry (Figure 5.9), 
revealing Notch1 activity has no significant effect on NK (CD3
-
 NK1.1
+
) (p=0.057, 
t-test) or NKT (CD3
+
 NK1.1
+
) cell recruitment. 
 
5.2.7 Epidermal Notch1 signaling may have a role in regulating maintenance of 
dendritic epidermal T cells 
Dendritic epidermal T cells (DETCs), a specialized γδ T cells residing in rodent 
epidermis and uniquely expressing invariant TCR Vγ3 (MacLeod and Havran, 2011),  
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              Control  2 days post-wounding              NRR1 2 days post-wounding 
  
 
Figure 5.9 Inhibiting Notch1 activity has no significant effects on NK cell 
recruitment. Punch-wounded wild type mice injected peritoneally with 5mg/kg anti-
NRR1 or anti-ragweed control antibody for 7 days prior to injury. Wounded back 
skin was collected on day 2 post-wounding. Cells isolated from wounded skin were 
labelled with NK1.1 and CD3 and were analyzed by flow cytometry, revealing NK/ 
NKT cell recruitment was not significantly changed in anti-NRR1 treated mice on 
day 2 post-wounding. Shown one biological sample, at least 3 biological samples 
were analyzed (not shown). Experiments were repeated ≥ 3 times.  
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have been reported to be critically important for skin wound healing by producing 
IGF-1 and KGF for epidermal keratinocyte proliferation and by promoting 
macrophage migration via hyaluronan (Jameson et al., 2002; MacLeod and Havran, 
2011). However, DETCs were down-regulated in early wounds on day 2 post-
wounding (Figure 3.7 and Figure 3.8) and were replenished via a currently 
undetermined mechanism (Jameson and Havran, 2007; MacLeod and Havran, 2011) 
in later wounds on day 5 post-wounding (Figure 3.7 and Figure 3.8), suggesting they 
may only play their roles in wound healing at later stage and thus are not of our main 
interest. Furthermore, the interpretation of epidermal Notch1 effects on T cell 
recruitment or replenishment in anti-NRR1 treated mice is complicated since the role 
of Notch1 signaling has been well established in T cell development in thymus (Izon 
et al., 2001; Robey et al., 1996). Nevertheless, unexpectedly, a dramatically 
increased clonal expansion of Vγ3+ CD3+ T cells was detected following epidermal 
Notch1 signaling activation in 4OHT treated K14NICDER skin. Cells isolated from 
7-day 4OHT-treated K14NICDER and wildtype littermate control ear skin were 
stained with antibodies to CD45, CD3, TCRβ and Vγ3 and were analyzed for 
DETCs (CD45
+
CD3
+TCRβ-Vγ3+) and other T cell subsets, such as αβ T cells 
(CD45
+
CD3
+TCRβ+Vγ3-) and dermal γδ T cells (CD45+CD3+TCRβ-Vγ3-). I 
detected a 3 to 4 -fold increase in DETCs population while αβ T cells and dermal γδ 
T cells did not differ from 4OHT treated wildtype controls (Figure 5.10 A). Back 
skin sections from 3-day 4OHT treated K14NICDER and wildtype control mice 
were stained with an antibody to CD3, revealing T cells were dramatically 
accumulated in 4OHT treated K14NICDER dermis (Figure 5.10 B). I concluded that 
these T cells accumulated in 3-day 4OHT treated K14NICDER dermis might be the 
precursors of DETCs, which would eventually migrate to epidermis to replenish  
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Figure 5.10 Ectopic activation of Notch1 activity causes the expansion of 
epidermal dendritic T cell.  (A) Ears of K14NICDER mice and wildtype littermates 
were topically treated with 4OHT for 7 days.  Cells isolated from 4OHT treated ears 
were labelled with CD45, CD3, TCRβ and Vγ3 and were analyzed by flow 
cytometry, suggesting the number of epidermal dendritic cells (DETCs) were 
significantly increased in 4OHT treated K14NICDER ears.  (B) Back skin of 
K14NICDER mice and wildtype littermates were topically treated with 4OHT for 3 
days. Back skin sections were stained with antibodies to CD3 (green), and 
counterstained with DAPI (blue). Arrows mark CD3+ cells in dermis, the majority of 
which were probably the precursors of DETCs or migratory DETCs to lymph nodes. 
Scale bar equals to 100 microns. 
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DETCs and cause clonal expansion of DETCs as detected in 7-day 4OHT treated 
K14NICDER skin. However, since there might be some differences in the 
distribution of immune cells between ear skin and back skin, further experiments are 
needed to confirm the role of Notch signaling in DETC maintenance. These results 
uncover a possible mechanism of DETC maintenance regulated by epidermal Notch1 
signaling through recruiting precursors of DETCs from circulating γδ T cells.  
 
5.3 Summary 
In this chapter, I presented evidence that Notch1 and Notch2 activities are 
immediately and robustly activated upon skin injury predominantly in epidermal 
keratinocytes. Interestingly, activated Notch1 levels are correlated with the number 
of immune cell accumulation at the wounded skin. By seven days post-wounding, 
during the remodeling phase when the epidermis has almost closed (Figure 3.1B) 
(Shaw et al., 2009) and there is very low risk of pathogen infection, Notch activity 
and immune cell number returns unwounded to skin levels (Figure 3.1 G and Figure 
5.1A). By using chemical tools including blocking antibodies specific to Notch1 or 
Notch2 receptor, I have shown that inhibition of Notch1 inhibits wound closure, 
ILC3 recruitment, and correspondingly IL22 production and  monocyte/macrophage 
recruitment, while inhibition of Notch2 did not differ from the controls, suggesting 
Notch1 signaling has an indispensable role in promoting skin wound healing 
especially at early stage by recruiting ILC3s that produce IL-22 for epidermal 
proliferation and facilitate the recruitment of monocytes/macrophages to the wound 
site. I further confirmed that these Notch1-regulated immune responses in skin 
wound healing is specifically dependent on epidermal Notch1 signaling by using 
genetic tools including a transgenic mouse (K14NICDER) where Notch can be 
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controllably activated specifically in the epidermis by 4OHT drug application. In 
conclusion, epidermal Notch1 signaling promotes skin wound healing through ILC3-
mediated process. However, since all 4 Notch receptors have been detected in skin, 
and Notch2 activity is increased upon wounding, it may be possible that the other 
Notch receptors play redundant roles or contribute to other aspects in skin wound 
healing.  
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Chapter 6 Mechanism of how epidermal Notch1 regulate ILC3s 
6.1 Introduction 
In last chapter, I have presented evidence that epidermal Notch1 signaling promotes 
skin wound healing through recruiting ILC3s, the key roles of which in wound 
healing have been determined in Chapter 4. In this chapter, I will investigate the 
mechanism of how Notch1 regulates ILC3s in terms of recruitment and activation.  
The cell-autonomous role for Notch signaling in determining the fate of cells 
expressing a Notch receptor within both adaptive and innate immune systems has 
been well established (Radtke et al., 2013). However, how epidermal keratinocytes 
Notch receptor activity regulates immune cell may be different from some of the 
currently established mechanisms, and may be rely on cytokines and chemokines 
soluble factors (Ambler and Watt, 2010). Using 4OHT-treated K14NICDER mouse 
model where Notch1 signaling can be controllably and specifically activated in 
epidermis, 4 key cytokine or chemokine candidates, including TNFα, CCL20, 
CXCL13 and IL23, have been identified by micro-array (NIH GEO:GSE 782, 
Ambler and Watt, 2008; NIH  GEO: GSE29777, Reynders et al., 2011) as Notch-
regulated factors that can function on ILC3s through their cell surface receptor, such 
as TNF receptor superfamily (TNFRSF), CCR6, CXCR5 and  IL12 receptor beta1 
subunit (IL12RB1) / IL23 receptor (IL23R) respectively. Among these factors, IL23 
have been determined to be largely expressed by dendritic/Langerhans cells (Figure 
4.5) and required for IL22 production by ILC3s for epidermal proliferation (Figure 
4.5 and Figure 4.6). To test the roles of the rest factors in recruiting ILC3s, each 
factor was blocked either by genetic or chemical tool in mice prior to wounding, then 
the number of ILC3s recruited in the wound site as well as the wound healing rate 
were examined. I found CXCL13
-/-
 mice had normal ILC3 recruitment and normal 
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healing rate, suggesting CXCL13 is not required for ILC3 recruitment in skin. 
Strikingly, I found both the number of ILC3s infiltrating in wound site and the 
wound closure rate were co-related with the level of TNFα by applying chemical 
drug recombinant TNFα or TNFα antagonist (Adalimumab) to the wound, 
suggesting TNFα is a key cytokine required for ILC3 recruitment. However, since 
TNFα, as a cytokine, usually acts transiently and in a relatively short range, other 
soluble factors are required to transmit this signaling. By stimulating dermal 
fibroblasts with TNFα, I demonstrated that CCL20 and IL22 can be expressed by 
dermal fibroblasts. I conclude that epidermal Notch1 regulates ILC3 recruitment in a 
mechanism dependent on TNFα/ CCL20. However, due to the availability of CCL20 
genetic or chemical tools, we were not able to directly demonstrate the role of 
CCL20 regulates ILC3 recruitment.    
 
6.2 Results 
6.2.1 Epidermal Notch1 up-regulates cytokine and chemokine production, 
including TNFα, CCL20, CXCL13 and IL-23.  
Previously, our lab has shown that Notch activity, via jagged1, stimulates epidermal 
production of pro-inflammatory TNFα (Ambler and Watt, 2010). To investigate the 
mechanism by which Notch1 leads to ILC recruitment, dermal and epidermal gene 
expression profiles of 10-day 4OHT treated, uninjured K14NICDER transgenic 
mouse back skin (NIH GEO:GSE 782, Ambler and Watt, 2008) were examined. 
Ingenuity Pathway Analysis software was used to identify secreted factors up-
regulated in 4OHT-treated K14NICDER skin (6x or greater) that could facilitate 
immune cell infiltration into the dermis and the subsequent activation. Analysis 
identified seven key candidates (Figure 6.1) (4 epidermal: IL-23(10.3x), 
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Figure 6.1 Ingenuity Pathway Analysis of secreted factors that can interact with 
receptors expressed on ILC3s (RORγt+ ILCs). (A) Factors expressed by epidermis. 
(B) Factors expressed by dermis. (NIH GEO: GSE 782, Ambler and Watt, 2008; 
NIH GEO: GSE29777, Reynders et al., 2011) 
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TNF-α (17.1x), CXCL12 (8.0x), CCL20 (14.1x) and 3 dermal: CXCL13 (6.5x), 
FGF23 (5.4x), neurexophilin-1 (6.0x) that could regulate innate immune cell 
recruitment and activation (NIH  GEO: GSE29777, Reynders et al., 2011). Of these 
Notch-regulated factors TNFα, CCL20, CXCL13 and IL23 were of particular 
interest as these factors regulate ILC3s through cell surface receptor TNF receptor 
superfamily (TNFRSF), CCR6, CXCR5 and  IL12 receptor beta1 subunit (IL12RB1) 
/ IL23 receptor (IL23R) respectively (Marchesi et al., 2009).  
 
6.2.2 CXCL13 is not required for ILC3 recruitment 
It has been reported that CXCL13 expression in the gut promotes accumulation of 
ILC3s and formation of isolated lymphoid follicles (Marchesi et al., 2009). To test if 
CXCL13 expression in skin also promotes ILC3 recruitment, CXCL13
-/- 
mice and 
wildtype littermate controls were wounded and the number of ILC3s recruited into 
wound site and wound healing rate were examined. Surprisingly, CXCL13
-/- 
mice 
did not show evident wound healing defects and no difference in ILC3 recruitment 
was detected in wounded skin sections between CXCL13
-/- 
mice and littermate 
controls by using an antibody to RORγ (Figure 6.2 and data not shown), suggesting 
CXCL13 is not required for ILC3 recruitment in wound healing. However, it may 
play a redundant role in recruiting ILC3s.   
 
6.2.3 Notch regulated factor TNFα mediates ILC3 recruitment 
To confirm that TNFα mediates ILC3 recruitment, wildtype mice were punch-
wounded and then treated with recombinant TNFα, TNFα antagonist (Adalimumab)  
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Figure 6.2 CXCL13 is not required for ILC recruitment into skin wounds. (a, b) 
Sections of wounded back skin 5 days post injury from CXCL13
-/- 
(B) and wild type 
(WT) control mice (A). Antibody labelling of RORγ (green) and DAPI 
counterstained (blue). No difference in ILC recruitment in CXCL13
-/-
 wounds; 
asterisk marks site of wound; scale bars equal 100 microns; arrows mark positive 
cells in dermis; experiments were repeated ≥ 2 times. 
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(Calabrese 2003) or PBS daily. By day 5 post-wounding, a substantial difference 
was observed between the three groups of mice (Figure 6.3): TNFα accelerated 
wound closure and ILC3 recruitment (1.8x), while the antagonist inhibited wound 
closure and ILC recruitment (0.4x). Moreover, injection of adalimumab for 7 days 
prior to 4OHT-activation of Notch in unwounded K14NICDER transgenic mice 
blocked Notch-mediated ILC recruitment into the skin (Figure 6.4) confirming that a 
Notch/TNFα mechanism recruits of ILC3s in to the skin dermis. 
 
6.2.4 TNFα regulates ILC3 recruitment by inducing CCL20 expression in 
dermal fibroblasts  
I have determined that Notch-regulated factor TNFα has a key role in recruiting 
ILC3s, however, as a cytokine, TNFα action is transient and usually short range and 
thus is not present in blood circulation (Delves et al., 2011). Therefore, TNFα may 
have to play its role in recruiting ILC3s through other soluble molecules (e.g. 
chemokines) which usually act in a longer range (Delves et al., 2011). Since TNFα 
can direct CCL20 expression in the skin (Tohyama et al., 2001), a key recruitment 
factor for
 
ILC3s in lymphoid tissues, I hypothesize TNFα regulates ILC3 recruitment 
by inducing CCL20 expression in skin. CCL20 mRNA levels were measured 4, 8, 
16, 24 and 40 hours after injury by QPCR and CCL20 levels were elevated 
immediately following wounding and returned to background levels by 24 hours post 
injury (Figure 6.5A) and were sustained at low levels 48-72 hours (Figure 6.5B) 
post-wounding in a TNFα-dependent process (Figure 6.5C, data collected by 
Rebecca Lamb). Primary dermal cells were treated with TNFα for 6 hours in vitro 
leading to increased CCL20 expression (13x) (Figure 6.5C, data collected by  
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Figure 6.3 Notch-regulated factor TNFα regulates ILC3 recruitment and 
activation. (A) Punch wounds treated with PBS (vehicle), TNFα or 
antagonist (Adalimumab) were photographed on day 2 and day 5 post-wounding. 
Note red, inflamed tissues were evident adjacent to TNFα-treated day 2 wounds. 
Experiment repeated twice (
antagonist; n = 8 TNF). (B)  RORγt (green) antibody stained back skin sections from 
punch-wounded mice treated with PBS (control), TNFα or TNFα antagonist 
(Adalimumab) collected 2 days post-wounding. DAPI counterstained. Positive cells 
are marked by white arrows. Asterisk marks wound site; scale bars equal 100 
microns. (C) Quantification of dermal RORγ+ cells in wounded back skin from mice 
treated with vehicle, TNFα or TNFα antagonist on day 2 post-wounding (n = 3 
control; n = 5 TNFα antagonist; n = 5 TNFα. Sample number equals biological 
replicates; quantified area < 1600 micrometres distal to wound site). Error bars 
represent standard error of the mean (SEM).  
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Figure 6.4 TNFα antagonist (Adalimumab) blocks Notch1-induced ILC3 
recruitment. Uninjured K14NICDER transgenic mice treated with PBS  or  
Adalimumab  for  7  days  followed  by  2  days  of  4OHT -treatment to activate  the  
transgene. Skin sections were stained with an antibody to RORγ (green) and 
counterstained with DAPI. Positive cells are marked by white arrows. Asterisk 
marks wound site; scale bars equal 100 microns. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
203 
 
 
 
 
A 
C 
B 
 
204 
Figure 6.5   CCL20 are immediately produced in skin wounds and can be 
expressed by dermal fibroblasts after stimulation by TNFα. (A) mRNA levels of 
CCL20 quantified by quantitative RT-PCR in unwounded and wounded back skin 4, 
8, 16, 24 and 40 hours post-wounding. mRNA levels were normalised to unwounded 
skin. (B)  mRNA levels of CCL20 quantified by quantitative RT-PCR in wounded 
back skin 8, 24 or 72 hours post-wounding. mRNA levels were normalised to 
unwounded skin (designated as 1). (C) mRNA levels of CCL20 quantified by QPCR 
in primary dermal cells treated in vitro with TNFα or TNFα Adalimumab for 6 
hours. mRNA levels were normalised to vehicle-only treated cells. Experiment 
repeated twice. Graph bars represent experimental mean of technical replicates (n = 
3) and error bars represent standard error of the mean (SEM). 
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Rebecca Lamb). Taken together these results show that activating the TNFα pathway 
either chemically or via Notch activation resulted in a correspondingly increased 
CCL20 expression in dermal fibroblasts linking TNFα to ILC3 recruitment.  
 
6.2.5 Epidermal Notch1 signaling might stimulate Langerhans cells to secrete 
IL23 that is required for ILC3s as well as dermal fibroblasts to produce IL22 
Previous studies suggested IL23 is required for ILCs to secrete IL22 in intestine 
(Sonnenberg et al., 2011). I have also determined that Langerhans/ dendritic cells are 
the main source of IL23 that is required for IL-22 production by ILC3s as well as 
other IL22-producing cells including non-lymphocytes in skin (Figure 4.4), although 
the candidate cell types which produce IL22 at skin wounds at later stage in the 
absence of ILC3 or T have not been determined. Since we have determined dermal 
fibroblasts can express CCL20 upon stimulated by TNFα, I hypothesize fibroblasts 
might be able to produce IL-22 as well in certain conditions. To test this, we used 
recombinant TNFα to stimulate primary dermal cells (Figure 6.6) and confirmed 
dermal fibroblasts have the capability to produce IL22. 
 
Since Langerhans cells are at least 4-fold more abundant than dermal dendritic cells 
at all stages of wound healing (Figure 3.2 and Figure 5.7), and epidermal Notch1 
induced IL23 expression are most significantly detected in epidermis (NIH 
GEO:GSE 782, Ambler and Watt, 2010), it is logical to deduce that epidermal 
Notch1 might activate Langerhans cells to secrete IL-23. However, we cannot 
exclude that some other cell types may also express IL23 following Notch activation,  
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Figure 6.6 IL-22 can be produced by dermal fibroblasts after stimulation by 
TNF-α. mRNA levels of IL22 in primary dermal cells treated with vehicle control, 
TNF-α, TNF-α antagonist (adalimumab) or both TNFα, adalimumab. TNF-α 
treatment induces IL22 expression in dermal fibroblasts.  Experiment repeated twice. 
mRNA levels were normalised to vehicle-only treated cells. Graph bars represent 
experimental mean of technical replicates (n = 3) and error bars represent standard 
error of the mean (SEM). 
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and epidermal Notch1 signaling does not appear to have a significant role in 
Langerhans cell number expansion as suggested by no change in epidermal F4/80
+
 
cell number in 4OHT-treated K14NICDER back skin (Figure 5.8). Taken together, 
these results suggest epidermal Notch1 signaling might stimulate Langerhans cells to 
secret IL23 that is required for ILC3s as well as dermal fibroblasts to produce IL22 
 
6.3 Summary 
In this chapter, using genetic and chemical tools including CXCL13
-/- 
mice and 
recombinant TNFα or TNFα antagonist (Adalimumab), I analyzed the effects of 
blocking the key Notch-regulated soluble factors that are known to function on 
ILC3s through their respective cell surface receptor, suggesting epidermal Notch1 
signaling recruits ILC3s in a mechanism dependent on TNFα/ CCL20, and activates 
ILC3s and dermal fibroblasts to produce IL22 by inducing epidermal expression of 
IL23 probably by Langerhans cells.  
 
However, due to the availability of genetic and chemical tools on targeting CCL20, 
we do not have direct evidence suggesting CCL20 recruits ILC3s through CCR6. I 
demonstrated that Notch1 stimulation of TNFα directly regulates CCL20 in 
wounded skin. However, although CCL20 expression is very rapidly expressed and 
it is transcriptionally down-regulated within 24-hours of wounding suggesting other 
factors in addition to TNFα tightly control CCL20 expression. CXCL13 is expressed 
in the wound site (data not shown) and might contribute to ILC3 recruitment and 
retention, however analysis of CXCL13 deficient mice show no evident defects in 
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wound healing or dermal ILC recruitment indicating that CXCL13 is either 
redundant or not key in this process.   
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Chapter 7   Discussion 
The normal wound healing is a highly coordinated process consisting of three 
sequential and overlapping phases: inflammation, proliferation and remodeling 
(Table 7.1) (Guo and DiPietro, 2010). The postponed, incomplete, or uncoordinated 
healing process usually causes pathologic inflammation, leading to delayed acute 
wounds or chronic wounds like ulcers. Non-healing wounds are associated with   
diabetes and other diseases, affecting about 3 to 6 million people in the United 
States, especially the elderly people (Mathieu et al., 2006). Treating and caring of 
these non-healing wounds cost more than 3 billion dollars per year according to 
estimation (Mathieu et al., 2006). Better understanding of how wound healing is 
regulated will help us to find a more efficient and economic solution for the delayed 
or non-healing wounds.  
 
In this thesis, I first analyzed normal immune responses in wound healing by using a 
surgical wounding mouse model. Consistent with previous results, I found that 
monocytes/ macrophages are the predominant immune cells residing in unwounded 
skin and infiltrating in wounded skin, and are recruited early into wound site at 
approximately day 2 post-wounding (Figure 3.2; Figure 3.6), while γδ T cells 
including dendritic epidermal T cells are dramatically replenished at later stage 
approximately from day 5 post-wounding (Figure 3.7; Figure 3.8), confirming these 
cells are heavily involved in normal skin wound healing and important for this 
process (Delavary et al 2011; Dupasquier et al 2004; Havran and Jameson 2010;  
Jameson et al, 2002; Jameson and Havran 2007; Rodero and Khosrotehrani 2010; 
Stout 2010). However, I am the first to Group 3 demonstrate innate lymphoid cells  
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Normal skin wound healing process 
Phase Major cellular events  
Inflammation 1. Neutrophil recruitment and infiltration 
 2. Innate lymphoid cell recruitment and infiltration 
 3. Monocyte recruitment, infiltration and differentiation 
into macrophage 
 4. Epidermal dendritic T cell replenishment 
Proliferation 1. Keratinocyte division  
    (re-epithelialization, epidermal proliferation) 
 2. Fibroblast differentiation into myofibroblast  
    (dermal collagen synthesis, wound contraction) 
 3. Vascular endothelial cell division 
     (granulation tissue formation) 
Remodeling  1. Vascular endothelial cell apoptosis  
    (granulation tissue repression) 
 2.  Dermal collagen type switch 
 
Table 7.1 Major cellular events of normal skin wound healing process. 
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(ILC3s) which were only identified in lymphoid tissues and some other epithelial 
tissues such as intestine, are recruited into skin wound site early on day 2 post-
wounding and  continue to infiltrate the wounded skin on day 5 post-wounding, and  
participate in normal skin wound healing.  I have determined that the phenotypes of 
these ILCs are CD45
+RORγt+CD3-CD127dim to +CD4dim to +CD117-NKp46-, which 
belong to Group 3 ILCs (ILC3), but are different from current subsets identified in 
other sites. Although RORγt is also reportedly expressed by some dermal γδ T cells 
(Gray et al., 2011), I confirmed that the vast majority (> 90%) of RORγ+ cells at 
wound site are non-T cells (CD3
-
) and thus are ILCs.  
 
I then analyzed the function of these ILC3s in skin wound healing. I have shown loss 
of ILC3 causes severely delayed wound healing partly due to lack of early IL22-
dependent epidermal proliferation and early CCL3-dependent monocyte/macrophage 
recruitment during wound healing, while transfer of ILC3 to the recipients inhibits 
the wound pathology. Furthermore, I have demonstrated IL23 signaling from 
localized dendritic/Langerhans cells is required for the production of IL22 in ILC3.  
Thus I suggest that ILC3 play key roles in skin repair through promoting epidermal 
proliferation via supplying early IL22 which is dependent on IL23 secreted by 
dendritic/ Langerhans cells and recruitment of monocytes/ macrophages via 
supplying early CCL3, which is consistent with previous studies on the role of ILC3s 
in tissue repair in thymus and intestine through IL-22 (Dudakov et al., 2012; 
Sonnenberg et al., 2012). Given the new evidence that IL22 receptorα is also 
expressed by dermal fibroblasts (McGee et al., 2013), IL-22 may have roles in both 
epidermal and dermal compartment and thus may be a key signaling to skin repair. 
However, I am the first to uncover a role of ILC3 in regulating monocyte/ 
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macrophage recruitment via CCL3. The recruitment of  monocytes/ macrophages are 
reportedly unrelated to the resident macrophages (MacDonald et al., 2010) and are 
thought to be partly regulated by neutrophils via an array of cytokines including 
CCL3 (Amulic et al., 2012). However, in our models neutrophil infiltration is not 
affected by absence of ILC3, confirming ILC3 has a specific role in regulating early 
macrophage/ monocyte recruitment into wound site via CCL3. Increasing evidence 
has shown that macrophages in wounds have complex phenotype in different stages 
of healing: in the initial inflammation phase (1 day post-wounding) (Daley et al., 
2010), the majority of macrophages are classically activated by interferon-γ (IFN-γ) 
(M1 macrophages) to perform extensive phagocytosis to clear wound of any debris 
including the short-life neutrophils and secrete pro-inflammatory cytokines such as 
TNF-α, IL-1β, IL-6 (Rodero and Khosrotehrani, 2010), while as the healing 
progresses M1 macrophages are converted to M2 macrophages which are activated 
by distinct cytokines (alternatively activated), thought to be IL4 and IL13, and play a 
key role in inflammation resolution and tissue repair (e.g. granulation tissue 
generation, dermal extracellular matrix deposition and wound contraction) via 
producing TGF-β (Delavary et al., 2011; Martin and Leibovich, 2005; Rodero and 
Khosrotehrani, 2010). However, the timing of macrophage phenotype conversion 
and the cytokines involved in this conversion are currently less clear (Daley et al., 
2010). I propose that the skin resident macrophages may display M1 phenotype to 
undertake phagocytosis, while ILC3-recruited macrophages may exert M2 
phenotype to provide an early signaling for tissue repair. However, further 
experiment to analyze the macrophage activation cytokines is required to confirm 
this. 
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More strikingly, I have demonstrated that epidermal Notch1 signaling promotes 
wound healing through an ILC3-mediated process. Previous studies suggested that 
Notch is implicated in wound healing by using topically-applied Notch activator and 
inhibitor, however, the mechanistic detail or the site of action was unknown (Ambler 
and Watt, 2010; Chigurupai et al., 2007; Estrach et al., 2006).  Using surgical 
wounding mouse models, I have shown that both Notch1 and Notch2 activities are 
robustly activated in wound edge skin predominately in epidermal keratinocytes after 
injury. Using chemical and genetic tools including blocking antibodies specific for 
Notch1 or Notch2 (Wu et al., 2010) and a transgenic mouse (K14NICDER) where 
Notch1 can be controllably activated in the epidermis by 4OHT drug application, I 
have shown that Notch1 signaling from non-immune cells (i.e. epidermal 
keratinocytes) rather than from immune cells has an essential temporal role in the 
wound healing process via regulating wound immune responses specifically 
recruiting ILC3 and monocytes/ macrophages, and inhibition of Notch1 inhibits 
wound closure (Figure 5.4). Since I have demonstrated ILC3 recruits monocytes/ 
macrophages via CCL3 in Chapter 4, I propose epidermal Notch1 signaling 
indirectly promotes macrophage/ monocyte recruitment through ILC3-dependent 
CCL3. This is partly supported by recent studies where Notch1
+/-
 mice had fewer 
macrophages in wound site (Outtz, et al., 2010; Outtz et al., 2011), although the 
authors concluded these defects in macrophage recruitment and inflammatory 
response are caused by lack of Notch1 activity within macrophages, without giving 
further evidence to show the sites of Notch activity in normal wound healing. 
However, in our wounding model, Notch1 activity is hardly detectable in dermal 
compartment where massive immune cells are normally infiltrating suggesting loss 
of Notch1 signaling from epidermal compartment was likely to cause decreased 
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macrophage response in Notch1
+/-
 mice. I have uncovered a novel connection 
between Notch signaling in epithelium and initiation of the immune response, which 
would become an important paradigm in understanding epithelial tissue repair and 
homeostasis. The capacity of ectopically activated epidermal Notch1 signaling to 
recruit ILC3 in unwounded skin, suggesting ILC3 recruitment is dependent on 
neither pathogen stimulation nor pattern recognition receptor. However, all 4 Notch 
receptors are expressed in skin epithelial, therefore it will be interesting to determine 
if other Notch receptors have a contributing role in other aspects in wound healing. 
 
Finally, I demonstrated the mechanism of how epidermal Notch1 recruits ILC3s and 
regulates their function during skin repair. I have shown that epidermal Notch1 
signaling stimulates epidermal production of TNFα which controls ILC3 recruitment 
to the wound site partly through inducing CCL20 synthesis in dermal fibroblasts, and 
induces IL23 production (Figure5.1; NIH GEO: GSE 782, Ambler and Watt, 2008) 
probably by Langerhans cells which together with dermal dendritic cells have been 
demonstrated as the main source of IL23 in skin wounds (Figure 4.5) in order to 
activate ILC3 to function through IL22 production. Interestingly, I have shown 
dermal fibroblasts also have the capacity to secrete IL22 following stimulation by 
TNFα (Figure 6.6) and may compensate for the absence of ILC3 to supply IL-22 in 
later stage of wound healing (Figure 4.4). Given the evidence showing fibroblasts are 
the key candidate phagocytes in the absence of macrophage during wound healing 
(Martin et al., 2003) and responsive to IL22 signaling (McGee et al., 2013), I suggest 
dermal fibroblasts are a versatile candidate playing roles in a wide range of events 
during wound healing.   
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In conclusion, I uncovered that the classic developmental signal Notch directs innate 
immune response after skin damage. The skin wounding activates Notch pathway 
robustly in epidermal keratinocytes (Figure 7.1). This injury induced Notch1 activity 
up-regulates epidermal cytokine TNFα, which induces CCL20 in fibroblasts, and 
recruits innate lymphoid cells (i.e. ILC3) to the wound site. ILC3 at the wound site 
are activated by Notch-stimulated production of IL23 from Langerhans cells to 
produce early IL22 and CCL3 which subsequently promotes epidermal proliferation 
and monocyte/ macrophage recruitment, two key events in normal skin wound 
healing programme. Thus we propose that epidermal Notch1 signaling acts as a 
damage “sensor” transmitting a “stress/injury signal” instigating skin repair through 
an ILC mediated process. This signaling may be conserved among different 
epithelial tissues in the body playing a key role in tissue homeostasis and repair. 
 
However, the cytokines and chemokines were only determined and compared at 
mRNA levels in this thesis. There might be some proportion of cytokines or 
chemokines that are preformed and secreted by cells after activation, for example, 
the preformed TNF-α can be released by skin mast cells via degranulation (Gibbs et 
al., 2001), and this might not be reflected in mRNA levels. Further studies using 
intracellular staining by flow cytometry or protein assay (e.g. enzyme-linked 
immunosorbent assay, ELISA) are required to determine both newly generated and 
preformed cytokines and chemokines. In addition, I did not find a direct link 
between TNF-α and CCL20 in skin wound healing context. Further studies using 
recombinant TNF-α or TNF-α antagonist at early hours in wounded mice are 
required to confirm CCL20 is regulated by TNF-α. In this thesis, CD3, CD4, CD117, 
CD127, NKp46 were RORγ were used to characterize the phenotypes of ILC3s, 
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however, more ILC3 markers such as CCR6 (receptor for CCL20), CD25 and CD90 
may need to be tested to confirm the phenotypes and subsets of ILC3s in skin 
wounds preferably using flow cytometry. Since CD11c
Cre
Rosa
DTR
 mice deficient in 
Langerhans and dendritic cells had poorly wound healing, specific depletion of skin 
Langerhans cell by using DT treated Langerin
Cre
Rosa
iDTR 
mice would be our next 
interest to examine their wound healing rate and cytokine production (e.g. IL-23, IL-
22), and compare them to DT treated CD11c
Cre
Rosa
iDTR
 as well as wildtype wounds. 
This future study would confirm whether Langerhans cells or skin conventional 
dendritic cells had a more critical role in producing IL-23 that activates ILC3 
functioning on wound healing. 
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Figure 7.1 Notch1 orchestrates wound healing through control of Innate 
Lymphoid Cells (i.e. ILC3s). Skin wounding activates Notch pathway (orange 
cells) in the basal and suprabasal epidermis. Injury induced Notch1 activity 
upregulates TNFα (TNF), which induces CCL20 in fibroblast cells (grey cells), and 
recruits ILC3s (green cells) to the wound site. ILCs at the wound site are activated 
by Notch-stimulated production of IL23 to produce IL22 and CCL3 (MIP1α) which 
subsequently influence epidermal proliferation and macrophage (Mϕ) recruitment, 
two key events in the skin wound-healing programme.  
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